amoxicillin has been researched along with omeprazole in 1254 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (0.16) | 18.7374 |
| 1990's | 474 (37.80) | 18.2507 |
| 2000's | 628 (50.08) | 29.6817 |
| 2010's | 127 (10.13) | 24.3611 |
| 2020's | 23 (1.83) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Hibi, T; Muraoka, H; Nishizawa, T; Suzuki, H | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Rune, S | 1 |
| Börsch, G; Labenz, J | 2 |
| Börsch, G; Gyenes, E; Labenz, J; Rühl, GH | 4 |
| Adamek, RJ; Birkholz, S; Opferkuch, W; Ricken, D; Rühl, GH; Wegener, M | 1 |
| Bär, W; Gebel, M; Haruma, K; Lange, P; Müller, MJ; Schorn, T; Soudah, B; Varrentrapp, M; Wagner, S | 1 |
| Gad, A; Gnarpe, H; Olsson, J; Unge, P | 1 |
| Höglund, P; Paulsen, O; Walder, M | 1 |
| Avunduk, C; Coughlin, B; Hampf, F; Navab, F | 1 |
| Becker, T; Börsch, G; Köhl, H; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B | 2 |
| Dettmer, A; Domschke, W; Fenner, T; Gregor, M; Hesse, P; Holtmann, G; Miederer, SE; Schentke, KU; Schütz, E; van Husen, N | 1 |
| Contreras, L; Giglio, M; Hoffenberg, P; Ossa, P; Reyes, V; Weitz, JC | 1 |
| Borchard, F; Goerz, G; Megahed, M; Reinauer, H; Reinauer, S; Ruzicka, T; Susanto, F | 1 |
| Ogura, K; Ota, S; Shimada, T; Terano, A | 1 |
| Fujita, N; Hisano, K; Kobayashi, T; Kurokawa, I; Ochiai, T; Sugiyama, T; Yabana, T; Yachi, A | 1 |
| Arai, H; Furuta, T; Futami, H; Hanai, H; Kaneko, E | 1 |
| Asaka, M; Kagaya, H; Katagiri, M; Katoh, M; Kudoh, M; Takeda, H | 1 |
| Itoh, H; Nakata, H; Nishioka, S | 1 |
| Harasawa, S; Kobayashi, H; Kurumada, T; Miwa, T; Ohta, U; Shirai, T; Takagi, A | 1 |
| Fukuda, Y; Okui, M; Shimoyama, T; Tonokatsu, Y; Yamamoto, I | 1 |
| Asagoe, K; Dekigai, H; Kusaka, S; Maeda, S; Matsumoto, M; Mizuno, M; Murakami, M; Saita, H; Seki, M; Takahashi, Y | 1 |
| Domizio, P; Farthing, MJ; Katelaris, PH; Patchett, SE; Zhang, ZW | 1 |
| de Boer, WA; Tytgat, GN | 2 |
| Brennenstuhl, M; Hammar, CH; Jaspersen, D; Körner, T; Schorr, W | 1 |
| Bayerdörffer, E; Dirschedl, P; Hatz, R; Höchter, W; Lehn, N; Mannes, GA; Miehlke, S; Ruckdeschel, G; Sommer, A; Weingart, J | 1 |
| Laine, L; Neil, G; Stein, C | 1 |
| al-Assi, MT; Cole, RA; el-Zimaity, H; Genta, RM; Graham, DY; Karttunen, TJ | 1 |
| al-Assi, MT; Cole, RA; el-Zimaity, HM; Genta, RM; Graham, DY; Graham, KS; Malaty, H; Neil, GA; Yousfi, MM | 1 |
| Dehbashi, N; Etaati, H; Fattahi, M; Javan, A; Massarrat, S; Saberi-Firoozi, M; Zare, S | 1 |
| Bayerdörffer, E | 2 |
| Bigard, MA; Choné, L; Fléjou, JF; Grignon, Y | 1 |
| Bertrams, J; Blum, AL; Börsch, G; Jorias, I; Labenz, J; Leverkus, F; Sollböhmer, M; Stolte, M | 1 |
| Giannikos, N; Karameris, A; Mavrogeorgis, A; Rallis, E; Rokkas, T | 1 |
| Brennenstuhl, M; Hammar, CH; Jaspersen, D; Koerner, T; Raschka, C; Schorr, W | 1 |
| Laine, L | 1 |
| Bargiggia, S; Bianchi Porro, G; Lazzaroni, M; Maconi, G; Minguzzi, M | 1 |
| Celle, G; Mela, GS; Savarino, V; Vigneri, S; Zentilin, P | 1 |
| Bayerdörffer, E; Heldwein, W; Höchter, W; Klann, H; Mannes, GA; Miehlke, S; Schmitt, W; Simon, T; Sommer, A; Weingart, J | 1 |
| Cederbrant, G; Kahlmeter, G; Kamme, C; Schalén, C | 1 |
| Hahm, JS; Kim, HJ; Park, KN | 1 |
| Atoyebi, W; Bell, GD; Bolton, GH; Bowden, AF; Brown, C; Burridge, SM; Jones, PH; Powell, KU | 1 |
| Brydon, WG; Eastwood, MA; Ferguson, A; Hudson, N; Palmer, KR | 1 |
| Bayerdörffer, E; Eidt, S; Lehn, N; Neubauer, A; Rudolph, B; Stolte, M; Thiede, C | 1 |
| Bätz, CH; Bayerdörffer, E; Eidt, S; Stolte, M | 1 |
| Goerz, G; Humfeld, S; Reinauer, H; Reinauer, S; Ruzicka, T; Susanto, F | 1 |
| de Boer, WA; Driessen, WM | 1 |
| Adamek, RJ; Freitag, M; Opferkuch, W; Rühl, GH; Wegener, M | 1 |
| Broglia, F; Fiocca, R; Luinetti, O; Solcia, E; Trespi, E; Villani, L | 1 |
| Bayerdörffer, E; Mannes, GA; Miehlke, S | 1 |
| Axon, AT | 2 |
| Atherton, JC; Bracewell, MA; Greaves, JL; Hawkey, CJ; Perkins, AC; Spiller, RC; Sutton, LJ; Washington, N | 1 |
| Atherton, JC; Hawkey, CK; Hudson, N; Kirk, GE; Spiller, RC | 1 |
| Borchard, F; Müller, W; Peters, U; tho Pesch, S | 1 |
| Börsch, G; Labenz, J; Leverkus, F | 1 |
| Bellas, C; Boixeda, D; Manzanal, A; Montalban, C; Redondo, C | 1 |
| Bertrams, J; Börsch, G; Domian, C; Labenz, J; Stolte, M | 1 |
| Celle, G; Mela, GS; Savarino, V; Termini, R; Vigneri, S | 1 |
| Goddard, AF | 1 |
| Bertrams, J; Börsch, G; Labenz, J; Rühl, GH | 3 |
| Domschke, W | 1 |
| Hunt, RH | 3 |
| Asaka, M; Horita, S; Inoue, K; Kato, M; Kimura, T; Kudo, M; Meguro, T; Ohtaki, T | 1 |
| Gad, A; Unge, P | 1 |
| Goh, KL; Lo, YL; Parasakthi, N; Peh, SC; Tan, KK; Wong, NW | 1 |
| Karita, M; Morshed, MG; Okita, K; Ouchi, K | 1 |
| Alvisi, C; Bianchi Porro, G; Boldorini, R; Fiocca, R; Lazzaroni, M; Luinetti, O; Perego, M; Solcia, E; Trespi, E; Villani, L | 1 |
| Freston, JW | 1 |
| Berman, D; George, J; Groisman, GM; Harpaz, N | 1 |
| Adamek, RJ; Opferkuch, W; Wegener, M | 1 |
| Ammann, R; Bauer, S; Flury, R; Meyenberger, C; Wirth, HP; Wüst, J; Zala, G | 1 |
| Ammann, R; Flury, R; Meyenberger, C; Wirth, HP; Wüst, J; Zala, G | 1 |
| Ammann, R; Flury, R; Giezendanner, S; Meyenberger, C; Wirth, HP; Wüst, J; Zala, G | 1 |
| Eidt, S; Stolte, M | 1 |
| Labenz, J; Stolte, M | 2 |
| Engstrand, L; Lööf, L | 1 |
| Brazer, SR; Maniatis, AG | 1 |
| Bayerdörffer, E; Brooks, W; Hatz, R; Ritter, MM; Ruckdeschel, G; Stolte, M | 1 |
| Lamouliatte, H | 1 |
| Annibale, B; Biancone, L; Capurso, L; Delle Fave, G; Luzza, F; Marcheggiano, A; Pallone, F; Torsoli, A | 1 |
| Celle, G; Sandro Mela, G; Savarino, V; Vigneri, S; Zentilin, P | 1 |
| Adamek, RJ; Wegener, M | 1 |
| Bell, GD; Bolton, G; Bowden, AN; Brown, C; Burridge, SM; Gant, PW; Harrison, G; Powell, KU; Purser, K; Rameh, B | 1 |
| Adamek, RJ; Freitag, M; Labenz, J; Opferkuch, W; Rühl, GH; Wegener, M | 1 |
| Arakawa, T; Fukuda, T; Higuchi, K; Kimura, S; Kobayashi, K; Uchida, T | 1 |
| Bayerdörffer, E; Dirschedl, P; Hatz, R; Höchter, W; Lehn, N; Mannes, GA; Ruckdeschel, G; Sommer, A; Stolte, M; Weingart, J | 1 |
| Malfertheiner, P | 2 |
| Bell, GD; Powell, KU | 2 |
| Raedsch, R | 1 |
| Barbara, L; Biasco, G; Corinaldesi, R; Gasperoni, S; Paparo, GF; Ricci-Maccarini, M; Stanghellini, V; Tucci, A; Varoli, O | 1 |
| Beattie, S; Collins, R; O'Morain, C; Xia, HX | 1 |
| Adamek, RJ; Opferkuch, W; Rühl, GH; Wegener, M | 1 |
| Baron, JH; Gummett, PA; Karim, QN; Logan, RP; Misiewicz, JJ; Walker, MM | 1 |
| Boixeda, D; Gisbert, JP; Martin de Argila, C | 2 |
| Moolenaar, W; ten Bokkel Huinink, J; Thijs, JC; van Zwet, AA; Wolfhagen, MJ | 1 |
| Adamek, RJ; Opferkuch, W; Pfaffenbach, B; Wegener, M | 1 |
| Badve, S; Finlayson, C; Khulusi, S; Lloyd, R; Marrero, JM; Mendall, MA; Northfield, TC; Patel, P | 1 |
| Buset, M; De Koster, E; Deltenre, M; Jonas, C; Otero, J; van Gossum, M | 1 |
| Bang, CJ; Berstad, A; Hatlebakk, JG; Hausken, T; Nesje, LB | 1 |
| Majka, J; Piotrowski, J; Slomiany, A; Slomiany, BL | 1 |
| Axon, AT; Bate, CM; Bell, GD; Emmas, CE; Green, JR; Kerr, GD; Taylor, MD; Tildesley, G | 1 |
| Armuzzi, A; Branca, G; Cammarota, G; Montalto, M; Papa, A; Pretolani, S; Renzi, C; Tursi, A; Vecchio, FM; Verzí, A | 1 |
| Lorenzetti, M; Marchetti, P; Navalesi, R; Volpe, L | 1 |
| Hentschel, E; Schütze, K | 1 |
| Fennerty, MB; Vakil, N | 1 |
| Treiber, G | 1 |
| Bagni, A; Bedogni, G; Bertoni, G; Bianchi, G; Della Casa, G; Nigrisoli, E; Sassatelli, R; Tansini, P | 1 |
| Davis, S | 1 |
| Cheng, AF; Chung, SC; Lau, JY; Leung, VK; Li, AK; Ling, TK; Suen, R; Sung, JJ | 1 |
| Kadayifci, A; Simsek, H; Tatar, G | 1 |
| Larsson, H; Sjöström, JE | 1 |
| Alvarez Baleriola, I; Boixeda, D; de Rafael, L; García Plaza, A; García, M; Gisbert, JP; Martín de Argila, C | 1 |
| Alván, G; Blomgren, K | 1 |
| Boixeda, D; Ceña, G; Gisbert, JP; Martín, C; Monés, J; Mur, M; Sainz, R; Sainz, S | 1 |
| Artan, R; Gelen, T | 1 |
| Alvisi, C; Bargiggia, S; Bianchi Porro, G; Cesana, B; Fiocca, R; Franceschi, M; Lazzaroni, M; Luinetti, O; Maconi, G; Perego, M; Solcia, E; Trespi, E; Villani, L | 1 |
| Cammarota, G; Fedeli, G; Gasbarrini, G; Montalto, M; Papa, A; Tursi, A | 3 |
| Acuña, R; Albornoz, V; Figueroa, G; Portell, DP; Toledo, MS; Troncoso, M; Vigneaux, J | 1 |
| Flury, R; Giezendanner, S; Meyenberger, C; Schwery, S; Wirth, HP; Wüst, J; Zala, G | 1 |
| Barrett, DA; Cederberg, C; Goddard, AF; Idström, JP; Jessa, MJ; Shaw, PN; Spiller, RC | 1 |
| Lambert, JR | 1 |
| Unge, P | 2 |
| Carlsson, J; Fiocca, R; Rudbäck, A; Solcia, E; Villani, L; Zeijlon, L | 1 |
| Alvisi, V; Balhous, W; Caselli, M; Fabbri, P; Ruina, M | 1 |
| Fox, JG; Hayward, A; Murphy, JC; Perkins, SE; Shen, Z; Yan, LL | 1 |
| Dankert, J; Keller, JJ; Rauws, EA; ten Kate, FJ; Tytgat, GN; van der Ende, A; van der Hulst, RW; Verheul, SB; Weel, JF | 1 |
| Becker, T; Börsch, G; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B | 1 |
| Bargiggia, S; Bianchi Porro, G; Colombo, E; Maconi, G; Parente, F | 1 |
| Polson, RJ; Rosengren, H | 1 |
| Caucheteur, B; De Koster, E; Deltenre, M; Jonas, C; Otero, J | 1 |
| Draf, W; Hammar, CH; Huppmann, A; Jaspersen, D; Keerl, R; Weber, R | 1 |
| Cantero, J; Gómez-Cedenilla, A; Grávalos, RG; Pajares, JM; Santander, C | 1 |
| Bermejo, F; Boixeda, D; de Rafael, L; Gisbert, JP; Martín de Argila, C; Redondo, C | 1 |
| Baniukiewicz, A; Bielański, W; Gabryelewicz, A; Hahn, EG; Jedynak, M; Konturek, PC; Konturek, SJ; Kwiecień, N; Sito, E | 1 |
| Burette, A; Cozzoli, A; de Koster, E; Deltenre, M; Denis, P; Jonas, C; Otero, J | 1 |
| Roesch, W | 1 |
| Bästlein, E; Bayerdörffer, E; Bolle, KH; Hatz, R; Heldwein, W; Höchter, W; Klann, H; Lehn, N; Mannes, GA; Meining, A; Miehlke, S; Ruckdeschel, G; Simon, T; Sommer, A; Stolte, M; Weingart, J | 1 |
| de Boer, WA; Driessen, WM; Jansz, AR; Tytgat, GN | 1 |
| Barthelemy, P; Chaussade, S; Delchier, JC; Elamine, I; Goldfain, D; Idström, JP | 1 |
| Estrada, R; Garcia, F; Laine, L; Stein, C; Trujillo, M | 1 |
| Branca, G; Cammarota, G; Cuoco, L; Fedeli, G; Gasbarrini, G; Montalto, M; Papa, A; Trua, F; Tursi, A; Veneto, G | 1 |
| Braun, M; Idström, JP; Londong, W; Pommerien, W; Wrangstadh, M | 1 |
| Braden, B; Lembcke, B; Londong, W; Pommerien, W; Schultze, V; Wrangstadh, M | 1 |
| Geypens, B; Ghoos, Y; Hiele, M; Maes, B; Perri, F; Rutgeerts, P | 1 |
| Isoda, K; Itakura, Y; Itoyama, S; Matsumura, O; Mitarai, T; Murakawa, M; Tamura, H; Tokushima, H | 1 |
| Das, K; Goenka, MK; Kocbhar, R; Nijhawan, R; Vaiphei, K | 1 |
| Dammann, HG | 1 |
| el-Zimaity, HM; Genta, RM; Graham, DY; Yousfi, MM | 1 |
| Atherton, JC; Cullen, DJ; Hawkey, CJ; Kirk, GE; Spiller, RC | 1 |
| Axon, AT; Bate, CM; Bell, GD; Martin, JL; Richardson, PD; Taylor, MD; Tildesley, G | 1 |
| Azumi, Y; Kawakita, N; Nagahata, Y; Numata, N; Saitoh, Y; Yano, M | 1 |
| Hackelsberger, A; Malfertheiner, P | 1 |
| Bohmeyer, J; Hartig, C; Heller, A; Huchzermeyer, H; Otte, HG; Stadler, R; Wetenberger-Treumann, M | 1 |
| Bianchi Porro, G; Caruso, I; Imbesi, V; Montrone, F; Parente, F | 1 |
| Asaka, M; Hokari, K; Kagaya, H; Katagiri, M; Kato, M; Koshiyama, T; Kudo, M; Nishikawa, K; Sugiyama, T; Sukegawa, M; Takeda, H | 1 |
| Behler, EM; Chey, WD; Crause, I; Elta, GH; Scheiman, JM | 1 |
| Buiatti, E; Kato, I; Muñoz, N; Oliver, W; Vivas, J | 1 |
| Bermejo, F; Boixeda, D; Gisbert, JP; Jiménez, I; Martín de Argila, C; Pérez, T | 1 |
| Dankert, J; ten Kate, FJ; Tytgat, GN; van der Ende, A; van der Hulst, RW; Weel, JF | 1 |
| Alder, JD; Ewing, PJ; Mitten, MJ; Oleksijew, A; Tanaka, SK | 1 |
| Chua, RT; Lee, SD; Lin, HJ; Perng, CL; Tsay, SH; Wang, K | 1 |
| Maruyama, M | 1 |
| Kawano, S; Murakami, M; Saita, H; Tsuji, S | 1 |
| Carpintero, P; García Grávalos, R; Hermida, C; Lara, S; Moreno, JA; Pajares, JM; Santander, C | 1 |
| Fukuda, S; Fukuda, Y; Munakata, A; Shimoyama, T; Yoshida, Y | 1 |
| Ishino, Y; Kihira, K; Kimura, K; Saifuku, K; Satoh, K; Takimoto, T; Taniguchi, Y; Yamamoto, H; Yoshida, Y | 1 |
| Fukuda, Y; Shimoyama, T; Tamura, K; Tonokatsu, Y; Tsujiai, T | 1 |
| Bourgain, C; Devis, G; Fernandes, E; Reynaert, H; Smekens, L | 1 |
| Aller, R; Alvarez Baleriola, I; Bermejo, F; Boixeda, D; Gisbert, JP; Martín de Argila, C | 1 |
| Cammarota, G; Cuoco, L; Fedeli, G; Gasbarrini, G; Montalto, M; Papa, A; Tursi, A; Veneto, G | 1 |
| Cole, RA; el-Zimaity, HM; Genta, RM; Graham, DY; Malaty, H | 1 |
| Estrada, R; Fukanaga, K; Laine, L; Neil, G; Trujillo, M | 1 |
| Goh, KL; Navaratnam, P; Peh, SC | 1 |
| Bästlein, E; Bayerdörffer, E; Lehn, N; Mannes, GA; Meining, A; Miehlke, S; Stolte, M | 1 |
| Fischbach, W; Greiner, A; Konrad, H; Tacke, W | 1 |
| Arai, H; Baba, S; Furuta, T; Futami, H; Kaneko, E | 1 |
| Hirose, H; Isoda, K; Itoyama, S; Matsumura, O; Mitarai, T; Murakawa, M; Sekine, S; Tamura, H; Tokushima, H | 1 |
| Alvarez Baleriola, I; Boixeda, D; Gisbert, JP; Jiménez, I; Pajares, JM; Pérez García, JI; Redondo, C | 1 |
| Cammarota, G; Cannizzaro, O; Cuoco, L; Fedeli, G; Gasbarrini, G; Montalto, M; Papa, A; Tursi, A; Veneto, GM | 1 |
| Adamsson, I; Edlund, C; Nord, CE; Seensalu, R; Sjösted, S; Stark, CA; Wikström, B | 1 |
| Amano, K; Goto, A; Kondo, H; Moriwaki, H; Muto, Y; Seko, A; Shimizu, H; Sugie, S; Takagi, S; Yoshimi, N | 1 |
| Alarcón, T; Díaz de Rojas, F; Domingo, D; López-Brea, M; Sánchez, I | 1 |
| Houben, P; Jonkers, D; Stobberingh, E; Stockbrügger, R | 1 |
| Klotz, U; Treiber, G; Walker, S | 1 |
| Aubert, E; Berge, T; Breder, O; Farup, P; Flaaten, B; Haug, JB; Høie, O; Lerang, F; Moum, B; Søberg, T; Tolås, P | 1 |
| Labenz, J; Lütke, A; Stolte, M; Tillenburg, B; Weismüller, J | 1 |
| Barrett, DA; Erah, PO; Goddard, AF; Shaw, PN; Spiller, RC | 1 |
| Axon, AT; Bardhan, KD; Baron, JH; Beattie, AD; Birrell, H; Crowe, JP; Dixon, MF; Gillon, KR; Hollanders, FD; Lynch, DA; O'Moráin, CA; Smith, PM; Thompson, RP; Tompkins, DS | 1 |
| Bayerdörffer, E; Hatz, R; Lehn, N; Müller, S; Neubauer, A; Neubauer, B; Otto, P; Ritter, M; Rudolph, B; Seifert, E; Stolte, M; Thiede, C | 1 |
| Chan, FK; Chan, LY; Chung, SC; Lee, YT; Leung, WK; Sung, JJ; Yung, MY | 1 |
| Labenz, J | 1 |
| Adachi, H; Ahmed, T; Hori, T; Matsubara, T; Nakahara, A; Sumazaki, R; Takita, H; Yamada, M | 1 |
| Daskalopoulous, G; Hazell, SL; Massey, D; Mitchell, HM | 1 |
| Fujioka, T; Kodama, R; Kubota, T; Murakami, K; Nasu, M; Tokieda, M | 1 |
| Akahane, T; Akamatsu, T; Gotoh, A; Katsuyama, T; Kawakami, Y; Kiyosawa, K; Shimizu, T | 1 |
| Lambert, JR; Midolo, PD; Turnidge, JD | 1 |
| Fernández Cadenas, F; García Calero, C; García Saavedra, L; Lomo Montero, J; Rodrigo Sáez, L | 1 |
| Boyle, S; Jacyna, M; Martin, J | 1 |
| Delpre, G; Livni, E; Niv, Y | 1 |
| Aubert, E; Berge, T; Efskind, PS; Haug, JB; Hauge, T; Henriksen, M; Lerang, F; Moum, B; Nicolaysen, K; Odegaard, A; Ragnhildstveit, E; Søberg, T; Tolås, P | 1 |
| Kooy, A; Thijs, JC; Thijs, WJ; Van der Wouden, EJ; Van Zwet, AA | 1 |
| Jönsson, KA; Sörberg, M; Ström, M | 1 |
| Bortoli, A; Colombo, E; Imperiali, G; Lesinigo, E; Minoli, G; Spinzi, G; Terruzzi, V; Venturelli, R | 1 |
| Bayerdörffer, E; Hele, C; Lehn, N; Mannes, GA; Miehlke, S; Stolte, M | 1 |
| Peterson, WL | 1 |
| Anania, MC; Annibale, B; D'Ambra, G; Delle Fave, G; Iannoni, C; Luzzi, I; Marcheggiano, A; Marignani, M; Paoletti, M | 1 |
| Kimura, M; Seki, H; Urakami, Y | 1 |
| Abraira, V; Alvarez Baleriola, I; Boixeda, D; Ceña, G; García Plaza, A; Gisbert, JP; Martín de Argila, C; Mur, M | 1 |
| Damianos, AJ; McGarrity, TJ | 1 |
| Brenner, C; Ebell, MH; Warbasse, L | 1 |
| Lee, SD; Lin, HJ; Lo, WC; Perng, CL; Wang, K | 1 |
| Dmitrović, B; Horvat, D; Ivandić, A; Kovacić, D; Mićunović, N; Mihaljević, S; Paulini, D; Vcev, A; Vceva, A; Volaric, M; Vuković, D | 1 |
| Dankert, J; Dekker, FW; Keller, JJ; Kruizinga, SP; Ten Kate, FJ; Tytgat, GN; van der Ende, A; van der Hulst, RW; Weel, JF | 1 |
| Kim, MJ; Michener, R; Triadafilopoulos, G | 1 |
| Alvarez, I; Bellas, C; Boixeda, D; Calleja, JL; Manzanal, A; Montalban, C; Redondo, C | 1 |
| Becker, K; Classen, M; Franck, H; Lehn, N; Schepp, W; Schweigart, U | 1 |
| Beker, JA; Dekker, CP; Farley, A; Jönsson, A; Klör, HU; Labenz, J | 1 |
| Breuer, T; Genta, RM; Graham, DP; Graham, DY; Gurer, IE; Kim, JG; Osato, M | 1 |
| Chambers, S; Gould, SR; Lim, AG; Walker, C | 1 |
| Flury, R; Fried, M; Kayser, S; Wirth, HP; Zbinden, R | 1 |
| Barnert, J; Busch, R; Demharter, R; Fleischmann, R; Füger, K; Wienbeck, M | 1 |
| Iida, M; Matsumoto, T; Shimizu, M | 1 |
| Hoffman, JS | 1 |
| Abraira, V; Alvarez Baleriola, I; Boixeda, D; García Plaza, A; Gisbert, JP; Martín De Argila, C | 1 |
| Attili, AF; de Francesco, V; Diana, F; Pugliano, F; Rinaldi, V; Zullo, A | 1 |
| Haruma, K; Kajiyama, G; Mashiba, H; Mukai, T; Okamoto, S; Sasaki, N; Sumii, K; Taniyama, K; Uemura, N; Yamaguchi, S | 1 |
| Domschke, W; Hilker, E; Pohle, T | 1 |
| Bobrzyński, A; Rudnicka, L; Stachura, J | 1 |
| Hirakawa, T | 1 |
| Matsukura, N | 1 |
| Hogan, J; Krasner, N; Lombard, M; Purkayastha, SK; Tan, WC | 1 |
| Ammon, S; Klotz, U; Treiber, G | 1 |
| Alpen, B; Bayerdörffer, E; Ehninger, G; Morgner, A; Neubauer, A; Neubauer, B; Ritter, M; Stolte, M; Thiede, C; Wündisch, T | 1 |
| Wright, DH | 1 |
| Bayerdoerffer, E; Boersch, G; Kraemer, W; Morgner, A; Neubauer, A; Rohde, P; Rudolph, B; Sackmann, M; Schulz, H; Seifert, E; Stolte, M; Thiede, C | 1 |
| Chien, CH; Lin, XZ; Sheu, BS; Su, IJ; Yang, HB | 1 |
| Dorlars, D; Kohler, B; Maier, M; Riemann, JF; Schauwecker, P; Schilling, D; Wehlen, G | 1 |
| Blazquez, M; Chaumette, MT; Delchier, JC; Haioun, C; Hammel, P; Lamarque, D; Lévy, M; Marty, O | 1 |
| Baker, A; Frantz, JE; Laine, L; Neil, GA | 1 |
| Chesters, SA; Copeman, MB; Cottrill, MR; Mason, I; McKinnon, C; Slatcher, G; Turbitt, ML | 1 |
| Archambault, A; Archimandritis, A; Bazzoli, F; Fedorak, R; Hentschel, E; Megraud, F; Mora, P; Rodrigo, L; Rokkas, T; Skandalis, N; Stamler, D; Wurzer, H | 1 |
| Harris, A | 2 |
| Altin, M; Dinc, I; Dobrucali, A; Eralp, YT; Goksel, S; Tuncer, M | 1 |
| Bargiggia, S; Bianchi Porro, G; Lazzaroni, M; Maconi, G; Sangaletti, O; Vago, L | 1 |
| Haber, M; Kidd, S; Riff, DS; Rose, P; Siepman, N; Weissfeld, A | 1 |
| Arora, A; Graham, D; Haber, M; Harford, W; Lanza, F; Rose, P; Siepman, N; Weissfeld, A | 1 |
| Jaup, BK | 1 |
| Axon, AT; Chalmers, DM; Dixon, MF; Langworthy, H; Moayyedi, P; Shanahan, K; Tompkins, DS | 1 |
| Malfertheiner, P; Mégraud, F | 1 |
| Bardhan, KD; Bayerdörffer, E; Bradette, M; Cederberg, C; Chiba, N; Idström, JP; Lind, T; O'Morain, C; Spiller, R; Unge, P; Veldhuyzen van Zanten, S; Wrangstadh, M | 1 |
| Keller, JJ; Rauws, EA; Tytgat, GN; van der Hulst, RW | 1 |
| Minocha, A; Srinivasan, R | 1 |
| de Vries, RA; den Hartog, G; Meijer, JW; Mulder, CJ; Tan, AC; Thies, JE | 1 |
| Bielański, W; Bobrzyński, A; Budzyński, A; Gedliczka, O; Konturek, S; Stachura, J | 2 |
| Neil, GA; Ronca, PD; Skoglund, ML; Suchower, LJ | 1 |
| Innerhofer, M; Malfertheiner, P; Pieramico, O; Zanetti, MV | 1 |
| Fujiki, K; Horiuchi, T; Ohkusa, T; Shimoi, K; Suzuki, S; Takashimizu, I | 1 |
| Berge, T; Haug, JB; Lerang, F; Moum, B; Sandvei, PK; Tolås, P; Torp, R; Tønnesen, T | 1 |
| Bielecki, D; Ciok, J; Dzieniszewski, J; Gabryelewicz, A; Knapik, Z; Laszewicz, W; Legutko, J; Marlicz, K; Poniewierka, E; Popiela, T | 1 |
| Akamatsu, T; Gotoh, A; Katsuyama, T; Kawakami, Y | 1 |
| Fennerty, MB | 1 |
| Cockeram, A; Hunt, RH; Jewell, D; Malatjalian, D; Matisko, A; Schep, G; Sidorov, J; Veldhuyzen van Zanten, S | 1 |
| Espinós, JC; Esteve, M; Fernández-Bañares, F; Forné, M; Garau, J; Lite, J; Quintana, S; Salas, A; Viver, JM | 1 |
| Bardhan, KD; Cooper, BT; Dixon, MF; Harris, AW; Kerr, GD; Langworthy, H; Levi, S; Misiewicz, JJ; O'Morain, C; Piper, D | 2 |
| Angelucci, D; Cellini, L; Di Campli, E; Diodoro, MG; Grossi, L; Marzio, L | 1 |
| Boku, N; Ohtsu, T | 1 |
| Cammarota, G; Cannizzaro, O; Cianci, R; Cuoco, L; Fedeli, G; Fedeli, P; Gasbarrini, G; Papa, A; Tursi, A | 1 |
| Hibi, T; Ishii, H; Iwai, N; Miyayama, A; Mori, M; Oonuki, M; Suzuki, H; Suzuki, M; Tsunematsu, N | 1 |
| Hotz, J | 1 |
| Lindberg, G; Nord, CE; Sagar, M; Seensalu, R; Sjöstedt, S; Wikström, B | 1 |
| Bayerdörffer, E; Bolle, KH; Fischer, G; Hatz, R; Höchter, W; Huber, F; Klann, H; Lehn, N; Meining, A; Simon, T; Sommer, A; Stolte, M; Weingart, J | 1 |
| Boixeda de Miquel, D | 1 |
| Alberdi, JM; Beckford, C; Blanco, MA; Carnicero, JA; Casanova, A; Crespo, L; Fernández Velázquez, J; Galán, JL; García Benito, MD; Güemes, C; Pérez Mota, A; Pérez Muñoz, C; Pita, L; Villalgordo, C | 1 |
| Hirayama, F; Hisadome, M; Ikeda, Y; Kusuhara, H; Matsuyuki, H | 1 |
| Berg, DE; Blaser, MJ; Dubois, A; Fiala, N; Heman-Ackah, LM; Perez-Perez, GI | 1 |
| Abe, T; Asai, A; Goto, M; Ito, T; Kawano, S; Kubo, M; Tanabe, J; Tanimura, H | 1 |
| Azian, M; Bux, S; Goh, KL; Lo, YL; Ong, KK; Paramsothy, M; Parasakthi, N; Peh, SC | 1 |
| Cho, SW; Hahm, KB; Joo, HJ; Kim, JH; Kim, YS; Lee, KJ; Yim, H | 1 |
| Annibale, B; Bordi, C; Cesana, B; Damilano, I; Franceschi, M; Maconi, G; Pilato, FP | 1 |
| Moayyedi, P | 1 |
| Abraira, V; Boixeda, D; García Plaza, A; Gisbert, JP; Martín de Argila, C; Moreno, L; Redondo, C | 1 |
| Leri, O; Losi, T; Mastropasqua, M; Perinelli, P; Tubili, S | 1 |
| Ardill, JE; el-Nujumi, A; McColl, KE; Oien, K; Williams, C | 1 |
| Johnson, E; Laine, L; Neil, G; Ronca, P; Suchower, L | 1 |
| Collins, BJ; Coombs, GW; Forbes, GM; McCullough, CA; Robins, PD | 1 |
| Daikeler, R; Glaser, J; Hein, J; Schmidt, M; Stolte, M; Vieth, M; Weithofer, G | 1 |
| Ammon, S; Klotz, U; Schneider, E; Treiber, G | 1 |
| Fujita, T; Kobayasi, I; Mine, T; Suzuki, J | 2 |
| Johnsen, R; Lindsetmo, RO; Revhaug, A | 1 |
| Calvet, X; Comet, R; García, N; Navarro, M; Sanfeliu, I | 1 |
| Carnicer, J | 1 |
| Hibi, K; Imaizumi, H; Koizumi, W; Ohida, M; Okabe, H; Okayasu, I; Saigenji, K; Tanabe, S | 1 |
| Freston, J; Haber, M; Krause, R; Rose, P; Sahba, B; Schwartz, H; Siepman, N; Weissfeld, A | 1 |
| Bei, L; Chen, S; Chen, Z | 1 |
| Arai, H; Baba, S; Furuta, T; Futami, H; Hanai, H; Kajimura, M; Kaneko, E; Takashima, M | 1 |
| Honda, T; Matsumoto, T; Mori, K; Nagatomi, Y; Takaba, M; Tsuneoka, H | 1 |
| Barbet, JP; Benhamou, PH; Bergeret, M; Dupont, C; Gendrel, D; Kalach, N; Raymond, J | 1 |
| Dasani, BM; Lieber, CS; Sigal, SH | 1 |
| Agosti, R; Bocus, P; Caletti, G; Grigioni, WF; Mazzoni, C; Orcioni, GF; Paparo, GF; Poli, L; Sottili, S; Togliani, T; Tucci, A | 1 |
| Ikezawa, K; Kashimura, H; Mahmudul, H; Matsuzaki, Y; Mutoh, H; Nakahara, A; Tanaka, N; Yanaka, A | 1 |
| Miwa, H; Murai, T; Nagahara, A; Ogihara, T; Ohkura, R; Sato, N; Watanabe, S; Yamada, T | 1 |
| Calvet Calvo, X | 1 |
| Arai, H; Furuta, T; Futami, H; Hanai, H; Kaneko, E; Takashima, M | 1 |
| Bargiggia, S; Bianchi Porro, G; Cesana, B; Fiocca, R; Franceschi, M; Lazzaroni, M; Maconi, G; Perego, M; Solcia, E | 1 |
| Macri, G; Milani, S; Passaleva, MT; Salvadori, G; Surrenti, C; Surrenti, E | 1 |
| Brullet, E; Calvet, X; Campo, R; Comet, R; García, N; Navarro, M | 1 |
| Ara, JR; Bertol, V; Brieva, L; Canellas, A; del Agua, C | 1 |
| Dickson, A; el-Nujumi, A; el-Omar, EM; Hilditch, TE; Kelman, AW; McColl, KE; Murray, LS | 1 |
| Bierti, L; Bortoli, A; Colombo, E; Fertitta, AM; Lanzi, GL; Minoli, G; Spinzi, GC; Venturelli, R | 1 |
| Dmitrović, B; Kovac, D; Stimac, D; Takac, B; Vcev, A; Vceva, A | 1 |
| Cheah, PL; Chin, SC; Chuah, SY; Goh, KL; Lo, YL; Parasakthi, N | 1 |
| Crobach, LF; Geraedts, AA; Kolkman, JJ; Nicolai, JJ; Oudkerk Pool, M; Tan, TG; Timmerman, RJ; Van Der Laan, J; Van Kleef, WA; Wolff, AA | 1 |
| Ballester Belenguer, J; Bonet Pla, A; García Tell, G; Jimeno Bernard, R; Navarro Pérez, J; Pereiró Berenguer, I; Sanfélix Genovés, J | 1 |
| Andriulli, A; Clemente, R; Conoscitore, P; Festa, V; Ghoos, Y; Niro, G; Perri, F; Quitadamo, M; Rutgeerts, P | 1 |
| Girdwood, AH; Grundlings, HD; Hanslo, D; Louw, JA; Marks, IN; van Rensburg, CJ | 1 |
| Ahuja, V; Bal, C; Dhar, A; Sharma, MP | 1 |
| Carvalho, AF; Da Silva, CM; De Nucci, G; Ferraz, JG; Fiorelli, LA; Jorge, VN; Pedrazzoli, J | 1 |
| Blot, WJ; Brown, LM; Chang, YS; Fraumeni, JF; Gail, MH; Groves, FD; Heinrich, JP; Hu, J; Jin, ML; Li, JY; Liu, WD; Ma, JL; Mark, SD; Rabkin, CS; Xu, GW; You, WC; Zhang, L | 1 |
| Benhamou, PH; Bergeret, M; Dupont, C; Gendrel, D; Kalach, N; Raymond, J; Senouci, L | 1 |
| Hwang, C; Johnson, E; Laine, L; Neil, G; Ronca, P; Suchower, L | 1 |
| Barthelemy, P; Bigard, MA; Delchier, JC; Riachi, G; Thibault, P | 1 |
| Bentivegna, C; Brogna, A; Catalano, F; Catanzaro, R; Cipolla, R; Condorelli, G | 1 |
| Butruk, E; Dziurkowska-Marek, A; Hennig, E; Kohut, M; Marek, T; Nowak, A; Ostrowski, J; Przytulski, K; Regula, J | 1 |
| Hashimoto, Y | 1 |
| Johnson, E; Neil, GA; Ronca, PD; Skoglund, ML; Suchower, LJ | 1 |
| Are, BM; Atzei, A; Carta, M; Dore, MP; Graham, DY; Maida, A; Massarelli, G; Mura, I; Piana, A; Realdi, G; Sepulveda, AR | 1 |
| Améndola, R; Corti, R; Ferro, FE; Kogan, Z; Lineado, A; Morgade, L; Musi, AO; Roldán, CD; Schenone, L; Solagna, A; Valero, J; Zerbo, O | 1 |
| Cecchi, R; Torelli, E | 1 |
| Kaitani, K; Kita, T; Murakami, M; Nishio, K; Saita, H; Sou, Y; Takahashi, Y | 1 |
| Higashi, Y; Kashima, K; Kodama, T; Sasaki, Y; Sawai, N; Tanahashi, T; Tatsumi, Y; Yamaoka, Y | 1 |
| Chan, FK; Cheng, AF; Chung, SC; Lee, YT; Leung, WK; Ling, TK; Sung, JJ; Yung, MY | 1 |
| Bazzoli, F; Berretti, D; De Luca, L; Fossi, S; Nicolini, G; Pozzato, P; Ricciardiello, L; Zagari, M | 1 |
| Adamek, RJ; Pfaffenbach, B; Szymanski, C | 1 |
| Cayla, R; de Mascarel, A; Forestier, S; Joubert-Collin, M; Lamouliatte, H; Mégraud, F; Zerbib, F | 1 |
| Cheng, AF; Chung, SC; Lau, JY; Leung, WK; Ling, JM; Ling, TK; Ng, EK; Siu, LK; Sung, JY | 1 |
| De Mas, CR; Neubauer, A; Seifert, E; Stolte, M; Thiede, C | 1 |
| Asaka, M; Hokari, K; Kagaya, H; Katagiri, M; Kato, M; Kudo, M; Nishikawa, K; Sato, F; Sugiyama, T; Sukegawa, M; Takeda, H | 1 |
| Ando, K; Arakawa, T; Harihara, S; Higuchi, K; Ito, H; Kobayashi, K; Kuroki, T; Nebiki, H; Uchida, T | 1 |
| Adamsson, I; Nord, CE; Seensalu, R; Sjöstedt, S; Wikström, B | 1 |
| Filipowicz-Sosnowska, A; Gillon, KR; Hawkey, CJ; Lanas, A; Peacock, RA; Szczepanski, L; Tulassay, Z; van Rensburg, CJ; Wason, CM | 1 |
| Doermann, HP; Mégraud, F | 1 |
| Kotze, D; Louw, JA; Marks, IN; Moola, S; Van Rensburg, CJ | 1 |
| Atherton, JC; Cockayne, A; Hawkey, CJ; Jenkins, D; Knifton, A; Stack, WA; Thirlwell, D | 1 |
| Meier, E; Meining, A; Stolte, M | 1 |
| Maeda, K; Nishimura, H; Oda, K; Ohkuma, K; Okabe, N; Okada, M; Oki, K; Seo, M; Shirotani, T | 1 |
| González Carro, P; Legaz Huidobro, ML; Pedraza Martín, C; Pérez Roldán, F; Ruíz Carrillo, F; Sáez Bravo, JM | 1 |
| Borody, TJ | 1 |
| Cammarota, G; Cianci, R; Cuoco, L; Fedeli, G; Gasbarrini, G; Papa, A; Tursi, A | 1 |
| Connors, A; Frantz, J; Laine, L; Neil, G; Suchower, L | 1 |
| Howden, CW; Hunt, RH | 1 |
| Kashifard, M; Malekzadeh, R; Massarrat, S; Mikaeli, J; Siavoshi, F | 1 |
| Borody, TJ; Reyes, E; Shortis, NP | 1 |
| Ariake, K; Fujiki, K; Horiuchi, T; Ishii, K; Kumagai, J; Ohkusa, T; Sakurazawa, T; Shimoi, K; Suzuki, S; Takashimizu, I; Tanizawa, T | 1 |
| Asaka, M; Iinuma, K; Kato, S; Ohnuma, K; Ritsuno, H; Sugiyama, T | 1 |
| Bermejo, F; Boixeda, D; García Arata, I; García Plaza, A; Gisbert, JP; Martín de Argila, C; Moreno, L; Ramos, F | 1 |
| Boixeda, D; García Plaza, A; Gisbert, JP; Martín de Argila, C | 2 |
| Dickson, A; El-Nujumi, A; El-Omar, E; Hilditch, T; Kelman, A; Knill-Jones, R; McColl, K; Murray, L; Penny, C; Wirz, A | 1 |
| Blum, AL; Bolling-Sternevald, E; Junghard, O; Labenz, J; Louw, JA; O'Moráin, C; Stolte, M; Stubberöd, A; Sundin, M; Talley, NJ; Theodórs, A; van Zanten, SV | 1 |
| Furuta, T; Hanai, H; Ishizaki, T; Kamata, T; Kaneko, E; Kawasaki, T; Kosuge, K; Kubota, T; Ohashi, K; Takashima, M | 1 |
| Hibi, T; Ishii, H; Kitahora, T; Mori, M; Nagahashi, S; Suzuki, H; Suzuki, M | 1 |
| Arakawa, T; Kamisawa, T; Kato, H; Kozawa, H; Momma, K; Sakaki, N; Yamada, Y | 1 |
| Fuentes, J; García, S; Gomollón, F; Martín Mir, ML; Simón, MA; Val, J; Yus, C | 1 |
| Baena Díez, JM; Comet Jaumet, D; Jiménez Navarrete, S; López Mompó, C; Rams Rams, F; Sancho Perpiñán, A | 1 |
| Garrido, A; Guerrero, FJ; Lepe, JA; Palomo, S | 1 |
| Bardhan, KD; Bayerdörffer, E; Cederberg, C; Hellblom, M; Lind, T; Mégraud, F; O'morain, C; Spiller, R; Unge, P; Veldhuyzen Van Zanten, S; Wrangstadh, M; Zeijlon, L | 1 |
| Klinkenberg-Knol, EC; Kuipers, EJ | 1 |
| Brullet, E; Calvet, X; Campo, R; Rué, M | 1 |
| Blazanović, A; Dmitrović, B; Ivandić, A; Karner, I; Kovac, D; Pezerović, D; Stimac, D; Stimac, T; Takac, B; Vcev, A; Vceva, A | 1 |
| Chua, AB; Cutler, A; Ding, RP; Goh, KL; Kandasami, P; Mazlam, MZ; Raj, SM | 1 |
| Fujita, R; Kirihara, K; Kojima, T; Sakurai, K; Takahashi, H; Yamada, M; Yamaguchi, Y | 1 |
| Iijima, K; Kato, K; Ohara, S; Sekine, H | 1 |
| Iwasaki, A | 2 |
| Habu, Y; Inokuchi, H; Kiyota, K; Ko, K; Sugano, Y; Waki, S | 1 |
| Harasawa, S; Kouda, K; Kurumada, T; Miwa, T; Shirai, T; Tada, U; Takagi, A; Wada, T; Watanabe, S | 1 |
| Kawamura, N; Nakagawa, M; Nakagawa, S; Ooishi, M; Ooizumi, H; Saitou, M; Yoda, Y | 1 |
| Braegger, CP; Schultz-Süchting, F; Stallmach, T | 1 |
| Udvardy, M | 1 |
| Batey, RG; Henry, A | 1 |
| Barrachina, M; Bixquert, M; Cuquerella, J; del Val, A; García-Romero, E; Garrigues, V; Higón, MD; Ponce, J; Pons, V | 1 |
| Bolling-Sternevald, E; Janssens, J; Lauritsen, K; Rácz, I; Talley, NJ | 1 |
| Finkel, Y; Sandstedt, B; Tirén, U | 1 |
| Bayerdörffer, E; Bradette, M; Farley, A; Leddin, D; Lind, T; O'Morain, C; Sinclair, P; Sipponen, P; Spiller, RC; Unge, P; Wrangstadh, M; Zanten, SJ; Zeijlon, L | 1 |
| Craig, AM; Davey, P; Malek, M; Murray, F | 1 |
| Brosolo, P; Damiani, D; de Pretis, G; Geromin, A; Grimaz, S; Skert, C | 1 |
| Cheybani, K; Estrada, R; Laine, L; Neil, G; Smith, S; Trujillo, M; Yeramian, P | 1 |
| Miwa, H; Murai, T; Nagahara, A; Ohkura, R; Sato, K; Sato, N; Shimizu, H; Watanabe, S | 1 |
| Chadwick, VS; Chen, W; Shu, D; Tie, A; Wilson, IR | 1 |
| Hassan, M; Ikezawa, K; Kashimura, H; Mutoh, H; Nakahara, A; Sawahata, T; Suzuki, K; Tanaka, N; Watanabe, T | 1 |
| Breslin, NP; Buckley, MJ; Hyde, DK; Lee, JM; O'Morain, CA | 1 |
| Axon, AT; Everett, S; Langworthy, H; Mapstone, NP; Moayyedi, P; Neville, PM; Tompkins, D | 1 |
| Gisbert, JP | 1 |
| Bozzola, L; Di Mario, F; Franceschi, M; Furlan, F; Leandro, G; Pilotto, A; Rassu, M; Valerio, G | 1 |
| Ando, K; Arakawa, T; Fujiwara, Y; Higuchi, K; Kuroki, T; Uchida, T | 1 |
| Bentivegna, C; Branciforte, G; Brogna, A; Catalano, F; Chodash, HB; Dawson, BK; Luca, S; Michalos, A; Terranova, R | 1 |
| Brehler, R; Domschke, W; Foerster, E; Luger, TA; Pohle, T; Wustlich, S | 1 |
| Arima, T; Goto, M; Imaizumi, M; Kitajima, S; Matsumoto, J; Shiota, K; Yamamoto, T | 1 |
| Helbling, A; Pichler, WJ; Schnyder, B | 1 |
| Abdul Aal, GM; Abdul Rasheed, Z; Awad, S; Dajani, AI; Gautam, S; Nayal, S; Nounou, M; Ukabam, S | 1 |
| Abdul Aal, G; Abdul Rasheed, Z; Awad, S; Dajani, AI; Gautam, S; Nayal, S; Nounou, MA; Ukabam, S | 1 |
| Ivandíc, A; Pezerovíc, D; Stimac, D; Takac, B; Vcev, A; Vceva, A | 2 |
| Bozzola, L; Di Mario, F; Fortunato, A; Franceschi, M; Leandro, G; Meli, S; Pilotto, A; Rassu, M; Scagnelli, M; Soffiati, G; Valerio, G | 1 |
| Jacoby, EB; Porter, KB | 1 |
| Bhasin, DK; Ray, P; Sharma, BC; Singh, K; Sinha, SK; Vaiphei, K | 1 |
| Becker, M; Behrens, R; Bindl, L; Keller, KM; Küster, P; Lang, T; Rodeck, B; Stolte, M; Wündisch, GF | 1 |
| Della Monica, P; Lombardo, L; Masoero, G; Pera, A | 1 |
| Schubert, ML | 1 |
| Are, BM; Atzei, A; Carta, M; Cugia, L; Dore, MP; Graham, DY; Maida, A; Manca, A; Massarelli, G; Mura, I; Piana, A; Realdi, G | 1 |
| Dai, S; Du, H; Li, Q; Li, Y; Nie, Y; Sha, W; Wang, H; Wu, H | 1 |
| Hirai, S; Miwa, H; Murai, T; Nagahara, A; Ohkura, R; Sato, K; Sato, N; Watanabe, S | 1 |
| Kawashima, M; Maeda, K; Nishimura, H; Ohkuma, K; Okabe, N; Okada, M; Seo, M; Takata, T | 1 |
| Ducóns, JA; Ferrero, M; Gomollón, F; Guirao, R; Montoro, M; Santolaria, S | 1 |
| Barè, M; Calvet, X; Cubells, M; Gálvez, E; López-Lorente, M; Molina, E | 1 |
| Fuchs, W; Hörner, M; Schlauch, D; Sellinger, M; Sieg, A | 1 |
| Cross, R; Grimley, CE; Illing, RC; Lismore, JR; Loft, DE; Nwokolo, CU; O'sullivan, M; Penny, A; Shebani, M | 1 |
| Ende, AV; Hensen, EF; Hoff, BW; Houben, MH; Hulst, RW; Kate, FJ; Rauws, EA; Tytgat, GN | 1 |
| Bravo, LE; Correa, P; DeLany, JP; Mera, R; Realpe, JL | 1 |
| Grimm, KJ | 1 |
| Baena Díez, JM; Barrera Aguilera, N; Hernández Chafes, FJ; López Gosp, D | 1 |
| Acciardi, C; Ali', A; Gatta, L; Holton, J; Landi, F; Menegatti, M; Miglioli, M; Ricci, C; Vaira, D | 1 |
| Bentivegna, C; Branciforte, G; Brogna, A; Catalano, F; Catanzaro, R; Cipolla, R; Nuciforo, G | 2 |
| Chen, X; Haruma, K; Kajiyama, G; Kamada, T; Kawamura, Y; Komoto, K; Mihara, M; Sumii, K; Tahara, K; Yoshihara, M | 1 |
| Balk, AG; Lamers, CB; Loffeld, RJ; van der Putten, AB; Veenendaal, RA; Werdmuller, BF | 1 |
| Zwimpfer, J | 1 |
| Caballero Plasencia, A; Carmona Soria, I; Herrerías Gutiérrez, J; López-Andrade, A; Martín Ruiz, J; Rodríguez Téllez, M; Valenzuela Barranco, M | 1 |
| Adler, G; Boeck, W; Ellenrieder, V; Glasbrenner, B; Marre, R; Richter, C | 1 |
| Bardhan, KD; Bayerdörffer, E; Delchier, JC; Díte, P; Lind, T; Mégraud, F; O'Morain, C; Sipponen, P; Spiller, R; Veldhuyzen van Zanten, S; Zeijlon, L | 1 |
| Spiller, RC | 1 |
| Ballard, ED; Fennerty, MB; Talley, NJ; Vakil, N | 1 |
| Chen, J; Chen, SY; Wang, JY; Zhang, SS; Zhang, XD | 1 |
| Carpio, D; Gisbert, JL; Gisbert, JP; Grávalos, RG; Marcos, S; Pajares, JM | 1 |
| Evans, MF; Hammett, DC | 1 |
| Adamsson, I; Edlund, C; Lundquist, P; Nord, CE; Sjöstedt, S | 1 |
| Norinder, A; Ohlin, B; Tennvall, GR | 1 |
| Boixeda, D; Martín de Argila, C | 1 |
| Abdulle, AM; Adeyemi, EO; Benedict, S; Danial, MF; Helal, T | 1 |
| De Mascarel, A; Lamouliatte, H; Megraud, F; Samoyeau, R | 1 |
| Bytzer, P; Madsen, JL; Madsen, LG; Taskiran, M | 1 |
| Mach, T; Zahradnik-Bilska, J | 1 |
| Aller, R; Boixeda de Miquel, D; de la Calle, H; de Luis, DA; Garcia Avello, A; Lasuncion, MA; Martin de Argila, C | 1 |
| Aoyama, N; Kasuga, M; Kita, T; Komada, F; Okumura, K; Shirakawa, K; Tanigawara, Y | 1 |
| Bayerdörffer, E; Burman, CF; Díete, U; Dité, P; Domján, L; Kisfalvi, I; Lonovics, J; Mégraud, F; Pap, A; Sipponen, P; Zeijlon, L | 1 |
| Annibale, B; D'Ambra, G; Delle Fave, G; Marcheggiano, A; Martino, G; Paoletti, M | 1 |
| Cryer, B; Feldman, M; Lee, E; Sammer, D; Spechler, SJ | 1 |
| Antoniades, D; Kalafatis, E; Karameris, A; Lazaris, A; Liatsos, C; Petridou, E; Rokkas, T | 1 |
| Asaka, M; Ishizuka, J; Kagaya, H; Katagiri, M; Kato, M; Komatsu, Y; Kudo, M; Kudo, T; Nishikawa, K; Sugiyama, T; Sukegawa, M; Takeda, H; Toyota, J | 1 |
| Habu, Y; Inokuchi, H; Kawai, K; Kimoto, K; Kiyota, K; Mizuno, S; Sugano, Y | 1 |
| Aoyama, N; Kasuga, M; Kita, T; Kodama, F; Okumura, K; Sakai, T; Shirakawa, K; Shirasaka, D; Tanigawara, Y | 1 |
| Kohigashi, K; Matsukawa, Y; Nakazawa, T; Saita, H; Sekikawa, A; Shio, S; Sou, Y; Takahashi, Y; Yoshinaga, T | 1 |
| Fujishiro, M; Gotoda, T; Kondo, H; Oda, I; Ono, H; Saito, D; Yamaguchi, H | 1 |
| Alonso García, I; García Pérez, A; Giménez Samper, M; Valverde de La Osa, J | 1 |
| Chang, FY; Chau, WK; Fen-Yau Li, A; Huang, CC; Lam, CP; Lee, SD; Ng, WW | 1 |
| Blondon, H | 1 |
| Hoshiya, S; Ishida, H; Itoh, T; Ninomiya, H; Saito, S; Shingaki, M; Takahashi, S; Tanaka, A; Tokunaga, K; Watanabe, K | 1 |
| Chan, FK; Chung, SC; Ling, TK; Suen, R; Sung, JJ; Wu, JC | 1 |
| Acevedo, C; Duarte, I; Figueroa, C; Fuster, F; Giancaspero, R; Hola, K; Rollan, A; Schulz, M | 1 |
| Dickson, A; El-Nujumi, A; El-Omar, E; Kelman, A; McColl, KE | 1 |
| Carpio, RE; Fock, KM; Ho, J; Hu, FL; Hu, PJ; Huang, NX; Kachintorn, U; Kullavanijaya, P; Lam, SK; Lesmana, L; Li, YY; Manan, C; Perez, JY; Phornphutkul, K; Qian, SC; Wong, BC; Xiao, SD | 1 |
| Chelvam, P; Fock, KM; Lim, SG | 1 |
| Attili, AF; Meddi, P; Moscatelli, R; Rinaldi, V; Winn, S; Zullo, A | 1 |
| Brullet, E; Calvet, X; Campo, R; Comet, R; García, N; Titó, L | 1 |
| Ertugrul, C; Fevzi Ersoy, F; Isitan, F; Sarikaya, M; Suleymanlar, G; Suleymanlar, I; Tugrul Sezer, M; Tuncer, M; Yakupoglu, G | 1 |
| Hanai, H; Kajimura, M; Kaneko, E; Sugimoto, M | 1 |
| Artikis, V; Georgopoulos, SD; Karatapanis, S; Ladas, SD; Mentis, A; Raptis, SA; Spiliadi, C | 1 |
| Miwa, H; Murai, T; Nagahara, A; Ogihara, T; Ohkura, R; Ohta, K; Sato, K; Sato, N; Takei, Y; Yamada, T | 1 |
| Ducóns, JA; Gomollón, F; Guirao, R; Montoro, M; Santolaria, S; Vera, J | 1 |
| Beglinger, C; Drewe, J; Lehmann, FS; Terracciano, L | 1 |
| Hirai, S; Kikuchi, S; Miwa, H; Murai, T; Nagahara, A; Nishira, T; Sato, N; Takei, Y; Watanabe, S | 1 |
| Ballardini, G; Boni, F; Bortoli, A; Colombo, E; Minoli, G; Spinzi, GC; Venturelli, R | 1 |
| Begum, S; Endo, H; Kawamata, H; Sano, T; Urakami, Y | 1 |
| Lin, CH; Peters, J; Rabah, R; Shashidhar, H; Thomas, R; Tolia, V | 1 |
| Bloemena, E; Festen, HP; Klinkenberg-Knol, EC; Kuipers, EJ; Lindeman, J; Luckers, AE; Meuwissen, SG; Nelis, GF; Schenk, BE; Snel, P; Thijs, JC; Viergever, PP | 1 |
| Armuzzi, A; Gasbarrini, A; Gasbarrini, G; Ghirlanda, G; Ojetti, V; Pitocco, D; Pola, P; Silveri, NG | 1 |
| Bisson, S; Bojarski, C; Epple, HJ; Fromm, M; Kirstein, FW; Riecken, EO; Schulzke, JD | 1 |
| Adamsson, I; Edlund, C; Nord, CE | 1 |
| Iglesias Rodríguez, M; Jovell Fernández, E; Roca Figueras, G; Roca Fusalba, A; Ureña Tapia, MM; Vernet Vernet, M | 1 |
| Gonlachanvit, S; Kladchareon, N; Kullavanijaya, P; Mahachai, V | 1 |
| Carpio, D; García Grávalos, R; Gisbert, JL; Gisbert, JP; Marcos, S; Pajares, JM | 1 |
| Kaushik, SP; Vu, C | 1 |
| Laine, L; Neil, G; Suchower, L; Sugg, J | 1 |
| Bernal, S; Castro Fernández, M; Grande, L; Otero, MA; Romero Gómez, M; Vargas, J | 1 |
| Baños, F; Burrull, M; Cabezas, C; Lafuente, C; Madridejos, R; Morera, R | 1 |
| Attili, AF; Hassan, C; Lionetti, R; Meddi, P; Rinaldi, V; Ripani, C; Tomaselli, G; Winn, S; Zullo, A | 1 |
| Adamthwaite, D; Davidson, G; Katelaris, PH; Lambert, J; Midolo, P; Yeomans, ND | 1 |
| Ammon, S; Kees, F; Klotz, U; Treiber, G | 1 |
| Bhasin, DK; Pathak, CM; Ray, P; Sharma, BC; Singh, K | 1 |
| Iida, N; Kurosawa, A; Miwa, H; Nagahara, A; Ogawa, K; Ohkura, R; Sato, N | 1 |
| Brkić, T; Cuzić, S; Jakić-Razumović, J; Kusec, V; Tentor, D | 1 |
| Bratović, I; Gogov, B; Gribajcević, M; Lacević, N; Radović, S; Vukobrat-Bijedić, Z | 1 |
| Furuta, T; Hanai, H; Ishizaki, T; Ohashi, K; Shirai, N; Takashima, M; Xiao, F | 1 |
| Arai, K; Kobayashi, R; Mori, M; Ohki, I; Saito, K | 1 |
| Chao, W; Ching, JY; Chung, SC; Lau, JY; Lee, YT; Leung, WK; Lin, SR; Ng, EK; Sung, JJ; To, KF; Wang, RT; Yeung, CK; Zhou, LY | 1 |
| Joubert-Collin, M; Lamouliatte, H; Perie, F | 1 |
| Kurosawa, A; Minowa, T; Miwi, H; Murai, T; Nagahara, A; Ohkura, R; Ohtaka, K; Sato, K; Sato, N; Yamada, T | 1 |
| Hu, WH; Hui, WM; Lai, KC; Lam, SK; Wong, BC | 1 |
| Battaglia, G; Di Mario, F; Franceschi, M; Germanà, B; Leandro, G; Marin, R; Pilotto, A; Valerio, G | 1 |
| Fukazawa, K; Ishino, Y; Kawakami, S; Kihira, K; Kimura, K; Saifuku, K; Satoh, K; Sugano, K | 1 |
| Haruma, K; Hattori, N; Kajiyama, G; Kamada, T; Kawamura, Y; Kitadai, Y; Mihara, M; Miyoshi, E; Mukai, T; Sumii, K; Tahara, K; Yoshihara, M | 1 |
| Mansi, C; Savarino, V; Vigneri, S | 1 |
| Mahachai, V; Thongnopnua, P; Wannachai, N; Wittayalertpanya, S | 1 |
| Gribajcević, M; Pasalić, G; Salaka, U; Vanis, N | 1 |
| Daudén, E; García-Díez, A; Jiménez-Alonso, I | 1 |
| Barrera, F; Fuentes, J; Garuz, R; Gomollón, F; Malo, J; Simón, MA; Tirado, M; Valdepérez, J | 1 |
| Piqué, JM | 1 |
| Bytzer, P; Madsen, LG; Taskiran, M | 1 |
| Castellote, J; Porta, F | 1 |
| Daake, H; Frevel, M; Janisch, HD; Kellner, HU; Krezdorn, HG; Tanneberger, D; Wack, R | 1 |
| Bart, A; Beumer, HJ; Cattoli, G; Klaver, PS; Kuipers, EJ; Kusters, JG; Pot, RG; Robijn, RJ; van der Gaag, I; van Vugt, R; Vandenbroucke-Grauls, CM | 1 |
| Andrea Grassi, S; Battaglia, F; Benedetti, E; Bottona, E; Caroli, A; Costan-Biedo, F; Dal Bò, N; De Bastiani, R; Di Mario, F; Germanà, B; Leandro, G; Madia, D; Marcon, V; Marin, R; Monica, F; Olivieri, P; Orzes, N; Pilotto, A; Ronzani, G; Saggioro, A; Tafner, G | 1 |
| Howden, CW | 1 |
| Huang, AH; Huang, CC; Lin, XZ; Sheu, BS; Wu, JJ; Yang, HB | 1 |
| Bermejo, F; Boixeda, D; Defarges, V; García Plaza, A; Gisbert, JP; Martín de Argila, C; Sanz, JM | 1 |
| Aguilera, R; Flores, S; Marchese, A; Opazo, H; Valderrama, D; Valderrama, S | 1 |
| Bentivegna, C; Branciforte, G; Brogna, A; Catalano, F; Catanzaro, R; Cipolla, R | 1 |
| Arancio, F; Armuzzi, A; Cammarota, G; Cannizzaro, O; Cianci, R; Cuoco, L; Gasbarrini, A; Gasbarrini, G; Pirozzi, G; Santarelli, L; Zocco, MA | 1 |
| Apfalter, P; Barousch, W; Binder, C; Hirschl, AM; Kuderna, C; Makristathis, A; Pasching, E; Rotter, ML | 1 |
| Cheah, P; Chin, S; Goh, K; Parasakthi, N; Ranjeev, C; Rosmawati, M; Tan, Y | 1 |
| Bock, H; Heep, M; Koop, H; Lehn, N | 1 |
| Braegger, CP; Frank, F; Stallmach, T; Stricker, T | 1 |
| Kawashima, A; Motoo, Y; Ohtsubo, K; Okai, T; Sakai, J; Sawabu, N; Watanabe, H | 1 |
| Herr, H; You, CH | 1 |
| Asaka, M; Hokari, K; Kagaya, H; Kato, M; Komatsu, Y; Mizushima, T; Nishikawa, K; Sugiyama, T; Sukegawa, M; Takeda, H | 1 |
| Abbas, Z; Abid, S; Chang, FY; Chen, PC; Destefano, M; Hamid, SS; Lam, SK; Lin, BR; Schneider, H; Seebaran, A; Simjee, AE; Van Rensburg, C; Wong, BC; Zhang, J | 1 |
| Aalykke, C; Bekker, C; Bonnevie, O; Bytzer, P; Eriksen, J; Gjørup, T; Hansen, J; Justesen, T; Kjaergaard, J; Kromann-Andersen, H; Rask-Madsen, J; Rune, S; Teglbjaerg, PS; Vilien, M; Vyberg, M; Weywadt, L | 1 |
| Ansaldi, N; Gaido, F; Lerro, P; Lombardo, L; Morra, I; Perrucci, V | 1 |
| Begum, S; Endo, H; Kawamata, H; Oki, Y; Sano, T; Urakami, Y | 1 |
| Aydin, A; Isler, M | 1 |
| Akura, Y; Fujiwara, T; Hamazaki, K; Ikeda, Y; Matsumoto, T; Murashima, N; Nishisita, C; Umekawa, Y | 1 |
| Cockeram, A; De Argila, CM; Delchier, JC; Göthe, L; Hasselgren, G; Labenz, J; Lauritsen, K; Lind, T; Sinclair, P; Stubberöd, A; Treichel, HC; Veldhuyzen Van Zanten, S; Wrangstadh, M | 1 |
| Furusu, H; Inoue, K; Isomoto, H; Kohno, S; Mizuta, Y; Morikawa, T; Murase, K; Murata, I; Nishiyama, T; Omagari, K | 1 |
| Armuzzi, A; Bartolozzi, F; Cammarota, G; Canducci, F; Cremonini, F; Gasbarrini, A; Gasbarrini, G; Pola, P | 1 |
| Bedogni, G; Bertoni, G; Ghirarduzzi, A; Iori, I; Silingardi, M; Tincani, E | 1 |
| Akagi, K; Hizawa, K; Inuzuka, S; Matsumoto, T; Nakahara, T; Yano, Y | 1 |
| Cheng, NN; Hu, PJ; Liu, WZ; Ouyang, Q; Wang, JL; Xiao, SD; Zhou, LY | 1 |
| García, S; Gomollón, F; Lago, A; Sicilia, B; Sierra, E; Villar, M | 1 |
| Bozzola, L; Di Mario, F; Franceschi, M; Furlan, F; Leandro, G; Pilotto, A; Rassu, M | 1 |
| De Francesco, V; Faleo, D; Sgarro, C; Stoppino, V | 1 |
| Adamsson, I; Edlund, C; Engstrand, L; Seensalu, R | 1 |
| Aegerter, PH; de Mascarel, A; Lavergne, A; Megraud, F; Molina, T; Palazzo, L; Rambaud, JL; Ruskoné-Fourmestraux, A | 1 |
| Rosandić, M | 1 |
| Bardhan, K; Bayerdörffer, E; Burman, CF; Delchier, JC; Gromark, P; Hellblom, M; Lind, T; Mégraud, F; Stubberöd, A; Veldhuyzen Van Zanten, SJ; Zeijlon, L | 1 |
| Befrits, R; Lindberg, G; Odman, B; Sjöstedt, S; Sörngård, H | 1 |
| Aller, R; Boixeda, D; Caballero, C; Cantón, R; Cordero, JM; de la Calle, H; de Luis, DA | 1 |
| Brullet, E; Calvet, X; Campo, R; Garcia, N; Gené, E | 1 |
| Asaka, M; Kashiwagi, S; Miyake, K; Nomura, H; Sugiyama, T | 1 |
| Andriulli, A; Bergoli, ML; Caruso, N; Clemente, R; Festa, V; Perri, F; Quitadamo, M; Villani, MR | 1 |
| Alizadeh, BZ; Fakheri, H; Fazel, A; Khatibian, M; Malekzadeh, R; Massarrat, S; Merat, S | 1 |
| Kurosawa, A; Miwa, H; Nagahara, A; Ohkura, R; Sato, N; Yamada, T | 1 |
| Asaka, M; Hokari, K; Kagaya, H; Kato, M; Sugiyama, T; Takeda, H | 1 |
| Fujioka, T; Kagawa, J; Kodama, M; Murakami, K; Okimoto, T; Satoh, R | 1 |
| Kohgo, Y; Satoh, T; Shibata, N; Tanabe, H; Watari, J; Yokota, K | 1 |
| Ohkusa, T; Watanabe, M | 1 |
| Harada, H; Kobayashi, S; Miki, H; Ohmori, M; Sotozono, M; Uraoka, T; Yamanoi, Y | 1 |
| Baik, SK; Cho, MY; Jeong, YS; Kim, HS; Kim, JW; Kim, KH; Kwon, SO; Lee, DK; Seo, JI | 1 |
| Arakawa, Y; Ishii, Y; Kato, K; Kawamura, F; Kawamura, Y; Komuro, S; Nagata, T; Nemoto, N; Nishinarita, S; Sugitani, M; Takahashi, Y; Yanai, M | 1 |
| Bianchi Porro, G; Imbesi, V; Maconi, G; Parente, F; Russo, A; Vago, L | 1 |
| Furuta, T; Hanai, H; Ishizaki, T; Kaneko, E; Ohashi, K; Shirai, N; Sugimura, H; Takashima, M; Xiao, F | 1 |
| Alam, E; Mehdi, I; Qureshi, H | 1 |
| Bastens, B; Delforge, M; Demoulin, JC; Fontaine, F; Gerard, A; Gillard, V; Lutgen, N | 1 |
| Fock, KM; Khor, CJ; Ng, A; Ng, TM; Sim, CS; Tan, AL; Teo, EK | 1 |
| Endo, H; Higuchi, S; Ohmi, N; Yoshida, H | 2 |
| Gopanpallikar, A; Rathi, P; Sawant, P | 1 |
| Fock, KM; Law, NM; Lim, CC; Ng, HS; Ng, TM | 1 |
| Broutet, N; de Mascarel, A; Lamouliatte, H; Marais, A; Mégraud, F; Salamon, R; Samoyeau, R | 1 |
| Bayerdörffer, E; Ehninger, G; Fischbach, W; Greiner, A; Miehlke, S; Morgner, A; Müller-Hermelink, H; Neubauer, A; Schetelig, J; Schmitt, W; Stolte, M; Thiede, C | 1 |
| Avidan, B; Bar-Meir, S; Keller, N; Melzer, E | 1 |
| Caffarelli, C; Caruana, P; de'Angelis, GL; Fornaroli, F; Magliani, W; Manfredi, M; Street, ME | 1 |
| Abbate, G; Carratù, R; Esposito, P; Ferraraccio, F; Iovene, MR; Iuliano, D; Montella, F; Russo, MI; Tufano, MA | 1 |
| Delchier, JC; Lamarque, D; Lascols, C; Soussy, CJ; Tankovic, J | 2 |
| Konorev, MR | 2 |
| Chuang, CH; Lin, XZ; Sheu, BS; Wu, JJ; Yang, HB | 1 |
| Axon, AT; Barrowclough, S; Crocombe, W; Moayyedi, P; Neville, PM; Wrangstadh, M | 1 |
| Chayama, K; Haruma, K; Hiyama, T; Ito, M; Kitadai, Y; Masuda, H; Miyamoto, M; Shimamoto, F; Sumii, K; Tanaka, S; Yoshihara, M | 1 |
| Kölbel, CB; Lüth, S; Singer, MV; Teyssen, S | 1 |
| Boknik, P; Domschke, W; Fischer, H; Huber, V; Konturek, JW; Luess, H; Neumann, J; Schmitz, W | 1 |
| Bucki, R; Gołebiewska, M; Kemona, A; Namiot, DB; Namiot, Z | 1 |
| Cathomas, G; Dent, J; Fried, M; Guldenschuh, I; Menne, D; Schwizer, W; Thumshirn, M | 1 |
| Andriulli, A; Annese, V; Niro, GA; Perri, F; Quitadamo, M; Villani, MR | 1 |
| Andriulli, A; Festa, V; Perri, F; Quitadamo, M; Villani, MR | 1 |
| Bozzola, L; Di Mario, F; Franceschi, M; Leandro, G; Pilotto, A; Rassu, M; Soffiati, G; Valerio, G | 1 |
| Gorensek, M; Gubina, M; Krizman, I; Orel, I; Tepes, B | 1 |
| Delves, HT; Doig, LA; Phillips, RH; Powell, JJ; Sieniawska, CE; Thompson, RP; Whitehead, MW | 1 |
| Hojo, M; Miwa, H; Nagahara, A; Ohkura, R; Sato, K; Sato, N; Yamada, T | 1 |
| Kawabe, T; Maeda, S; Ogura, K; Okamoto, M; Omata, M; Shiratori, Y; Yamaji, Y; Yoshida, H | 1 |
| Kawamura, K; Kimura, M; Mukai, K; Nakamura, S; Nakamura, T; Sawa, H; Shiku, H; Suzuki, H; Toyoda, H; Yamaguchi, M | 1 |
| Huang, JJ; Sheu, BS; Wang, YL; Yang, HB | 1 |
| Chan, KL; Ng, DK; Tam, PK; Zhou, H | 1 |
| Brown, LM; Chang, YS; Fraumeni, JF; Gail, MH; Heinrich, J; Liu, WD; Ma, JL; Xu, GW; Yang, CS; You, WC; Zhang, L | 1 |
| Furuta, T; Hanai, H; Ishizaki, T; Nakagawa, K; Ohashi, K; Shirai, N; Sugimura, H; Takashima, M; Xiao, F | 1 |
| Ell, C; Moser, W; Ridl, W; Schoerner, C; Solbach, W; Stolte, M; Vieth, M | 1 |
| Hojo, M; Miwa, H; Nagahara, A; Sato, N | 1 |
| Ashorn, M; Mäkipernaa, A; Ruuska, T | 1 |
| Ishiki, K; Maga, T; Miyoshi, M; Mizuno, M; Nagahara, Y; Nasu, J; Oguma, K; Okada, H; Torigoe, T; Tsuji, T; Yokota, K | 1 |
| Barton, R; Campbell, M; Eccles, M; Hall, L; Steen, N | 1 |
| Aoyama, N; Hohda, T; Kasuga, M; Kita, T; Komada, F; Okumura, K; Saijoh, Y; Sakaeda, T; Sakai, T; Tanigawara, Y | 1 |
| Kurt, N; Oncel, M; Walsh, M | 1 |
| Adachi, K; Fujishiro, H; Hashimoto, T; Hattori, S; Hirakawa, K; Ishihara, S; Ishimura, N; Kaji, T; Kawamura, A; Kinoshita, Y; Niigaki, M; Sato, H; Watanabe, M | 1 |
| Fung, TT; Hui, PK; Lam, KM; Lau, CF; Loo, CK; Tung, SY; Wong, AM | 1 |
| Avcu, F; Avcu, N; Beyan, C; Kaptan , K; Nevruz, O; Ozyurt, M; Ural, AU; Yalçin, A | 1 |
| Hotz, J; Madisch, A; Plein, K; Stolte, M | 1 |
| Changchien, CS; Chen, JJ; Hsu, CC; Hu, TH; Lu, SN | 1 |
| Azuma, T; Dojo, M; Ito, Y; Kato, T; Kuriyama, M; Ohtani, M; Suto, H | 1 |
| Beglinger, C; Burnand, B; Froehlich, F; Gonvers, JJ; Hildebrand, P; Saraga, E; Schneider, C; Vader, JP; Wietlisbach, V | 1 |
| Bianchi Porro, G; Cucino, C; Imbesi, V; Maconi, G; Russo, A | 1 |
| Antonenko, OM; Dicheva, DT; Lebedev, EG; Maev, IV; Ovsiannikova, EV; Shchekina, MI; V'iuchnova, ES | 1 |
| Bujanda, L; Cosme, A; Iriondo, C; Muñoz, C; Sánchez, A; Santos, A | 1 |
| Burm, M; Faigel, D; Fennerty, MB; Kelly, C; Magaret, N; Peterson, W | 1 |
| Aragona, F; Di Vita, G; Leo, P; Montalto, G; Patti, R | 1 |
| Asaka, M; Hige, S; Hokari, K; Ishizuka, J; Kagaya, H; Kato, M; Komatsu, Y; Kudo, M; Miyagishima, T; Mizushima, T; Nishikawa, K; Saito, M; Sugiyama, T; Takeda, H | 1 |
| Hsu, CT; Kuo, CF; Wang, CS; Wang, TH; Yang, JC; Yang, KC | 1 |
| Hirakoba, M; Kume, K; Murata, I; Otsuki, M; Yoshikawa, I | 1 |
| Chey, WD; Fendrick, AM | 1 |
| Lucas, M; Palhano, MJ; Ribeiro, JM; Victorino, RM | 1 |
| Araj, GF; Chahine, C; Chedid, M; Moukhachen, O; Sharara, AI | 1 |
| Ahmad, MM; Arefin, MS; Bardhan, P; Bauerfeind, P; Beglinger, C; Glatz-Krieger, K; Gyr, N; Hasan, M; Hildebrand, P; Khan, AK; Parvin, S; Rahman, A; Rossi, L; Terracciano, L | 1 |
| Asaka, M; Hamashima, C; Ikeda, S; Tamamuro, T | 1 |
| Barthélemy, P; Caekaert, A; Fléjou, JF; Laurent, J; Mégraud, F | 1 |
| Asaka, M; Fujioka, T; Fukuda, Y; Kato, M; Kimura, K; Kobayashi, S; Kuwayama, H; Satoh, K; Shimizu, K; Shimoyama, T; Sugiyama, T; Takemoto, T | 2 |
| Veldhuyzen van Zanten, SJ | 1 |
| Farkkilä, M; Koskenpato, J; Sipponen, P | 2 |
| Chen, CL; Chen, LT; Cheng, AL; Chiang, IP; Jan, CM; Lin, JT; Liu, SM; Shyu, RY; Su, IJ | 1 |
| Barthélemy, P; Dupont, C; Gottrand, F; Guimber, D; Husson, MO; Kalach, N; Lachaux, A; Lenaerts, C; Maurage, C; Morali, A; Mougenot, JF; Roquelaure, B; Spyckerelle, C; Tounian, P | 1 |
| Misawa, H; Miwa, H; Nagahara, A; Ohtaka, K; Sato, N; Yamada, T | 1 |
| Esaki, M; Fukuda, T; Kurahara, K; Kusano, Y; Matsumoto, T; Nakamura, S | 1 |
| Endo, H; Higuchi, S; Ohmi, N; Ohta, K; Yoshida, H | 1 |
| Bartuzi, Z; Dite, P; Hasselgren, G; Kleczkowski, D; Kryszewski, A; Larkö, A; Rudzinski, J; Tulassay, Z; Wrangstadh, M | 1 |
| Mai, AL; Mai, KT | 1 |
| Starostin, BD | 1 |
| Akao, T; He, JX; Nishino, T; Tani, T | 1 |
| Azuma, T; Dojo, M; Kuriyama, M; Muramatsu, A; Ohtani, M; Saito, T | 1 |
| De Francesco, V; Faleo, D; Hassan, C; Ierardi, E; Morini, S; Panella, C; Zullo, A | 1 |
| Barbir, A; Hovat, D; Ivandić, A; Kurbel, S; Mihaljević, S; Ostojić, R; Stimac, D; Takac, B; Vcev, A; Vceva, A | 1 |
| Ammon, S; Klotz, U; Treiber, G; van Doorn, LJ; Walker, S; Wittig, J | 1 |
| Aoyama, N; Okumura, K; Shirasaka, D | 1 |
| Bavbek, N; Koçkar, C; Oztürk, M | 1 |
| Fujioka, T; Kodama, M; Murakami, K; Nasu, M; Okimoto, T; Sato, R | 1 |
| Antos, D; Bayerdörffer, E; Dite, P; Dragosics, B; Ehninger, G; Gschwantler, M; Kirsch, C; Labenz, J; Läuter, J; Leodolter, A; Malfertheiner, P; Miehlke, S; Neubauer, A; Oberhuber, G; Stolte, M | 1 |
| Jung, HC; Kim, CW; Kim, CY; Kim, JS; Kim, YS; Lee, CH; Song, IS | 1 |
| Goto, H; Hino, R; Kikuta, T; Ota, A; Tsuji, H | 1 |
| Quandalle, P; Tran, TT | 2 |
| Furukawa, F; Sakurane, M; Shiotani, A | 1 |
| Asgari, AA; Dariani, NE; Malekzadeh, R; Massarrat, S; Sotoudehmanesh, R; Vahedi, H | 1 |
| Khan, Z; Nair, P; O'Shea, C; Playford, RJ; Spiers, N; Wicks, AC | 1 |
| Andreu, R; De la Rubia, J; Gomis, F; Jarque, I; Jiménez, C; Llopis, I; Martín, G; Martínez, JA; Ponce, J; Sanz, GF; Sanz, MA; Senent, L | 1 |
| Ahn, DS; Choi, IJ; Choi, KW; Chung, IS; Chung, JM; Hong, WS; Jung, HC; Kim, JH; Lee, SI; Rew, JS; Rhee, JC; Yang, US | 1 |
| Alampi, G; Bazzoli, F; Berretti, D; De Luca, L; Di Pietro, C; Fossi, S; Morelli, P; Nicolini, G; Pozzato, P; Ricciardiello, L; Roda, E; Zagari, RM | 1 |
| Choi, IJ; Jung, HC; Kim, BG; Kim, JS; Kim, SG; Park, MJ; Song, IS | 1 |
| Chang, CS; Chen, GH; Lai, CH; Poon, SK; Su, J; Wang, WC; Yang, CC | 1 |
| Börsch, G; Kahl, S; Labenz, J; Leodolter, A; Malfertheiner, P; Peitz, U; Stolte, M; Sulliga, M; Von Arnim, U; Wolle, K | 1 |
| Brousse, N; Copie-Bergman, C; de Mascarel, A; Delchier, JC; Flejou, JF; Gaulard, P; Hemery, F; Lavergne-Slove, A; Levy, M; Traulle, C | 1 |
| Haapiainen, R; Härkönen, M; Kokkola, A; Kosunen, TU; Puolakkainen, P; Rautelin, H; Sipponen, P | 1 |
| Chan, FK; Lee, YT; Leung, WK; Sung, JJ; Wong, SK; Wu, JC | 1 |
| Bujanda, L; Castiella, A; Cosme, A; De Argila, CM; Elizalde, I; Elizalde, JI; Moreno, V; Morillas, JD; Piqué, JM; Ros, E | 1 |
| Barbier, C; Benhamou, PH; Bergeret, M; Dupont, C; Gottrand, F; Husson, MO; Kalach, N; Raymond, J | 1 |
| Koyama, H; Nomura, F; Odaka, T; Saisho, H; Yamaguchi, T | 1 |
| Fung, FM; Gu, Q; Lai, KC; Lam, SK; Lu, H; Wang, WH; Wong, BC; Wong, WM; Xia, HH; Xiao, SD; Yin, Y | 1 |
| Baena, JM; García, M; Hernández, MR; Hidalgo, A; Jiménez, S; López, C; Rams, F | 1 |
| Andriulli, A; Clemente, R; Festa, V; Merla, A; Perri, F; Quitadamo, M | 1 |
| Nakamura, T | 1 |
| Asaka, M; Kato, M; Komatsu, Y; Shimizu, Y; Sugiyama, T; Takeda, H | 1 |
| Kato, S | 1 |
| Satoh, K | 2 |
| Fu, HY; Kawano, S; Tanimura, H | 1 |
| Ohkusa, T; Sato, N | 1 |
| Miwa, H; Miyazaki, A; Nagahara, A; Sato, N | 1 |
| Furuta, T; Shirai, N | 1 |
| Takahashi, S; Tokunaga, K | 1 |
| Mitsuno, Y; Yoshida, H | 1 |
| Asaka, M; Kagaya, H; Kato, M | 1 |
| Inoue, K; Sugano, K | 1 |
| Kurosawa, A; Miwa, H; Sato, N | 1 |
| Sakaki, N | 2 |
| Haruma, K; Kamada, T; Kusunoki, H | 1 |
| Sawada, A | 1 |
| Chiba, T; Watanabe, T | 1 |
| Kawata, H; Satoh, K | 1 |
| Yoshino, J | 1 |
| Kato, C; Sato, K | 1 |
| Azuma, T; Ito, S; Yamazaki, Y | 1 |
| Fukuda, Y; Shimoyama, T | 1 |
| Takahashi, S; Tanaka, A | 1 |
| Kiriyama, Y; Koizumi, K; Kuwayama, H; Ohara, T; Suga, M; Suzuki, K; Takahashi, M; Takata, H | 1 |
| Chayama, K; Haruma, K; Ito, M; Kamada, T; Kawamura, Y; Kitadai, Y; Yoshihara, M | 1 |
| Isomoto, H; Kohno, S | 1 |
| Baumann, R; Buri, P; Cunningham, M; Dederding, JP; Gallaz, L; Girard, L; Godin, N; Merki, H; Metry, JM; Sitavanc, R; Wermeille, J; Zelger, G | 1 |
| Sugano, K | 1 |
| Kapp, A; Wedi, B | 1 |
| Dhir, V; Laine, L | 1 |
| Calvet, X; Gisbert, JP; Vallve, M; Vergara, M | 1 |
| Colin, R | 1 |
| Bernasconi, G; Calafatti, SA; Corazzi, A; De Souza, CA; Deguer, M; Ferraz, JG; Marchioretto, MA; Ortiz, RA; Pedrazzoli, J; Souza, JM | 1 |
| Azagra, R; Calvet, X; Cubells, MJ; Gené, E; López, T | 1 |
| Gościmski, A; Matras, J; Wallner, G | 1 |
| Akamatsu, T; Gotoh, A; Ikeno, T; Ishida, K; Kaneko, T; Katsuyama, T; Kawakami, Y; Kiyosawa, K; Ota, H; Shimizu, T; Shimodaira, K; Sugiyama, A | 1 |
| Ateşkan, U; Mas, MR; Ozdemir, A; Sağlamkaya, U; Sahin, S | 1 |
| Inaba, T; Kawai, K; Miyoshi, M; Mizuno, M; Oguma, K; Okada, H; Take, S; Tsuji, T; Yokota, K | 1 |
| Adamek, HE; Riemann, JF; Schilling, D | 1 |
| Bloemena, E; Cats, A; Kuipers, EJ; Lindeman, J; Meuwissen, SG; Quint, WG; Scholte, GH; van Doorn, LJ | 1 |
| Asaka, M; Shimodan, M; Sugiyama, T; Tsuchida, M; Yokota, K | 1 |
| Hirayama, Y; Kanisawa, Y; Kogawa, K; Kohda, K; Koike, K; Kuga, T; Kuroiwa, G; Niitsu, Y; Sato, Y | 1 |
| Andreu, V; Bory, F; Calvet, X; Ducons, J; Guardiola, J; Guirao, R; Tito, L | 1 |
| Amat, C; Ancelin-Malbreil, E; Becquart, JP; Faulques, B; Michault, A; Picot, S; Sapin, G; Simac, C | 1 |
| Echizen, H; Nachi, S; Ohnishi, A; Ushiama, H | 1 |
| Endo, H; Higuchi, S; Ohmi, N; Ohta, K; Suga, T; Yoshida, H | 1 |
| Fujimoto, K; Fujise, T; Ishibashi, S; Iwakiri, R; Kawasaki, S; Kikkawa, A; Oda, K; Ootani, A; Ootani, H; Sakata, H; Shimoda, R; Tadano, J; Tsunada, S; Yoshida, T | 1 |
| Bettoni, L; Cattaneo, R; Rizzini, FL; Tosoni, C | 1 |
| Blum, AL; Bolten, WW; Dragosics, B; Koelz, HR; Labenz, J; Rösch, W; Stolte, M | 1 |
| Nakamura, T; Terano, A | 1 |
| Chen, JH; Lin, MD; Lin, YS; Lo, CY; Sheu, BS; Wu, HW; Wu, JJ | 1 |
| Lam, EK; Lo, KY; Loo, CK; Mak, SK; Tong, GM; Wong, AK; Wong, AM; Wong, PN | 1 |
| Endo, H; Kohno, Y; Suga, T; Yoshida, H | 1 |
| Furukawa, K; Hisabe, T; Imamura, K; Kanda, M; Kikuchi, M; Matsui, T; Ohshima, K; Tsuda, S; Yao, T | 1 |
| Kas'ianenko, VI; Vasil'ev, IuV | 1 |
| Bondarenko, OY; Fedchenko, VI; Grigoriev, PY; Gulyaev, PV; Ivashkin, VT; Lapina, TL; Sklanskaya, OA; Vasiliev, YV; Yakovenko, EP | 1 |
| Bevanda, M; Falisevac, V; Korać, B; Pilas, V; Rosandić, M | 1 |
| Figueroa, LS; Guarner, J; Halperin, D; Herrera-Goepfert, R; Ley, C; Mohar, A; Parsonnet, J | 1 |
| De Francesco, V; Faleo, D; Ierardi, E; Margiotta, M; Panella, C | 1 |
| Abe, H; Arita, T; Fujioka, T; Kagawa, J; Kodama, M; Murakami, K; Nasu, M; Okimoto, T; Sato, R; Sato, S | 1 |
| Chuang, CH; Huang, AH; Sheu, BS; Wu, JJ; Yang, HB | 1 |
| Bellini, M; Costa, F; De Bortoli, N; Maltinti, G; Marchi, S; Petrini, M | 1 |
| Mishra, RM; Yusuf, SW | 1 |
| Borner, K; Koeppe, P; Kotwas, J; Lode, H; Mainz, D | 1 |
| Fang, L; Huang, S; Jiang, K; Jiang, X; Lin, N; Pan, W; Wan, Y; Xu, R | 1 |
| Handa, Y; Kawai, T; Kawakami, K; Kudo, T; Moriyasu, F; Ogiahara, S | 1 |
| Bago, J; Bevanda, M; Bilić, A; Halle, ZB; Jandrić, D; Kućisec, N; Strinić, D; Tomić, M | 1 |
| Cui, M; Hu, F; Jiang, H; Zheng, X | 1 |
| Alarcón, T; Domingo, D; García, JA; López-Brea, M; Martínez, MJ; Vega, AE | 1 |
| Amberiadis, P; Archavlis, E; Chiotakakou, E; Christoforidis, P; Kourtessas, D; Mantzaris, GJ; Petraki, K; Triantafyllou, G | 1 |
| Kawano, S | 1 |
| Fukai, Y; Fukuchi, M; Katoh, H; Kuwano, H; Manda, R; Masuda, N; Miyazaki, T; Nakajima, M; Ojima, H; Tsukada, K; Tsukada, O | 1 |
| Arnold, R; Blum, AL; Fischer, M; Koelz, HR; Stolte, M | 1 |
| Bentivegna, C; Branciforte, G; Brogna, A; Catalano, F; Scalia, A; Terminella, C | 1 |
| Chung, IS; Chung, KW; Kim, JI; Kim, JK; Park, SH; Sun, HS | 1 |
| Bancel, B; Corthesy-Theulaz, I; Crabtree, JE; Diezi, J; Felley, CP; Felley-Bosco, E; Michetti, P; Ohshima, H; Patricot, LM; Pignatelli, B; Stolte, M; Van Melle, GD | 1 |
| Fujioka, T; Kagawa, J; Kodama, M; Murakami, K; Nasu, M; Okimoto, T; Sato, R | 1 |
| Habu, Y; Hayakumo, T; Inokuchi, H; Kawabata, H; Kawai, K; Kimoto, K; Kiyota, K; Kobayashi, M; Kutsumi, H; Mizuno, S; Nakajima, M; Oyasu, K; Tomioka, H | 1 |
| Berg, DE; Bhattacharya, S; Chattopadhya, S; Chaudhuri, S; Chowdhury, A; Datta, S; Dhali, G; Mukhopadhyay, AK; Nair, GB; Saha, DR; Santra, A | 1 |
| Aoyama, N; Kasuga, M; Kita, T; Kuroda, K; Maekawa, S; Miki, I; Okumura, K; Sakaeda, T; Sakai, T; Shirasaka, D; Tamura, T; Wambura, CM | 1 |
| Orr, CF; Rowe, DB | 1 |
| Arima, N; Tsudo, M | 1 |
| Sano, T; Urakami, Y | 1 |
| Campo, SM; De Francesco, V; Faleo, D; Fornari, F; Gatta, L; Hassan, C; Ierardi, E; Marinone, G; Menegatti, M; Merla, A; Mete, LS; Miglioli, M; Morini, S; Papadìa, C; Perna, F; Perri, F; Pilati, S; Potì, R; Ricci, C; Rinaldi, V; Savioli, A; Tampieri, A; Vaira, D; Vakil, N; Zullo, A | 1 |
| Anagnostopoulos, GK; Arvanitidis, D; Kostopoulos, P; Margantinis, G; Tsiakos, S | 1 |
| Bielanski, W; Galuschka, K; Hahn, EG; Karcz, D; Konturek, PC; Konturek, SJ; Rembiasz, K; Stachura, J | 1 |
| Mikhaleva, EN; Tsimmerman, IaS | 1 |
| El-Zimaity, H; Hunt, R; Laine, L; Nguyen, B; Osato, M; Spénard, J | 1 |
| Blum, AL; Bolling-Sternevald, E; Mitchell, HM; O'Morain, CA; Stolte, M; Talley, NJ; Xia, HH | 1 |
| Furusu, H; Inoue, K; Isomoto, H; Kohno, S; Mizuta, Y; Murase, K; Murata, I; Nishiyama, H; Omagari, K; Shikuwa, S | 1 |
| Matsuda, M; Noda, Y; Takemori, Y | 1 |
| Brzozowski, T; Drozdowicz, D; Hahn, EG; Konturek, PC; Konturek, SJ; Kwiecien, S; Pajdo, R; Pawlik, M; Pawlik, WW; Ptak, A; Stachura, J | 1 |
| Atherton, JC; Hawkey, CJ; Ravic, M; Thjodleifsson, B; Treichel, HC | 1 |
| Orbay, E; Sargýn, H; Sargýn, M; Uygur-Bayramicli, O; Yavuzer, D; Yayla, A | 1 |
| Asaka, M | 2 |
| Hamajima, N; Ikehara, Y; Matsuo, K; Matsuura, A; Nakamura, T; Suzuki, T; Tajima, K; Tominaga, S | 1 |
| Iihara, K; Kaise, M; Miwa, J; Oda, Y; Ohta, Y; Suzuki, N | 1 |
| Chayama, K; Haruma, K; Ito, M; Kamada, T; Masuda, H; Miyamoto, M; Nishisaka, T; Sumioka, M; Tanaka, S; Yoshihara, M | 1 |
| Bohuschke, M; Gatz, G; Kirchner, T; Kist, M; Leodolter, A; Malfertheiner, P; Peitz, U; Strobel, S | 1 |
| Huang, AH; Huang, JJ; Sheu, BS; Wu, JJ; Yang, HB | 1 |
| Bermejo, F; Boixeda, D; García Plaza, A; Hernández Ranz, F; López Sanromán, A; Martín De Argila, C | 1 |
| Borda, F; Domínguez-Muñoz, JE; Ducons, J; Gallego, S; Gisbert, JP; Gomollón, F; Hervás, A; Iglesias, J; Jiménez, I; Miño, G; Pajares, JM; Pastor, G; Santolaria, S; Vázquez, MA | 1 |
| Bottiglieri, ME; Budillon, G; Cuomo, R; Grasso, R; Ierardi, E; Nardone, G; Sarnelli, G; Verde, C | 1 |
| Ekström, P; Hellblom, M; Kihira, K; Kimura, K; Ohlin, B; Satoh, K; Sipponen, P; Stubberöd, A; Unge, P; Yoshida, Y; Yube, T | 1 |
| Butorab, Z; Massarrat, S; Roghani, HS; Shirekhoda, M | 1 |
| Angeletti, S; De Francesco, V; Hassan, C; Ierardi, E; Lorenzetti, R; Marignani, M; Morini, S; Zullo, A | 1 |
| Biagi, GL; Cantelli-Forti, G; Gatta, L; Miglioli, M; Paolini, M; Perna, F; Ricci, C; Sapone, A; Tampieri, A; Trespidi, S; Vaira, D | 1 |
| Kolesnikow, T; Lee, A; Leung, V; O'Rourke, JL; van Zanten, SJ | 1 |
| Chayama, K; Haruma, K; Manabe, N; Sasaki, A; Tanaka, S; Yoshihara, M | 1 |
| Ford, A; Moayyedi, P | 1 |
| Enjoji, A; Fujimoto, C; Furusu, H; Hirakata, Y; Inoue, K; Isomoto, H; Kohno, S; Mizuta, Y; Murase, K; Murata, I; Omagari, K; Shimada, S; Yamakawa, M | 1 |
| Chen, TK; Huang, SH; Lai, YC; Lee, CL; Wang, TH; Wu, CH; Yang, SS | 1 |
| Fujita, I; Kato, S; Masuda, G; Matsukura, N; Tajiri, T; Togashi, A; Tokunaga, A; Yamada, N | 1 |
| Haruma, K; Hata, J; Ito, M; Kamada, T; Kusunoki, H; Sasaki, A; Tanaka, S; Yoshihara, M | 1 |
| Ermolaev, IA; Nazarov, VE; Rukhliada, NV | 1 |
| Uthaisaengsook, W | 1 |
| Barrett, DA; Kumagai, N; Nakamura, M; Spiller, RC; Tanaka, T; Tsuchimoto, K; Wibawa, JI | 1 |
| Bästlein, E; Bayerdörffer, E; Haferland, C; Jacobs, E; Kirsch, C; Lehn, N; Miehlke, S; Neumeyer, M; Papke, J; Schneider-Brachert, W; Stolte, M; Vieth, M | 1 |
| Demleitner, K; Fischbach, W; Fuchs, W; Layer, P; Leodolter, A; Malfertheiner, P; MOssner, J; Stolte, M | 1 |
| De Francesco, V; Hassan, C; Ierardi, E; Morini, S; Panella, C; Piglionica, D; Scaccianoce, G; Zullo, A | 1 |
| Cohen, L; Fedorak, RN; Lambert, J; Vanjaka, A; Veldhuyzen van Zanten, S | 1 |
| Lam, EK; Lo, KY; Loo, CK; Mak, SK; Tong, GM; Wong, AK; Wong, PN | 1 |
| Cisneros, G; Gurney, M; Jarjoura, D; Lara, LF; Moauro, B; Polen, A; Rutecki, G; Van Ness, M; Whittier, F | 1 |
| Hoshino, Y; Ishii, H; Kurabayashi, K; Masaoka, T; Minegishi, Y; Nomura, S; Suzuki, H; Suzuki, M | 1 |
| Choi, BK; Chung, JM; Jang, YS; Lee, SH; Lee, YJ; Park, ET; Seol, SY; Yang, SY | 1 |
| Barkun, A; Chiba, N; Cockeram, A; Dallaire, C; Fallone, C; Farley, A; Nicholls, B; Simms, L; Veldhuyzen van Zanten, S | 1 |
| Barthelemy, P; Bretagne, JF; Courillon-Mallet, A; De Korwin, JD; Delchier, JC; Fauchère, JL; Fléjou, JF; Labigne, A; Lamouliatte, H; Mégraud, F | 1 |
| Andriulli, A; Barberani, F; Festa, V; Merla, A; Perri, F; Pilotto, A | 1 |
| Balatsinou, C; Caldarella, MP; Cuccurullo, F; Di Bonaventura, G; Lapenna, D; Laterza, F; Milano, A; Neri, M; Piccolomini, R | 1 |
| Chan, CK; Chan, OO; Chu, KM; Hu, HC; Hui, WM; Kwok, KF; Lai, KC; Lam, SK; Wong, BC; Wong, WM | 1 |
| Chang, FY; Chen, CY; Jium, KL; Lee, SD; Lu, CL; Luo, JC | 1 |
| Bautista, CT; Berg, DE; Dailide, G; Gilman, RH; Katz, U; Meza, R; Monath, TP; Ogura, M; Razuri, M; Roth, DE; Soto, G; Taylor, DN; Velapatiño, B | 1 |
| Atisook, K; Kachintorn, U; Kositchaiwat, C; Ovartlarnporn, B | 1 |
| Garrido-Serrano, A; Hergueta, P; Martínez-Delgado, C; Montojo, C; Navarro, JM; Romero-Gómez, M; Santos, O | 1 |
| Aoyama, N; Fukuda, M; Kachi, M; Kasuga, M; Kuroda, K; Maekawa, S; Miki, I; Shirasaka, D; Tamura, T; Wambura, C; Watanabe, Y | 1 |
| Bochenek, WJ; Davis, KD; El-Zimaity, HM; Fraga, PD; Graham, DY; Mack, ME; Osato, MS; Peters, S; Wang, W | 1 |
| Inaba, T; Ishiki, K; Mizuno, M; Nagahara, Y; Oguma, K; Okada, H; Shiratori, Y; Take, S; Yamamoto, K; Yokota, K; Yoshida, T | 1 |
| Barbato, A; Landi, L; Panizzolo, C; Rugge, M; Semenzato, R | 1 |
| Il'chenko, LIu; Nazarenko, IV; Parfenov, AI; Ruchkina, IN; Zvenogorodskaia, LA | 1 |
| Furuta, T; Ishizaki, T; Ohashi, K; Shirai, N; Sugimoto, M | 1 |
| Dragosics, B; Fischbach, W; Goebeler-Kolve, ME; Greiner, A; Stolte, M | 1 |
| Fakheri, H; Hosseini, V; Malekzadeh, R; Merat, S | 1 |
| Bae, JS; Jung, HS; Kim, HJ; Lee, JK; Lee, SB; Park, SJ; Park, SM; Ryu, JK | 1 |
| Vithayasai, N | 1 |
| Abdulkhakov, RA; Isakov, VA; Kononov, AV; Livzan, MA; Maev, IV; Predvechnaia, IK; Simanenkov, VI; Zakharova, NV | 1 |
| Chan, FK; Ching, JY; Chung, SC; Hui, Y; Leong, R; Leung, WK; Sung, JJ; Wu, JC | 1 |
| Díaz de Rojas, F; Esteban López Jamar, JM; González Carro, P; Legaz Huidobro, ML; Pedraza Martín, C; Pérez Roldán, F; Ponte Tellechea, A; Ruiz Carrillo, F; Sáez Bravo, JM; Valenzuela Gámez, JC | 1 |
| Aiba, M; Hamaguchi, K; Katsube, T; Konno, S; Ogawa, K | 1 |
| Barone, M; Berloco, P; Burattini, O; De Francesco, V; Di Leo, A; Francavilla, A; Ierardi, E; Marangi, S; Margiotta, M; Minenna, MF; Morini, S; Panella, C; Russo, F; Stoppino, V; Zullo, A | 1 |
| Saltanova, SD; Tkach, OS | 1 |
| Gisbert, JL; Gisbert, JP; Marcos, S; Pajares, JM | 1 |
| Chen, JH; Chen, TJ; Lee, SC; Wang, GM; Yang, KC | 1 |
| Ganskaia, ZhIu; Isakov, VA; Maev, IV; Podgrobunskikh, EI | 1 |
| Hao, YT; He, XX; Zhao, YH | 1 |
| Boyacioglu, S; Cosar, AM; Gumurdulu, Y; Gur, G; Gursoy, M; Kayaselcuk, F; Ozer, B; Ozsahin, K; Serin, E; Yilmaz, U | 1 |
| Guo, CY; Liu, HL; Wu, JY; Wu, YB; Zhong, MZ | 1 |
| El-Omar, EM; Furuta, T; Ishizaki, T; Ohashi, K; Rabkin, CS; Shirai, N; Sugimura, H; Xiao, F | 1 |
| Cuomo, A; De Simone, T; Del Vecchio Blanco, C; Iovene, MR; Marmo, R; Montella, F; Mucherino, C; Nardone, G; Romano, M; Tufano, MA | 1 |
| Hotz Dagger, J; Leodolter, A; Malfertheiner, P; Peitz, U; Plein, K; Raps, S | 1 |
| Asaka, M; Sugiyama, T | 1 |
| Klochko, OG; Kornienko, EA | 1 |
| Ahuja, V; Bal, CS; Chaudhary, A; Das, B; Pandey, RM; Sharma, MP | 1 |
| Cammarota, G; Candelli, M; Crea, F; Gasbarrini, A; Gasbarrini, G; Marietti, G; Nista, EC; Petrucci, S; Pignataro, G; Rigante, D; Schiavino, A | 1 |
| Avni, Y; Birkenfeld, S; Boaz, M; Epstein, J; Levine, A; Niv, Y; Shevah, O; Shirin, H | 1 |
| Inami, N; Kanazawa, S; Nomura, S | 1 |
| Amoruso, A; De Francesco, V; Della Valle, N; Ierardi, E; Muscatiello, N; Panella, C; Stoppino, V | 1 |
| Amarapurkar, A; Amarapurkar, D; Das, HS; Makesar, M | 1 |
| Färkkilä, M; Sarna, S; Sipponen, P; Valtonen, V | 1 |
| Gribajcević, M; Mesihović, R; Vanis, N | 1 |
| Baldwin, L; Bell, GD; Cameron, EAB; Jones, P; Powell, KU; Williams, SGJ | 1 |
| Ahuja, V; Bal, C; Bhatia, V; Das, B; Sharma, MP | 1 |
| Altintas, E; Aydin, O; Camdeviren, H; Sezgin, O; Ulu, O | 1 |
| Araj, GF; Barada, KA; Chaar, HF; Moukhachen, O; Mourad, FH; Racoubian, E; Sharara, AI | 1 |
| Altun, S; Aslan, M; Kocazeybek, B; Memisoglu, N; Öner, YA; Saribas, S; Seyhun, Y | 1 |
| Kemona, A; Namiot, DB; Namiot, Z; Stasiewicz, J | 1 |
| De Francesco, V; Della Valle, N; Hassan, C; Ierardi, E; Minenna, MF; Monno, R; Morini, S; Panella, C; Pietrini, L; Stoppino, V; Winn, S; Zullo, A | 1 |
| Burroughs, R; Lane, E; Lobetti, R | 1 |
| Fujiyama, Y; Inoue, T; Kakinoki, R; Sakabe, H; Yagi, Y; Yoshikawa, K | 1 |
| Asaumi, N; Niiya, K; Niiya, M; Shibakura, M; Tanimoto, M; Yoshida, C | 1 |
| Celikel, CA; Giral, A; Kalayci, C; Ozdogan, O; Tozun, N; Ulusoy, NB | 1 |
| Barth, J; Lanza, F; Schwartz, H; Vakil, N | 1 |
| Chen, A; Chen, JL; Hsu, PI; Jou, HS; Lai, KH; Lin, CK; Lo, CC; Lo, GH; Peng, NJ; Shie, CB; Tsai, PM; Tseng, HH; Wu, CJ | 1 |
| Karaoglu, AO; Yasa, MH; Yukselen, V | 1 |
| Chen, XX; Ou, BY; Qü, YP; Shang, SQ; Tang, HF; Wu, XY; Zhou, XL | 1 |
| Doherty, GM; Farrell, S; McCallion, WA; Milliken, I; Murphy, JL; Wootton, SA | 1 |
| Cucchiara, S; de'Angelis, GL; Ferzetti, A; Franco, MT; Kuvidi, M; Lerro, P; Marinello, D; Oderda, G; Pensabene, L; Romano, C; Strisciuglio, P | 1 |
| Ando, T; El-Omar, E; Goto, H; Ichiyama, S; Iinuma, Y; Ina, K; Kusugami, K; Minami, M; Nada, T; Nobata, K; Ohta, M; Tsuzuki, T | 1 |
| Ishii, H; Kamiya, AG; Masaoka, T; SuzukiKurabayashi, HK | 1 |
| Itoh, K; Itoh, M; Joh, T; Kataoka, H; Kondo, Y; Nomura, T; Ohara, H; Oshima, T; Sasaki, M; Tanida, S | 1 |
| Chan, FK; Ching, JY; Lau, JY; Leung, WK; Lin, SR; Ng, EK; Sung, JJ; To, KF | 1 |
| Arslan, N; Bekem, O; Buyukgebiz, B; Hizli, S; Ozer, E; Ozturk, Y | 1 |
| Ashorn, M; Karikoski, R; Kokkonen, J; Rägö, T; Rautelin, H; Ruuska, T | 1 |
| Ghazzawi, IM; Obeidat, WA; Zuriekat, FA | 1 |
| Akarsu, M; Bozbas, A; Hulagu, S; Kadayifci, A; Koruk, M; Savas, MC; Simsek, I; Sivri, B; Tozun, N; Uraz, S | 1 |
| Schluter, PJ; Wallace, RA; Webb, PM | 1 |
| Blancas-Valencia, JM; Bosques-Padilla, FJ; Calderón-Lozano, IE; de Ariño Suárez, M; Garza-González, E; Orozco-Gámiz, A; Reed-SanRoman, G; Tamayo-de la Cuesta, JL; Valdovinos-Díaz, MA | 1 |
| Güliter, S; Kandilci, U | 1 |
| Calvet, X; Gené, E; Güell, M; Montserrat, A; Vergara, M | 1 |
| Bago, J; Bago, P; Belosić Halle, Z; Bevanda, M; Bilić, A; Galović, A | 1 |
| Fujioka, T; Kodama, M; Miyajima, H; Murakami, K; Nasu, M; Ogata, M; Ohtsuka, E; Okimoto, T; Saburi, Y; Sato, R; Watanabe, K | 1 |
| Barros, H; David, L; Lunet, N; Mendes, N; Serpa, J | 1 |
| Blanche, P; Chauvelot-Moachon, L; Kélaïdi, C; Nazal, EM; Pajot, O; Rollot, F | 1 |
| Cao, X; Kaminishi, M; Kumagai, T; Mizoshita, T; Nozaki, K; Shimizu, N; Tatematsu, M; Tsukamoto, T | 1 |
| Fukuda, S; Fukushi, M; Mikami, T; Munakata, A; Shimoyama, T | 1 |
| Accornero, L; Bilardi, C; Dulbecco, P; Iiritano, E; Mamone, M; Mansi, C; Parodi, A; Reglioni, S; Savarino, E; Savarino, V; Vigneri, S; Zentilin, P | 1 |
| Isakov, VA | 1 |
| Fujioka, T; Kashimura, K; Kodama, M; Miura, M; Miyajima, H; Murakami, K; Nasu, M; Okimoto, T; Ootsu, S; Sato, R; Watanabe, K | 1 |
| Iinuma, K; Kato, S; Konno, M; Maisawa, S; Nakayama, Y; Shimizu, T; Tajiri, H; Toyoda, S; Yoshimura, N | 1 |
| Buzás, GM | 1 |
| Cammarota, G; Candelli, M; Cazzato, IA; Cremonini, F; Franceschi, F; Gasbarrini, A; Gasbarrini, G; Nista, EC; Zocco, MA | 1 |
| Hirashima, N; Ito, K; Kato, A; Kato, H; Kondo, H; Matsunaga, S; Nukaya, H; Sakakibara, K; Sakamoto, T; Tanaka, Y | 1 |
| Asaoka, D; Hojo, M; Iijima, K; Kawabe, M; Kurosawa, A; Miwa, H; Miyazaki, A; Nagahara, A; Ohkusa, T; Sato, N; Terai, T | 1 |
| Casanovas, N; Elizalde, JI; Escolar, G; González, J; Heras, M; Lozano, M; Martorell, T; Pérez-Pujol, S; Piqué, JM; Sanz, G; Sionis, A | 1 |
| Górski, J; Jaroszewicz, W; Kemona, A; Markowski, AR; Namiot, DB; Namiot, Z; Stasiewicz, J | 1 |
| Chan, CK; Chen, MH; Cui, Y; Gu, Q; Hu, PJ; Hu, WH; Huang, JQ; Lai, KC; Lam, SK; Li, CJ; Wang, WH; Wong, BC; Wong, WM; Wu, SM; Xia, HH; Xiao, SD | 1 |
| Chen, TW; Cheng, HC; Hunag, SF; Kao, AW; Lu, CC; Sheu, BS; Wu, JJ | 1 |
| Imase, K; Ishida, H; Itoh, T; Kai, A; Sugano, H; Takahashi, S; Tanaka, A; Tokunaga, K; Watanabe, K | 1 |
| Bory, F; Calvet, X; Ducons, J; Guardiola, J; Marko, D; Tito, L | 1 |
| Iinuma, K; Kato, S; Minoura, T; Ohyauchi, M; Ozawa, K; Sekine, H; Shimosegawa, T | 1 |
| Ishizone, S; Katsuyama, T; Maruta, F; Miyagawa, S; Ota, H; Sugiyama, A | 1 |
| Fukuda, Y; Hori, K; Matsumoto, T; Miwa, H; Ohkusa, T; Shintani, S; Tanaka, J; Tomita, T | 1 |
| Castellaneta, S; Di Leo, A; Francavilla, A; Francavilla, R; Ierardi, E; Lionetti, E; Magistà, AM; Miniello, VL; Rigillo, N; Ros, P | 1 |
| de Mascarel, A; Dubus, P; Lavergne-Slove, A; Megraud, F; Merlio, JP; Ruskone-Fourmestraux, A | 1 |
| Chang, CC; Chen, SH; Fang, CL; Hsieh, CR; Lee, YJ; Lien, GS; Lou, HY; Pan, S | 1 |
| Chang, FY; Chen, CY; Lee, SD; Lu, CL; Lu, RH; Luo, JC | 1 |
| Feng, LY; Jiang, SL; Yao, XX | 1 |
| Gadzhieva, MG; Maev, IV | 1 |
| Färkkilä, MA; Heikkinen, MT; Koivisto, TT; Koskenpato, JP; Rautelin, HI; Voutilainen, ME | 1 |
| Furusu, H; Inoue, K; Isomoto, H; Kohno, S; Ohnita, K; Wen, CY | 1 |
| Chen, CB; Chou, JW; Hsu, CH; Lai, HC; Liao, KF; Lin, ZY; Wang, HH | 1 |
| Terano, A | 1 |
| Arranz Martínez, E; Gordillo López, FJ; Hermosa Hernán, JC; Ruiz García, A; Villares Rodríguez, JE | 1 |
| Amadori, S; Newland, AC; Provan, D; Rossi, Z; Stasi, R; Stipa, E | 1 |
| Filik, L; Köksal, AS; Odemiş, B; Ozden, A; Parlak, E; Sahin, B; Saşmaz, N; Ulker, A; Yolcu, OF | 1 |
| Marshall, BJ; Viiala, CH; Windsor, HM | 1 |
| Niv, Y | 2 |
| Cho, YK; Jeon, WK; Keum, DK; Kim, BI; Kim, HJ; Kim, SH; Park, DI; Park, SH; Sohn, CI; Sung, IK | 1 |
| Caner, B; Gedik, GK; Karaduman, A; Sivri, B | 1 |
| Bar-Meir, M; Benenson, S; Faber, J; Halle, D; Rachman, E; Rudensky, B; Schlesinger, Y; Sirota, G; Stankiewic, H; Wilschanski, M | 1 |
| Cartell, A; Edelweiss, MI; Francesconi, CF; Mazzoleni, LE; Ott, EA; Prolla, JC; Rivero, LF; Sander, GB; Somm, G; Theil, AL; Uchôa, DM; Wortmann, AC | 1 |
| Hershko, C; Hoffbrand, AV; Keret, D; Lahad, A; Maschler, I; Monselise, Y; Souroujon, M | 1 |
| Shao, Y; Yu, ZL; Zhang, L; Zhang, ST | 1 |
| Chan, AO; Chan, CK; Cheung, KL; Fung, FM; Ho, VY; Huang, J; Hui, CK; Lai, KC; Lam, SK; Tong, TS; Wong, BC; Wong, WM; Xia, HH | 1 |
| Cao, Q; Si, JM; Wu, JG | 1 |
| Calvet, X; Catalán, M; Gisbert, JP; Vergara, M | 1 |
| Bernabucci, V; Cavina, M; De Francesco, V; Gatta, L; Hassan, C; Ierardi, E; Morini, S; Ricci, C; Vaira, D; Zullo, A | 1 |
| Egashira, T; Furuta, T; Hishida, A; Ishizaki, T; Kenmotsu, K; Kodaira, M; Nagano, M; Nakamura, A; Ohashi, K; Sagehashi, Y; Shirai, N; Sugimoto, M; Ueda, K; Yoneyama, M | 1 |
| Akamatsu, T; Hidaka, E; Matsuzawa, K; Okiyama, Y; Ota, H; Sano, K | 1 |
| Furuta, T; Hishida, A; Ishizaki, T; Nakamura, A; Shirai, N; Sugimoto, M | 1 |
| Beinborn, M; Ishida, H; Nagamatsu, S; Takahashi, S; Watanabe, K | 1 |
| Boyacioğlu, S; Gür, G; Kanbay, M; Yilmaz, U; Yücel, M | 1 |
| Bonner, RA; Delaney, KH; Gee, LC; Jury, J; Perdue, MH | 1 |
| Asaka, M; Ehira, N; Imamura, M; Kanamori, H; Kawamura, T; Masauzi, N; Mori, A; Obara, S; Ogura, N; Tanaka, J; Tsutsumi, Y; Umehara, S; Yamato, H | 1 |
| Bory, F; Bujanda, L; Calvet, X; Ducons, J; Gisbert, JP; Montserrat, A | 1 |
| Bjarnason, IT; Charlett, A; Dobbs, RJ; Dobbs, SM; Ibrahim, MA; Kerwin, RW; Mahler, RF; Oxlade, NL; Peterson, DW; Plant, JM; Price, AB; Weller, C | 1 |
| Itoh, K; Itoh, M; Joh, T; Kataoka, H; Kondo, Y; Nakao, H; Ogasawara, N; Ohara, H; Okada, N; Oshima, T; Sano, H; Sasaki, M; Sobue, S; Tanida, S | 1 |
| Klotz, U; Schwab, M; Treiber, G | 1 |
| Chen, YH; Li, HY; Wang, H; Wang, WM | 1 |
| Abasiyanik, MF; Huten, O; Salih, BA; Sander, E; Saribasak, H | 1 |
| Ahlawat, S; Benjamin, S; Cohen, P; Haddad, N; Kanber, Y; Ozdemirli, M | 1 |
| Dmitrović, B; Horvat, D; Ivezić, Z; Kraljik, N; Misević, T; Soldo, I; Timarac, J; Vcev, A | 1 |
| Cho, YS; Kim, SS; Konkin, TA; Meitner, P; Moss, SF; Resnick, MB | 1 |
| Domínguez-Martín, A; Domínguez-Muñoz, A; Gisbert, JL; Gisbert, JP; Marcos, S | 1 |
| Chen, CL; Chen, GH; Chen, LT; Cheng, AL; Jan, CM; Kuo, SH; Lin, JT; Sheu, BS; Su, IJ; Tai, JJ; Wang, HP; Wang, TE; Wang, WM; Whang-Peng, J; Wu, CW; Yang, SS; Yeh, HZ | 1 |
| Carvalhaes, A; Magalhães, AF; Natan-Eisig, J; Paraíso-Ferraz, JG; Trevisan, M; Zaterkaad, S | 1 |
| Arai, D; Chen, G; Fukuchi, K; Gomi, K; Kikuchi, R; Takeuchi, Y | 1 |
| Baggett, HC; Bruce, MG; Dunaway, E; Gessner, BD; Gold, BD; Muth, PT; Parkinson, AJ | 1 |
| Al Khashash, R; Khasanov, RSh; Nijevitch, AA; Sataev, VU; Shcherbakov, PL; Tuygunov, MM | 1 |
| Hibi, T; Ishii, H; Masaoka, T; Sakai, G; Suzuki, H | 1 |
| Ateş, Y; Bağci, S; Ciğerim, M; Dağalp, K; Kadayifçi, A; Karslioğlu, Y; Savaş, MC; Uygun, A; Yeşilova, Z | 1 |
| Cengiz, DU; Güliter, S; Keleş, H; Kolukisa, E; Ozkurt, ZN | 1 |
| Foucar, MK; Pai, RK; Snider, WK; Starkey, CR; Viswanatha, D; Wilson, CS | 1 |
| Vakil, N | 1 |
| Amoruso, A; Boscarelli, G; Castellaneta, SP; Cavallo, L; Di Leo, A; Francavilla, A; Francavilla, R; Ierardi, E; Lionetti, E; Magistà, AM; Miniello, VL; Piscitelli, D | 1 |
| Fujioka, T | 1 |
| Aoyagi, K; Maeda, K; Nishiyama, M; Sakisaka, S | 1 |
| Kawai, T; Kawakami, K; Moriyasu, F; Takagi, Y | 1 |
| Furuta, T; Miura, S; Okudaira, K; Shirai, N; Sugimoto, M | 1 |
| Arakawa, T; Fujiwara, Y; Higuchi, K; Tominaga, K; Watanabe, T | 1 |
| Takeda, H | 1 |
| Yanaka, A; Zhang, S | 1 |
| Nagahara, A; Sato, N | 1 |
| Fujioka, T; Murakami, K; Okimoto, T | 1 |
| Furuta, T; Nakamura, A; Shirai, N; Sugimoto, M | 1 |
| Bray, R; Hiratsuka, H; Hiratsuka, T; Kimura, K; Suzuki, T; Tamura, K | 1 |
| Fujishiro, M; Kobayashi, K; Oka, M; Omata, M | 1 |
| Fujishiro, M; Ichinose, M; Oka, M; Omata, M | 1 |
| Konno, M | 1 |
| Kaminishi, M; Kubota, K; Shimizu, N | 1 |
| Katoh, H; Kuwano, H; Miyazaki, T; Tsukada, K | 1 |
| Abe, C; Hikichi, T; Irisawa, A; Obara, K; Sato, Y | 1 |
| Bertin, P; Broutet, N; Combe, B; Joubert-Collin, M; Lamouliatte, H; Mégraud, F; Perié, F; Schaeverbeke, T; Zerbib, F | 1 |
| Campos, A; Cardenas, VM; Chavez, A; El-Zimaity, HM; Graham, DY; Guerrero, L; Opekun, AR | 1 |
| Barros, SG; Cartell, A; Edelweiss, MI; Francesconi, CF; Fritscher, LG; Mazzoleni, LE; Ott, EA; Polanczyk, CA; Prolla, JC; Rivero, LF; Sander, GB; Theil, AL; Uchôa, DM; Wortmann, AC | 1 |
| Asano, M; Sato, Y; Shimizu, T; Taniwaki, H; Tsuji, D | 1 |
| Burattini, O; De Francesco, V; Di Leo, A; Hassan, C; Ierardi, E; Marangi, S; Margiotta, M; Monno, R; Morini, S; Panella, C; Russo, F; Stella, F; Stoppino, V; Troiani, L; Zullo, A | 1 |
| Chan, AO; Chan, CK; Chu, KM; Fung, FM; Gu, Q; Lai, KC; Tong, TS; Wong, BC; Wong, WM; Yee, YK | 1 |
| Bielanski, W; Brzozowski, T; Drozdowicz, D; Hahn, EG; Konturek, PC; Konturek, SJ; Kwiecien, S; Mierzwa, M; Pawlik, WW; Stachura, J | 1 |
| Chan, AO; Chan, CK; Cheung, HK; Kwong, YL; Lai, KC; Lam, SK; Peng, JZ; Rashid, A; Wong, BC; Yuen, MF | 1 |
| Bayerdörffer, E; Kuhlisch, E; Lehn, N; Madisch, A; Miehlke, S; Morgner, A; Neuber, F; Rappel, S; Seitz, G; Stolte, M | 1 |
| Borody, TJ; Clancy, R; Herdman, K; Llorente, R; Ng, C; Pang, G; Surace, R; Wettstein, AR | 1 |
| Benito, LM; Bermejo, F; Bory, F; Castro-Fernández, M; Cosme, A; Ducons, J; Fernández-Bermejo, M; Gisbert, JP; Lamas, E; López-Rivas, L; Olivares, D; Pabón, M; Pérez-Aisa, A | 1 |
| Abe, T; Arita, T; Fujioka, T; Kodama, M; Murakami, K; Nasu, M; Okimoto, T; Sato, R; Sato, S; Watanabe, K | 1 |
| Hirakawa, K; Ishikawa, T; Katsuragi, K; Maeda, K; Mino, A; Ohira, M; Onoda, N; Sawada, T; Wakasa, K | 1 |
| Postavnyĭ, VE | 1 |
| Butorov, IV; Butorov, SI; Maksimov, VV; Osoianu, IuP | 1 |
| Barry, M; Bennett, K; Keeling, PW; O'Morain, C; Walshe, V | 1 |
| Franceschi, M; Leandro, G; Perri, F; Pilotto, A | 1 |
| Ariyama, I; Furusyo, N; Hayashi, J; Kochi, S; Kubo, N; Murata, M | 1 |
| Aladağ, M; Alan, H; Ateş, F; Cikim, K; Demirel, U; Harputluoğlu, MM; Hilmioğlu, F; Kantarçeken, B; Karincaoğlu, M; Sertkaya, A; Yildirim, B | 1 |
| Castro-Fernández, M; Cosme, A; Gisbert, JP; Gómez, B; Herrerías, JM; Luna, M; Monés, J; Olivares, D; Pajares, JM; Sánchez-Pobre, P | 1 |
| Aghakhani, S; Bahremand, S; Fourutan, H; Mir, E; Nematollahi, LR; Nouripour, S; Tirgari, F | 1 |
| Lule, GN | 1 |
| Chan, FK; Ching, JY; Lau, W; Lee, IY; Lee, KK; You, JH; Yung, M | 1 |
| Asaka, M; Kato, M; Katsuyama, T; Kikuchi, S; Tominaga, S | 1 |
| Athanasiou, E; Delli, FS; Kountouras, I; Kountouras, J; Mandekou-Lefaki, I; Mattheou-Vakali, G | 1 |
| Goh, KL; Rizal, AM; Rosmadi, MY; Tan, HJ | 1 |
| Chu, JK; Huo, XH; Ma, JC; Wang, J; Yang, XF; Yu, J; Zhang, LJ | 1 |
| Havelund, T; Jarbol, DE; Kragstrup, J; Schaffalitzky de Muckadell, OB; Stovring, H | 1 |
| Bytzer, P | 1 |
| Classen, M; Li, J; Lin, SR; Liu, WD; Ma, JL; Pan, KF; Shen, L; Xiao, SD; You, WC; Zhang, L | 1 |
| Bästlein, E; Bayerdörffer, E; Hansky, K; Jacobs, E; Kirsch, C; Kuhlisch, E; Lehn, N; Madisch, A; Miehlke, S; Morgner, A; Schneider-Brachert, W; Stolte, M | 1 |
| Blot, WJ; Brown, LM; Chang, YS; Crystal-Mansour, S; Fraumeni, JF; Gail, MH; Hu, Y; Jin, ML; Li, JY; Liu, WD; Ma, JL; Pan, KF; Pee, D; Xu, GW; You, WC; Zhang, L | 1 |
| Mousavi, S; Toussy, J; Yaghmaie, S; Zahmatkesh, M | 1 |
| Abdul-Baki, H; Aoun, E; Araj, GF; Chaar, HF; Kanj, SS; Sharara, AI | 1 |
| Akyol Erikci, A; Ozturk, A; Sayan, O | 1 |
| Hirakawa, K; Inoue, T; Komoto, M; Nakata, B; Takashima, T; Tominaga, K | 1 |
| Pistiolas, D; Robotis, J; Rokkas, T; Sechopoulos, P | 1 |
| Abouzari, M; Hasibi, M; Mirbagheri, SA; Rashidi, A | 1 |
| Amagase, H; Brown, LM; Gail, MH; Ma, JL; Moslehi, R; Pan, KF; Wang, YQ; You, WC; Zhang, L | 1 |
| Bazzoli, F; Bianchi-Porro, G; Fiocca, R; Gasbarrini, G; Roda, E; Zagari, RM | 1 |
| Ben Ayed, M; Ben Khelifa, H; Chedly-Debbiche, A; Gargouri, D; Ghorbel, AJ; Kharrat, J; Khayat, O; Kilani, A; Souissi, A; Zeddini, A | 1 |
| Apikoglu-Rabus, S; Besisik, F; Dulger, G; Izzettin, FV; Sancar, M; Tozun, N | 1 |
| Bella, A; Caracciolo, F; Crispino, P; Gurnari, M; Iacopini, F; Nardi, F; Paoluzi, P; Pica, R; Rivera, M; Rossi, P; Zippi, M | 1 |
| Arakawa, T; Asahina, K; Chouno, S; Endo, M; Hayakumo, T; Higuchi, K; Hirano, M; Inomoto, T; Maekawa, T; Matsuura, N; Nakagawa, K; Orino, A; Sakamoto, C; Tanimura, H; Tomono, N | 1 |
| Choe, YH; Choi, J; Jang, JY; Kim, JS; Kim, KM; Park, HY | 1 |
| Alliet, P; Bontemps, P; Cadranel, S; Lauvau, D; Van Biervliet, S; Vandenhoven, G; Vandenplas, Y | 1 |
| Baik, GH; Chun, HJ; Hahm, KB; Hong, SJ; Jung, HC; Kim, BG; Kim, BW; Kim, HY; Kim, JJ; Kim, SG; Kim, SK; Kim, SW; Lee, DH; Lee, JH; Lee, KH; Lee, SW; Lee, YC; Park, CY; Park, JJ; Ye, BD | 1 |
| Bucki, R; Gotebiewska, M; Kemona, A; Namiot, DB; Namiot, Z | 1 |
| Chatzimavroudis, G; Katsinelos, P; Katsinelos, T; Papaziogas, B; Paroutoglou, G; Pilpilidis, I; Triantafillidis, I; Tziomalos, K; Vasiliadis, T | 1 |
| Higuchi, K | 1 |
| Bashiri, H; Keshavarz, AA; Rahbar, M | 1 |
| Tepes, B | 1 |
| Dorchy, H; Khalil, T; Melot, C; Scaillon, M | 1 |
| Chodick, G; Koren, R; Niv, Y; Ofek, I; Samra, Z; Shmuely, H; Yahav, J | 1 |
| Heijboer, H; Neefjes, VM; Tamminga, RY | 1 |
| Aoki, T; Itoi, T; Kawai, T; Kawakami, K; Matsumoto, Y; Mikinori, K; Moriyasu, F; Noguchi, N; Rimbara, E; Sasatsu, M; Takagi, Y; Takei, K; Watanebe, K | 1 |
| Tsimmerman, IaS; Vologzhanina, LG | 1 |
| Abbott, E; Arellano, M; Arrese, M; Bustamante, A; Greig, D; Medina, B; Otarola, F; Pattillo, A; Pedreros, C; Riquelme, A; Rollan, A; Soza, A; Valenzuela, F | 1 |
| Cabrera, E; Castro, M; Fernández, N; Méndez, I; Moreno, JL; Navarro-Jarabo, JM; Perea-Milla, E; Ramírez, LM; Rivas-Ruiz, F; Rivera, R; Sousa, FL; Ubiña, E; Vera, F | 1 |
| Fan, D; Guo, W; Han, Y; Hong, L; Li, X; Wang, J; Zhao, Y | 1 |
| Barbatzas, C; Demonakou, M; Giamarellos-Bourboulis, EJ; Giamarellou, H; Koussoulas, V; Spyridaki, E; Vaki, I; Vassiliou, S | 1 |
| Bijlsma, JW; Boers, M; de Leest, HT; Dijkmans, BA; Houben, HH; Huisman, AM; Kadir, SW; Kostense, PJ; Kuipers, EJ; Lems, WF; Steen, KS; van de Laar, MA; van Tulder, MW; Vonkeman, HE | 1 |
| Magen, E; Mishal, J; Scharf, S; Schlesinger, M | 1 |
| Brown, LM; Gail, MH; Liu, WD; Ma, JL; Pan, KF; Pfeiffer, RM; You, WC; Zhang, L | 1 |
| Almela, P; Barrio, J; Benito, LM; Bermejo, F; Bory, F; Calvet, X; Carneros, JA; Castro-Fernández, M; Cosme, A; Fernández-Bermejo, M; Franco, A; García-Durán, F; Gisbert, JP; Khorrami, S; Lamas, E; Modolell, I; Niño, P; O'Callaghan, E; Ortiz, V; Ortuño, J; Pérez-Aisa, A; Ponce, J; Rodrigo, L; Sánchez-Pobre, P; Tomas, A; Valer, MP | 1 |
| Achiel, K; Hazazi, R; Lederfein, T; Niv, Y; Waked, A | 1 |
| Hassan, C; Lorenzetti, R; Zullo, A | 1 |
| Cantu, M; Ferguson, D; Page, RL | 1 |
| Gisbert, JL; Gisbert, JP; Jimenez-Alonso, I; Marcos, S; Moreno-Otero, R; Pajares, JM | 1 |
| Cho, YK; Choi, HS; Hwang, SJ; Jeon, WK; Kim, BI; Kim, HJ; Park, DI; Park, JS; Sohn, CI | 1 |
| Shaoul, R; Shehada, S; Srugo, I | 1 |
| Roblin, X | 1 |
| Esfahani, FS; Keshtkar-Jahromi, M; Rahnavardi, M; Rostami, N | 1 |
| Fujioka, T; Kodama, M; Murakami, K; Okimoto, T; Sato, R; Watanabe, K | 1 |
| Bergeret, M; Dupont, C; Kalach, N; Raymond, J; Serhal, L; Spyckerelle, C | 1 |
| Cavanna, L; Pagani, R; Paties, C; Seghini, P; Zangrandi, A | 1 |
| Castellanos Monedero, JJ; González Carro, P; Legaz Huidobro, ML; Pérez Roldán, F; Roncero García-Escribano, O; Ruiz Carrillo, F; Villafáñez García, MC | 1 |
| Borzym-Kluczyk, M; Gindzieński, A; Kisiel, DG; Namiot, Z; Radziejewska, I; Wosek, J | 1 |
| Hallas, J; Hansen, JM; Schaffalitzky de Muckadell, OB; Wildner-Christensen, M | 1 |
| Nijawan, S; Rishi, JP; Yadav, MK | 1 |
| Landivar, B; Moncayo, M; Parrales, J; Robles-Jara, C; Robles-Medranda, C | 1 |
| Deng, D; Feng, G; Gu, L; Li, Q; Liu, Z; Ma, J; Shen, J; Shen, L; You, WC; Zhang, B; Zhang, L; Zhou, J | 1 |
| Dissemond, J; Körber, A | 1 |
| Barbuti, RC; Eisig, JN; Mattar, R; Navarro-Rodriguez, T; Silva, FM; Teixeira, AC | 1 |
| Baek, YH; Cho, YK; Choi, WH; Hong, CH; Hong, EJ; Jeon, WK; Kim, BI; Kim, HJ; Oh, SJ; Park, DI; Park, JH; Park, SK; Sohn, CI; Song, MJ | 1 |
| Egan, BJ; O'Connor, HJ; O'Morain, CA | 1 |
| Dragomir, D; Hurduc, V; Plesca, D; Sajin, M; Vandenplas, Y | 1 |
| Aysev, D; Ensari, A; Girgin, N; Kansu, A; Kirsaçlioğlu, CT; Küçük, NO; Kuloğlu, Z; Ustündağ, G | 1 |
| Bijlsma, JW; Bloemena, E; Boers, M; De Leest, HT; Dijkmans, BA; Houben, HH; Janssen, M; Kostense, PJ; Kuipers, EJ; Lems, WF; Steen, KS; Van de Laar, MA | 1 |
| Bhattacharya, S; Ganesh, N; Jain, NK; Ramteke, S | 2 |
| Barbuti, RC; Eisig, JN; Felga, GE; Navarro-Rodriguez, T; Silva, FM; Zaterka, S | 1 |
| Dehghani, SM; Erjaee, A; Haghighat, M; Imanieh, MH | 1 |
| Andrés, PR; Bermejo, AB; Bermejo, MF; Gallardo, BP; García, GG; Gisbert, JP; Infante, JM; Rodríguez, JM | 1 |
| Brown, LM; Gail, MH; Hu, Y; Liu, W; Ma, J; Moslehi, R; Pan, K; Pee, D; Wang, Y; You, W; Zhang, L; Zhou, T | 1 |
| Cho, YK; Choi, WH; Hong, CH; Hong, EJ; Jeon, WK; Kim, BI; Kim, HJ; Oh, SJ; Park, DI; Park, JH; Shon, CI; Song, MJ | 1 |
| Ran, ZH; Shen, J; Tong, JL; Xiao, SD | 1 |
| Aladag, I; Erkokmaz, U; Eyibilen, A; Guven, M | 1 |
| Abd El-Hamed, TM; El Awady, S; El-Nakeeb, A; Farid, M; Fikry, A; Fouda, el Y; Sherief, D; Youssef, T | 1 |
| Oganesian, TS | 1 |
| Boziki, M; Chatzopoulos, D; Deretzi, G; Gavalas, E; Grigoriadis, N; Katsinelos, P; Kountouras, J; Tsolaki, M; Tzilves, D; Venizelos, I; Zavos, C | 1 |
| Albrecht, P; Szajewska, H; Topczewska-Cabanek, A | 1 |
| Abdou, AG; Elnaidany, NF; Elshayeb, EI; Farag, AG | 1 |
| Derakhshan, F; Haghazali, M; Mirsattari, D; Mohsenian, N; Molaei, M; Talaie, R; Zali, MR; Zojaji, H | 1 |
| Amakawa, R; Baba, S; Hoshino, S; Inaba, M; Iwai, H; Konishi, M; Nakae, K; Nakamichi, N | 1 |
| Buka, GIu; Veligotskiĭ, NN | 1 |
| Esedov, EM; Magomedéminova, AS | 1 |
| Fukase, K; Kawata, S; Mabe, K; Matsuda, T; Oizumi, H; Shibata, A; Takahashi, M; Takeda, H; Tsukuma, H | 1 |
| Chaudhry, AS; Kochhar, R; Kohli, KK | 1 |
| Kucheriavyĭ, IuA | 1 |
| Jian, Z; Li, Y; Tang, F; Wu, S | 1 |
| Al-Mekhaizeem, K; Alazmi, WM; Buhaimed, W; Siddique, I | 1 |
| Abadia, EG; Dueñas, C; Fernandez-Bermejo, M; Gisbert, JP; Gonzalez-Garcia, G; Hernandez-Alonso, M; Mateos-Rodriguez, JM; Molina-Infante, J; Perez-Gallardo, B; Vinagre, G | 1 |
| Dutta, U; Kochhar, R; Noor, MT; Sidhu, GS; Singh, K; Udawat, H; Vaiphei, K | 1 |
| Correa, P; Duque, X; Martinez, H; Medina, M; Mendoza, ME; Mera, R; Moran, S; Torres, J | 1 |
| Changsom, D; Chawansuntati, K; Koosirirat, C; Linpisarn, S; Wipasa, J | 1 |
| Best, L; Cooper-Lesins, G; Desai, S; Haldane, D; Malatjalian, D; Peltekian, K; van Zanten, SV | 1 |
| Gu, W; Liang, X; Liu, W; Lu, H; Sun, Q; Xiao, S; Zheng, Q | 1 |
| Beck, SE; Brayton, C; Del Carmen Martino-Cardona, M; Watson, J | 1 |
| Cristofari, F; De Francesco, V; Hassan, C; Manes, G; Scaccianoce, G; Zullo, A | 1 |
| Abdelfatah, M; Assem, M; El Azab, G; Rasheed, MA; Shastery, M | 1 |
| Chang, WC; Jegal, J; Jin, CJ; Jo, YI; Lee, JH; Park, HS; Park, JH | 1 |
| Gao, XZ; Liu, F; Qiao, XL; Song, WC; Wang, XF | 1 |
| Amendola, G; Baronci, C; Battisti, L; Bisogno, G; Branciforte, F; Ceppi, S; Corti, A; De Mattia, D; Farruggia, P; Giordano, P; Jankovic, M; Matarese, SM; Miraglia, V; Nardi, M; Nobili, B; Notarangelo, L; Palazzi, G; Parodi, E; Ramenghi, U; Russo, G; Tucci, F; Zecca, M | 1 |
| Ae, T; Azuma, M; Higuchi, K; Ishido, K; Katada, C; Koizumi, W; Nakatani, K; Nakayama, N; Nishimura, K; Saigenji, K; Sasaki, T; Tanabe, S | 1 |
| Chen, WJ; Lu, H; Sun, QJ; Xiao, SD; Zheng, Q | 1 |
| Jonaitis, L; Kiudelis, G; Kupčinskas, J; Kupčinskas, L | 1 |
| Islamova, EA; Komarov, FI; Kvetnoĭ, IM; Osadchuk, AM; Osadchuk, MA | 1 |
| Jamshidi, S; Khoshnegah, J; Mohammadi, M; Sasani, F | 1 |
| Barbuti, RC; Eisig, JN; Felga, G; Navarro-Rodriguez, T; Silva, FM; Zaterka, S | 1 |
| Abbas, Z; Abid, S; Jafri, SN; Yakoob, J | 1 |
| Bazzoli, F; Celiñski, K; Delchier, JC; Giguère, M; Malfertheiner, P; Mégraud, F; Rivière, M | 1 |
| Chern, HD; Lin, BR; Lin, CJ; Shun, CT; Wang, HL; Wang, TH; Yang, JC | 1 |
| Albrecht, P; Kotowska, M; Szajewska, H | 1 |
| Buonavolontà, R; Miele, E; Russo, D; Staiano, A; Vecchione, R | 1 |
| Ahmad, K; Farzaneh, M; Fatemeh, F; Fatemeh, M; Hossein, FG; Kambiz, E; Mehri, N | 1 |
| Ghadir, MR; Iranikhah, A; Joukar, F; Mansour-Ghanaei, F; Pakdin, A; Shafaghi, A | 1 |
| Chechoulin, Y; Levi, Z; Niv, Y; Schmilovitz-Weiss, H; Schmiloviz-Weiss, H; Sehayek-Shabbat, V; Shalev, T; Shirin, H; Yishai, R | 1 |
| Basu, D; Jagdish, S; Kate, V; Valooran, GJ | 1 |
| Choi, KH; Chung, WC; Jung, SH; Kang, BK; Kim, EJ; Lee, KM; Oak, JH; Paik, CN | 1 |
| Bontems, P; Cadranel, S; Kalach, N; Miendje, DY; Muyshont, L; Oderda, G; Raymond, J; Salame, A; Scaillon, M | 1 |
| Bo, J; Chen, MH; Fan, DM; Ge, ZZ; Ji, F; Jung, HC; Kim, JH; Lee, SW; Lee, YC; Song, KH | 1 |
| Attumi, TA; Graham, DY | 1 |
| Ben Mahmoud, L; Ghozzi, H; Hakim, A; Sahnoun, Z; Zeghal, K | 1 |
| Hwang, JH; Jeong, SH; Jo, HJ; Jung, HC; Kim, JM; Kim, JW; Kim, JY; Kim, N; Lee, DH; Lee, JH; Lee, SH; Nam, RH; Park, HK; Park, YS; Shin, CM; Song, IS | 1 |
| Akyuz, F; Ermis, F; Kaymakoglu, S; Kurt, R; Mungan, Z; Nazik, H; Pinarbasi, B; Uyanikoglu, A | 1 |
| Guleria, K; Kaur, I; Malik, R; Radhakrishnan, G; Sikka, M | 1 |
| Campuzano-Maya, G | 1 |
| Kolesnikova, IIu; Liubskaia, LA; Volkov, VS | 1 |
| Feng, GS; Lam, S; Li, J; Li, JY; Liu, WD; Lu, AP; Ma, JL; Pan, KF; Shen, L; Wong, BC; Xia, HH; You, WC; Zhang, L; Zhang, XD | 1 |
| Pan, G | 1 |
| Basu, PP; Flynn, M; Krishnaswamy, N; Pacana, T; Rayapudi, K; Shah, NJ | 1 |
| Geng, QM; Han, YJ; Tian, XL; Zhang, JZ; Zhou, LY | 1 |
| Falaknazi, K; Hadizadeh, M; Lahmi, F; Mirsattari, D; Orimi, PG; Roshani, M; Seyyedmajidi, M; Zali, M; Zojaji, H | 1 |
| Hokari, R; Miura, S | 1 |
| Adouni, O; Azouz, H; Chelly, I; Chouaib, S; Haouet, S; Kchir, N; Nfoussi, H; Zitouna, M | 1 |
| Kolber, MR; Korownyk, C | 1 |
| Blot, WJ; Brown, LM; Crystal-Mansour, S; Fraumeni, JF; Gail, MH; Han, ZX; Hu, Y; Li, JY; Liu, WD; Ma, JL; Pan, KF; Pee, D; Shen, L; You, WC; Zhang, L | 1 |
| Bdioui, F; Ben Chaabane, N; Bouhlel, W; Hellara, O; Loghmari, H; Melki, W; Safer, L; Saffar, H; Zakhama, A | 1 |
| Gu, XM; Ji, R; Li, YQ; Li, Z; Yu, T; Zhou, CJ; Zuo, XL | 1 |
| Hasan, M; Islam, N; Masud, H; Raihan, AS; Roy, PK; Saha, SK | 1 |
| Bujanda, L; Cosme, A; Gil, I; Ibarra, B; Martos, M; Mendarte, U; Montes, M; Piñeiro, L; Recasens, MT; Salicio, Y; Sarasqueta, C | 1 |
| Abid, A; Abu-Elheja, O; Diab, H; Mahamid, M; Mograbi, J; Nseir, W; Samara, M | 1 |
| Almela, P; Barrio, J; Bermejo, F; Bory, F; Calvet, X; Castro-Fernández, M; Cosme, A; Fernández-Bermejo, M; Franco, A; Gisbert, JP; Guerra, I; Khorrami, S; Lamas, E; Modolell, I; Ortuño, J; Pérez-Aisa, A; Ponce, J; Rodrigo, L; Sánchez-Pobre, P; Tomas, A | 1 |
| Akyuz, F; Ermis, F; Mungan, Z | 1 |
| Bizzarri, B; de'Angelis, GL; Manfredi, M | 1 |
| Figura, N; Giordano, N; Langone, F; Moretti, E; Vaglio, L; Vernillo, R; Vindigni, C | 1 |
| Agah, S; Ekhlasi, G; Ghourchian, S; Salehpour, A; Shidfar, F | 1 |
| Chen, PY; Geng, LL; Gong, ST; He, WE; Huang, H; Huang, J; Liu, LY; Ou, WJ; Pan, RF; Zhou, LY | 1 |
| Otsuka, SH | 1 |
| Alaoui, S; Amarti, A; Benajah, DA; Bennani, B; El Abkari, M; El Rhazi, K; Ibrahimi, SA; Lahbabi, M; Mahmoud, M; Nejjari, C | 1 |
| Bai, J; Jia, Q; Qu, L; Song, C; Tao, Z; Wu, Y; Zhi, K | 1 |
| Almasi, S; Mirsattari, D; Seyedmajidi, S; Seyyedmajidi, M; Zali, M; Zanganeh, E; Zojaji, H | 1 |
| Barrio, J; Bory, F; Calvet, X; Castro, M; de la Coba, C; Ducons, J; Forné, M; Gisbert, JP; Marin, AC; McNicholl, AG; Molina-Infante, J; Montoro, M; Perez-Aisa, A | 1 |
| Abouqal, R; Ahid, S; Benkirane, A; Cherrah, Y; El Adioui, T; El Hamdi, FZ; Hassar, M; Seddik, H | 1 |
| Bonfrate, L; Castorani, L; D'Ambrosio, P; De Francesco, V; Hassan, C; Portincasa, P; Ruggiero, V; Scaccianoce, G; Vannella, L; Zullo, A | 1 |
| Asaoka, D; Ito, M; Kawai, T; Kawakami, K; Kurihara, N; Matsuhisa, T; Mine, T; Mizuno, S; Nagahara, A; Nishizawa, T; Ohkusa, T; Omata, F; Sakaki, N; Sasaki, H; Suzuki, H; Suzuki, M; Takahashi, S; Tokunaga, K; Torii, A | 1 |
| Ghadir, MR; Iranikhah, A; Sarkeshikian, SS | 1 |
| Ding, ZL; Geng, L; Gong, ST; Huang, J; Li, DY; Li, ZL; Mao, M; Wang, ZL; Xu, XW; Yang, M; Zhou, L | 1 |
| Jalalzadeh, M; Nazarian, M; Vafaeimanesh, J | 1 |
| Iakubov, AV; Khamraev, AA; Pulatova, NI | 1 |
| Cho, KB; Jang, BI; Jeon, SW; Jung, JT; Jung, MK; Jung, YS; Kim, ES; Kim, EY; Kim, KO; Kim, WJ; Kwon, JG; Lee, SH; Oh, MJ; Park, CS; Park, KS; Yang, CH | 1 |
| Fejza, H; Kraja, B; Manxhuka-Kerliu, S; Prifti, S; Qirjako, G; Telaku, S | 1 |
| Chen, ZY; Duan, BP; Ou-Yang, HJ; Tang, J; Xu, B; You, JY; Zhao, HM | 1 |
| Du, FC; Fu, Q; Gan, le L; Guo, G; Liu, KY; Sun, HW; Yue, ZY; Zhang, WJ; Zhang, Y; Zou, QM | 1 |
| Altintaş, E; Barlas, IO; Sezgin, O; Uçbilek, E; Yengel, E | 1 |
| Cui, R; Ding, S; Guo, C; Huang, X; Jin, Z; Li, Y; Lin, S; Meng, L; Xue, Y; Yan, X; Zhang, J; Zhang, L; Zhou, L | 1 |
| Fakharian, T; Ghanei, H; Hosseini, SM; Nazemian, F; Sharifipoor, F; Zivarifar, HR | 1 |
| Blot, WJ; Brown, LM; Crystal-Mansour, S; Fraumeni, JF; Gail, MH; Han, ZX; Hu, Y; Li, JY; Li, WQ; Liu, WD; Ma, JL; Pan, KF; Pee, D; Shen, L; You, WC; Zhang, L | 1 |
| Khaĭrullaeva, SS; Khamraev, AA; Rustamova, MT | 1 |
| Bani-Sadr, F; Boulagnon, C; Diebold, MD; Hentzien, M; Jaussaud, R; Lambert, D; Nguyen, Y; Ramaholimihaso, F; Rouger, C | 1 |
| Jain, AK; Mishra, GN; Nath, G; Patel, SK; Pratap, CB | 1 |
| Bujanda, L; Cosme, A; Fernández-Reyes, M; Ibarra, B; Martos, M; Mendarte, U; Salicio, Y; Sarasqueta, C | 1 |
| Hakimi, P; Khoshnood, A; Reza Mirjalili, M; Salman-Roghani, H | 1 |
| Asaoka, D; Ito, M; Kawai, T; Kawakami, K; Kurihara, N; Masaoaka, T; Matsuhisa, T; Mine, T; Mizuno, S; Nagahara, A; Nishizawa, T; Ohkusa, T; Omata, F; Sakaki, N; Sasaki, H; Suzuki, H; Suzuki, M; Takahashi, S; Tokunaga, K; Torii, A | 1 |
| Hajaghamohammadi, A; Kazemifar, AM; Oveisi, S; Safiabadi Tali, SH; Samimi, R | 1 |
| Hauser, G; JajacKnez, A; Salkic, N; Stimac, D; Vukelic, K | 1 |
| Brennan, DE; Breslin, N; Haider, RB; Hall, B; Holleran, G; McNamara, D; O'Connor, HJ; O'Morain, C; Omorogbe, J; Smith, SM | 1 |
| Akhtar, N; Asif, HM; Sugiyama, T; Usmanghani, K; Zaidi, SF | 1 |
| Belzer, C; de Vos, WM; den Dunnen, JT; Devilee, P; Dingemanse, C; Günthel, M; Kuijper, EJ; Robanus-Maandag, EC; Salvatori, D; van Hijum, SA; van Ommen, GB | 1 |
| Li, JY; Ma, JL; Pan, KF; Shen, L; You, WC; Zhang, L; Zhang, Y; Zhou, T | 1 |
| Al Kaabi, S; Babu, R; Chandra, P; Derbala, M; Doiphode, S; John, A; Sharma, M; Yacoub, R | 1 |
| Alimadadi, M; Amirkhanlou, S; Hafezi, AA; Homapour, S; Seyyedmajidi, M; Vafaeimanesh, J; Vakili, MA | 1 |
| Baldoni, HA; Ellena, J; Narda, GE; Russo, MG; Sancho, MI; Silva, LM; Venancio, T | 1 |
| Akyuz, F; Baran, B; Besisik, F; Demir, K; Emrence, Z; Evirgen, S; Gokturk, S; Karaca, C; Kaymakoglu, S; Ormeci, A; Soyer, OM; Ustek, D | 1 |
| Abd-Elsalam, S; Ali, LA; El-Kalla, F; Elkhalawany, W; Habba, E; Kobtan, A; Mansour, L; Nawasany, SE; Rizk, F; Saif, SA; Shehata, MA; Soliman, H; Soliman, S; Yousef, M | 1 |
| Basso da Silva, L; Cristovam, RA; de Moraes, GS; Francesconi, CF; Klein, MG; Mazzoleni, F; Mazzoleni, LE; Nabinger, DD; Nardelli, EF; Osório, MC; Rech, TF; Sander, GB; Simon, D | 1 |
| Ejtehadi, F; Farshad, S; Mahmoudi, L; Mahmoudi, P; Niknam, R; Seddigh, M | 1 |
| Bravo, LE; Bustamante-Rengifo, JA; Matta, AJ; Pazos, AJ | 1 |
| Fang, JY; Ji, F; Li, JS; Li, YQ; Luo, HQ; Luo, HS; Lv, NH; Qian, JM; Ren, JL; Shi, RH; Tan, B; Xu, H; Zou, YY | 1 |
| Dolatkhah, H; Eidi, A; Noormohammadi, Z; Nouri, M; Sharifi, R; Shirmohammadi, M | 1 |
| Colak, Y; Doganay, L; Ozdil, K; Ozturk, O; Tuncer, I; Ulasoglu, C; Yilmaz Enc, F | 1 |
| Donday, MG; Gisbert, JP; McNicholl, AG; Ramas, M | 1 |
| Chen, Y; Du, Y; Li, Y; Liu, D; Lv, N; Pan, X; Wang, H; Wang, J; Wu, K; Xie, Y; Xu, J; Zeng, Z; Zhang, G | 1 |
| Álvarez-Pantoja, E; Gallardo-Montoya, JM; Gallardo-Wong, I; Guerrero-Rivera, S; Gutiérrez-Espíndola, G; Maillón-García, LA; Medrano-Contreras, J; Morán-Villota, S | 1 |
| Ramadan, M | 1 |
| Chen, L; Chen, S; Chen, X; Chen, Y; Chu, H; Deng, Y; Ge, Q; He, H; He, J; Li, A; Long, Y; Wang, L | 1 |
| Baghbanian, M; Mirvakili, M; Salmanroghani, H; Salmanroghani, R; Sanati, G; Yazdian, P | 1 |
| Bayingana, C; Dusabejambo, V; Hale, D; Hategeka, C; Kabakambira, JD; Ndoli, J; Ngabonziza, F; Ntirenganya, C; Page, C; Walker, T | 1 |
| Benkirane, A; Berrag, S; Berraida, R; Boutallaka, H; Elkoti, I; Loubaris, K; Nejjari, F; Seddik, H; Sentissi, S | 1 |
| Andreev, DN; Dicheva, DT; Maev, IV; Partzvania-Vinogradova, EV; Samsonov, AA | 1 |
| Andreev, DN; Dicheva, DT; Maiev, IV; Partzvania-Vinogradova, EV; Yurenev, GL | 1 |
| Arévalo Galvis, A; Otero Regino, W; Trespalacios Rangel, AA | 1 |
| Cardona, F; Clemente-Postigo, M; Coin-Aragüez, L; Cornejo-Pareja, I; Martín-Núñez, GM; Moreno-Indias, I; Muñoz-Garach, A; Roca-Rodríguez, MDM; Tinahones, FJ | 1 |
| Cholleti, SM; Jodesty, Y; Li, D; Pham, HV; Tseng, DS; Wei, JC | 1 |
| Balzan, D; Callus, R; Delicata, L; Felice, T | 1 |
| Abagyan, R; Dai, W; Dong, M; Shi, D; Zhang, Y | 1 |
| Andreolla, HF; Breyer, HP; Canevese, AP; da Silva, CA; da Veiga Chaves Picon, R; De Araujo, A; De Bona, LR; de Lucena Theil, A; de Magalhães Francesconi, CF; Edelweiss, MI; Krumel, CF; Longo, L; Mazzoleni, F; Mazzoleni, LE; Michalczuk, MT; Milbradt, TC; Ott, EA; Sander, GB; Schaefer, PG; Simon, D; Spinato Torresini, R; Stifft, J; Talley, NJ; Titton, NF; Uchoa, DM; Volpato, N; Von Reisswitz, PS; Wortmann, AC; Zenker, RP | 1 |
| de Andrés, E; Gómez Hernando, C; Gómez Rodríguez, R; Muñoz Gómez, P; Sierra Bernal, C; Valle Muñoz, J | 1 |
| Attia, TZ; Derayea, SM; Tsujino, H; Tsutsumi, Y; Uno, T; Yamashita, T | 1 |
| Bernardino, JI; Martín Carbonero, L; Montejano, R; Moreno, V; Serrano, L; Valencia, ME | 1 |
| Huang, Y; Jiang, Y; Tang, Z; Wang, Y; Yan, W; Ye, Z; Zhang, Y; Zhou, Y | 1 |
| Aumpan, N; Gamnarai, P; Mahachai, V; Ratanachu-Ek, T; Tshering, L; Uchida, T; Vilaichone, RK; Yamaoka, Y | 1 |
| Canaan, Y; Graham, DY; Hulten, KG; Kalfus, IN; Maher, J; Wiener, G | 1 |
| Jeon, H; Kang, SC; Kim, BY; Kim, SE; Lee, WK; Memon, A | 1 |
| Calvo, PL; Cisarò, F; Pizzol, A | 1 |
| Jr, JM | 1 |
| Elhendawy, M; Hagras, MM; Shaker, ESE; Soliman, SS | 1 |
| Arj, A; Gilassi, H; Madani, M; Razavizadeh, M | 1 |
| Graham, DY; Howden, CW | 1 |
| Damanhuri, NS; Kumolosasi, E; Mansor, AH; Omar, MS; Razak, AFA | 1 |
| Fukuda, K; Fukuda, M; Hirashita, Y; Kawahara, Y; Kodama, M; Kudo, Y; Matsunari, O; Mizukami, K; Murakami, K; Ogawa, R; Okamoto, K; Okimoto, T; Wada, Y | 1 |
| Bunchorntavakul, C; Buranathawornsom, A | 1 |
| Hassib, ST; Mostafa, EA; Sharf, MG; Taha, EA | 1 |
| Florholmen, JR; Goll, R; Halvorsen, FA; Johnsen, KM; Melby, KK; Moayeri, B; Nestegard, O; Paulssen, E; Sørbye, SW; Tønnesen, T | 1 |
| Bai, G; Du, H; Yi, J; Yu, Y | 1 |
| Iakovenko, AV; Ivanov, AN; Soluyanova, IP; Strokova, TV; Vasilyev, NN; Yakovenko, EP | 1 |
| Ding, J; Du, Y; Fan, H; Huang, C; Li, Z; Lyu, N; Pan, X; Pan, Z; Shi, Z; Sun, H; Wang, Q; Zhang, L; Zhu, H | 1 |
| Bonafede, M; Cappell, K; Jacob, R; Pelletier, C; Sedgley, R; Shah, S; Yadlapati, R | 1 |
| Ding, YM; Han, ZX; Ji, R; Li, YY; Lin, BS; Zhang, WL | 1 |
| Alamri, ZZ; Faraj, RK; Hussein, MM; M Hussein, A; Mojarradgandoukmolla, S; Muhialdin, AJ; Taha, ZB | 1 |
117 review(s) available for amoxicillin and omeprazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Helicobacter pylori, peptic ulcer disease and inhibition of gastric acid secretion.
Topics: Amoxicillin; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Gastric Acid; Gastric Acidity Determination; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Omeprazole; Peptic Ulcer; Recurrence; Stomach Diseases | 1992 |
[Proton pump blockade and Helicobacter pylori: status of current knowledge and clinical importance].
Topics: Amoxicillin; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Proton Pumps | 1992 |
The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice?
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Randomized Controlled Trials as Topic; Tetracycline | 1995 |
[Helicobacter pylori eradication therapy with omeprazole and amoxicillin: current status].
Topics: Amoxicillin; Double-Blind Method; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Multicenter Studies as Topic; Omeprazole; Randomized Controlled Trials as Topic | 1994 |
The role of omeprazole and antibiotic combinations in the eradication of Helicobacter pylori--an update.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer | 1994 |
Omeprazole, Helicobacter pylori, and gastritis.
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole | 1994 |
Hp and pH--the relevance of gastric acid to the treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Drug Therapy, Combination; Gastric Acid; Gastric Mucosa; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Omeprazole; Pepsin A; Pepsinogens; Proton Pumps; Stomach Ulcer | 1994 |
Antibacterial therapy of Helicobacter pylori-associated peptic ulcer disease: a new strategy. The Swedes go for it.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer | 1994 |
Helicobacter pylori in peptic ulcer disease.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; United States | 1994 |
The role of acid inhibition in the treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Depression, Chemical; Drug Administration Schedule; Drug Therapy, Combination; Gastric Acid; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer | 1994 |
Emerging strategies for managing peptic ulcer disease.
Topics: Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Depression, Chemical; Drug Therapy, Combination; Gastric Acid; Gastritis; Helicobacter Infections; Humans; Omeprazole; Peptic Ulcer | 1994 |
[Current therapy of Helicobacter pylori infection].
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Recurrence | 1994 |
Effect of lansoprazole on Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Microbial Sensitivity Tests; Omeprazole; Tinidazole | 1993 |
Hp and pH: implications for the eradication of Helicobacter pylori.
Topics: Amoxicillin; Drug Synergism; Duodenum; Gastric Acid; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Omeprazole; Pepsin A; Peptic Ulcer; Proton Pumps; Stomach | 1993 |
Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment.
Topics: Amoxicillin; Bismuth; Cimetidine; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Patient Compliance; Peptic Ulcer; Tinidazole | 1993 |
Eradication of Helicobacter pylori and its effect in peptic ulcer disease.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Campylobacter Infections; Drug Therapy, Combination; Humans; Omeprazole; Peptic Ulcer; Recurrence | 1993 |
[Omeprazole and amoxycillin in the eradicating treatment of Helicobacter pylori].
Topics: Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins | 1995 |
The influence of drug dosage on Helicobacter pylori eradication: a cost-effectiveness analysis.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Imidazoles; Omeprazole; Penicillins; Regression Analysis; Stomach Ulcer; Tetracycline; Time Factors | 1996 |
Triple therapy and Helicobacter pylori.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Stomach Neoplasms; Stomach Ulcer; Tetracycline; Time Factors | 1996 |
Review of Helicobacter pylori eradication regimens.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Omeprazole | 1996 |
[How to eradicate Helicobacter pylori in 1995? Critical review of available treatments].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Humans; Omeprazole; Penicillins; Ranitidine | 1996 |
Strategies for Helicobacter pylori eradication in 1995: a review of international and Belgian experience.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Belgium; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Peptic Ulcer; Treatment Outcome | 1996 |
Cost-effectiveness of H. pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Markov Chains; Omeprazole; Penicillins; Peptic Ulcer; Stomach Neoplasms; Treatment Outcome | 1996 |
[Helicobacter pylori eradication: triple therapy versus dual therapy].
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Tetracycline; Tinidazole; Treatment Outcome | 1996 |
A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Nitroimidazoles; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Risk Assessment; Tetracyclines | 1996 |
The role of antisecretory drugs in the treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Metronidazole; Omeprazole; Penicillins; Proton Pump Inhibitors | 1997 |
Treatment strategies for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Protein Synthesis Inhibitors; Salicylates; Tetracycline | 1997 |
[Diagnosis and treatment of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Bacteriological Techniques; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Polymerase Chain Reaction; Ranitidine | 1997 |
Treatment of Helicobacter pylori infection: a review of the world literature.
Topics: Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors; Smoking; Tetracycline; Treatment Outcome | 1996 |
Amoxycillin dual therapy against Helicobacter pylori--the final nail in the coffin?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole | 1997 |
Current regimens for treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Omeprazole; Proton Pump Inhibitors; Ranitidine; Stomach Diseases; Treatment Outcome | 1998 |
[Treatment of Helicobacter pylori infections].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins; Tetracycline; Time Factors | 1998 |
Helicobacter pylori eradication as a surrogate marker for the reduction of duodenal ulcer recurrence.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Biomarkers; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter pylori; Humans; Male; Multicenter Studies as Topic; Omeprazole; Penicillins; Randomized Controlled Trials as Topic; Secondary Prevention | 1998 |
Efficacy of lansoprazole in eradicating Helicobacter pylori: a meta-analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Patient Selection; Penicillins; Peptic Ulcer; Randomized Controlled Trials as Topic | 1998 |
Clinical relevance of resistant strains of Helicobacter pylori: a review of current data.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Penicillins; Proton Pump Inhibitors | 1998 |
Eradication therapies for Helicobacter pylori.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Organometallic Compounds; Stomach Diseases | 1998 |
[Omeprazole plus 2 antibiotics for the eradication of H. pylori, are 5 days of treatment sufficient?].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies | 1998 |
[Role of pantoprazole in the eradicating treatment of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Pantoprazole; Sulfoxides | 1998 |
Helicobacter pylori, acid, and omeprazole revisited: bacterial eradication and rebound hypersecretion.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Gastric Acid; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Treatment Outcome | 1999 |
[Importance of drug selection and the use of sensitivity tests for the eradication therapy for Helicobacter pylori].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole | 1999 |
[Eradication rate and side effect from a point of view of Helicobacter pylori eradication of peptic ulcer disease in dual therapy or new triple therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors | 1999 |
[Lansoprazole: a review of its role in Helicobacter pylori eradication therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Nitroimidazoles; Omeprazole; Penicillins | 1999 |
Microbial ecology and treatment of Helicobacter pylori infections: review.
Topics: Adenocarcinoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Female; Gastric Mucosa; Gastritis; Genetic Variation; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Stomach Neoplasms | 2000 |
Cure of refractory duodenal ulcer and infection caused by Helicobacter pylori by high doses of omeprazole and amoxicillin in a homozygous CYP2C19 extensive metabolizer patient.
Topics: Amoxicillin; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Homozygote; Humans; Middle Aged; Mixed Function Oxygenases; Omeprazole; Penicillins; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Recurrence; Treatment Outcome | 2000 |
Helicobacter pylori and idiopathic chronic urticaria.
Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Carbon Isotopes; Case-Control Studies; Chronic Disease; Clarithromycin; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prevalence; Turkey; Urea; Urticaria | 2000 |
[Menetrier's disease. Another Helicobacter pylori associated disease?].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Macrolides; Male; Middle Aged; Omeprazole; Stomach Diseases | 2000 |
[Recent guidelines for the management of Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Practice Guidelines as Topic; Proton Pump Inhibitors | 2001 |
[Selection of antibiotics and planning of eradication for H. pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole | 2001 |
[A strategy for second-line anti-Helicobacter pylori therapy in patients with previously failed treatment].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Mixed Function Oxygenases; Omeprazole; Patient Compliance; Polymorphism, Genetic; Proton Pump Inhibitors; Treatment Failure | 2001 |
Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection.
Topics: Abietanes; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diterpenes; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors; Ranitidine; Recurrence; Research Design; Tetracycline; Treatment Outcome | 2001 |
[Experience in the use of losek (omeprazole) in gastroenterology].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Gastroesophageal Reflux; Gastrointestinal Diseases; Humans; Metronidazole; Omeprazole; Penicillins; Placebos; Randomized Controlled Trials as Topic; Stomach Diseases; Stomach Ulcer; Tablets; Time Factors; Zollinger-Ellison Syndrome | 2001 |
[Progress of tailor-made treatment of peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Asian People; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors | 2002 |
[The outline of medical treatment of peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Misoprostol; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors | 2002 |
[Guidelines for the management of Helicobacter pylori infection in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Omeprazole; Practice Guidelines as Topic | 2002 |
[Guidelines of Helicobacter pylori eradication in children].
Topics: Amoxicillin; Breath Tests; Child; Clarithromycin; Drug Therapy, Combination; Europe; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Metronidazole; North America; Omeprazole; Pediatrics; Practice Guidelines as Topic | 2002 |
[New triple therapy for Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors | 2002 |
[Dual therapy for Helicobacter pylori resistance to anti microbial agents].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole | 2002 |
[Proton pump inhibitor-based quadruple therapy regimen for Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Bismuth; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Tetracycline | 2002 |
[Effect of PPI/AM re-treatment regimen for the patients with Helicobacter pylori infection after failure of first line eradication therapy by PPI/AC regimens].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Treatment Failure; Treatment Outcome | 2002 |
[High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy: CYP2C19 polymorphism].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Administration Schedule; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Pharmacogenetics; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Treatment Failure | 2002 |
[Second line treatment regimen of PPI + AMPC + MNZ for patients with clarithromycin-resistant Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Treatment Failure | 2002 |
[Ecabet sodium (ECA) + PPI + AMPC therapy for clarithromycin-resistant Helicobacter pylori infections].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Clinical Trials as Topic; Diterpenes; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Treatment Outcome | 2002 |
[Eradication therapy for clarithromycin-resistant and metronidazole-resistant Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Treatment Failure | 2002 |
[Adverse effects of H. pylori eradication therapy and its measure].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Clarithromycin; Diarrhea; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus acidophilus; Lansoprazole; Mouth Diseases; Omeprazole; Skin Diseases | 2002 |
[Acute mucosal lesion of the upper-gastrointestinal tract observed after H. pylori-eradication].
Topics: Acute Disease; Amoxicillin; Clarithromycin; Esophagitis, Peptic; Gastric Acid; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Omeprazole; Peptic Ulcer | 2002 |
[H. pylori eradication therapy and natural history of peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Secondary Prevention | 2002 |
[Peptic ulcer in the elderly].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors | 2002 |
[Proton pump inhibitors: Omeprazole].
Topics: Amoxicillin; Clarithromycin; Clinical Trials as Topic; Depression, Chemical; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors; Treatment Outcome | 2002 |
[Proton pump inhibitors: Efficacy of lansoprazole in eradicating Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Depression, Chemical; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors | 2002 |
[Proton pump inhibitors: Rabeprazole].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Depression, Chemical; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome | 2002 |
[Amoxicillin (AMPC)].
Topics: Amoxicillin; Animals; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Proton Pump Inhibitors | 2002 |
[Plaunotol].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Diterpenes; Drug Resistance, Bacterial; Drug Therapy, Combination; Fatty Alcohols; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Neutrophil Activation; Omeprazole; Peptic Ulcer; Prognosis | 2002 |
[Sofalcone].
Topics: Amoxicillin; Anti-Ulcer Agents; Chalcone; Chalcones; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Treatment Outcome | 2002 |
[Ecabet sodium].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Amoxicillin; Animals; Anti-Ulcer Agents; Diterpenes; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Randomized Controlled Trials as Topic; Secondary Prevention; Urease | 2002 |
[Polaprezinc].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Ulcer Agents; Carnosine; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer; Urease; Zinc Compounds | 2002 |
[Non-ulcer dyspepsia and H. pylori].
Topics: Amoxicillin; Clarithromycin; Dyspepsia; Gastric Acid; Gastric Emptying; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Randomized Controlled Trials as Topic | 2002 |
[Helicobacter heilmannii-associated gastritis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter heilmannii; Helicobacter Infections; Humans; Lansoprazole; Metronidazole; Omeprazole; Organometallic Compounds; Tetracycline | 2002 |
[Practice guidelines for diagnosis and treatment of Helicobacter pylori infections and their application in clinical practice].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Practice Guidelines as Topic; Proton Pump Inhibitors | 2002 |
Helicobacter pylori infection in skin diseases: a critical appraisal.
Topics: Amoxicillin; Clarithromycin; Clinical Trials as Topic; Comorbidity; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Metronidazole; Omeprazole; Prognosis; Risk Factors; Severity of Illness Index; Skin Diseases, Bacterial; Urticaria | 2002 |
Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; Treatment Outcome | 2002 |
[Eradication therapy of Helicobacter pylori for elderly patients in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Omeprazole; Practice Guidelines as Topic | 2002 |
[Helicobacter pylori induced gastritis: recent topics on eradication therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Penicillins; Proton Pump Inhibitors; Tetracyclines | 2002 |
[New triple therapy for Helicobacter pylori infection in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole | 2003 |
Extragastric mucosa-associated lymphoid tissue lymphoma showing the regression by Helicobacter pylori eradication therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Omeprazole; Stomach Neoplasms; Thyroid Neoplasms; Thyroiditis, Autoimmune | 2003 |
[Guidelines in the management of Helicobacter pylori infection in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Microbiology; Omeprazole; Peptic Ulcer; Polyps; Practice Guidelines as Topic; Proton Pump Inhibitors; Societies, Medical; Stomach Neoplasms | 2003 |
How can the current strategies for Helicobacter pylori eradication therapy be improved?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Time Factors | 2003 |
Current consensus on the diagnosis and treatment of H. pylori-associated gastroduodenal disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Apoptosis; Chemistry, Clinical; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastrointestinal Diseases; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Japan; Lansoprazole; Omeprazole; Peptic Ulcer; Urease | 2003 |
[Eradication effect of lansoprazole-based triple therapy against H. pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Neoplasms; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Stomach Ulcer | 2004 |
[Proton pump inhibitors as the basis of anti-helicobacter therapeutic schemes].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine | 2004 |
[Evaluation of the efficacy of an Helicobacter pylori eradication treatment for idiopathic thrombocytopenic purpura patients].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Purpura, Thrombocytopenic, Idiopathic | 2004 |
Helicobacter heilmannii infection in a child after successful eradication of Helicobacter pylori: case report and review of literature.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter heilmannii; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole | 2005 |
[Diagnosis of and therapy for peptic ulcer].
Topics: Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Hemostasis, Endoscopic; Histamine H2 Antagonists; Humans; Japan; Omeprazole; Peptic Ulcer; Practice Guidelines as Topic; Proton Pump Inhibitors; Stress, Psychological; Sucralfate | 2005 |
Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clinical Trials as Topic; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Odds Ratio; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors | 2005 |
Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Esomeprazole; Gastroesophageal Reflux; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole | 2005 |
[Eradication of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Stomach Neoplasms; Sulfoxides | 2005 |
[Guidelines in the management of H. pylori infection in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Metronidazole; Omeprazole; Practice Guidelines as Topic; Proton Pump Inhibitors | 2005 |
[Establishment of 2nd line treatment regimen for H. pylori infection--future prospect for the application for national health insurance system in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Metronidazole; National Health Programs; Omeprazole; Proton Pump Inhibitors; Rabeprazole | 2005 |
[Cap polyposis and Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Intestinal Polyposis; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Treatment Outcome | 2005 |
[Concomitant dosing of a H2 receptor antagonist (H2RA) with a triple therapy increases the cure rate of Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Enzyme Inhibitors; Famotidine; Gastric Acidity Determination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic | 2005 |
[Quality of ulcer healing and rebamipide].
Topics: Alanine; Amoxicillin; Animals; Anti-Ulcer Agents; Antioxidants; Cytokines; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Quinolones; Recurrence; Stomach Ulcer; Wound Healing | 2005 |
[Triple therapy for eradication of Helicobacter pylori in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Humans; Insurance, Health; Japan; Lansoprazole; Omeprazole; Patient Compliance; Practice Guidelines as Topic; Proton Pump Inhibitors | 2005 |
[Adverse effects of Helicobacter pylori eradication and its prevention].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors | 2005 |
[Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Patient Compliance; Proton Pump Inhibitors; Treatment Outcome | 2005 |
[Second-line eradication therapy for H. pylori infection--PPI+AMPC+MNZ triple therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome | 2005 |
[High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Treatment Failure | 2005 |
[Comparison between one-week and two-week regimens of new triple therapy in H. pylori eradication].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Time Factors; Treatment Outcome | 2005 |
[Helicobacter pylori eradication therapy for children].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Enzyme Inhibitors; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Patient Compliance; Proton Pump Inhibitors; Purpura, Thrombocytopenic, Idiopathic; Treatment Outcome | 2005 |
[Eradication therapy for the remnant stomach infected with Helicobacter pylori ].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Stump; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Proton Pump Inhibitors; Stomach Neoplasms; Tranexamic Acid | 2005 |
[Eradication of Helicobacter pylori in patients with end-stage renal disease undergoing dialysis treatment].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dialysis; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Failure, Chronic; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors | 2005 |
[Gastroduodenal erosions observed after Helicobacter pylori eradication].
Topics: Adult; Amoxicillin; Clarithromycin; Duodenitis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Omeprazole; Ranitidine | 2005 |
[Influence of cytochrome P450 2C19 genetic polymorphism on H. pylori eradication therapy].
Topics: Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Mixed Function Oxygenases; Omeprazole; Pharmacogenetics; Polymorphism, Single Nucleotide; Proton Pump Inhibitors; Treatment Outcome | 2005 |
[Cytochrome P450 2C19 genotype -based second line therapy with amoxicillin and lansoprazole after failure of initial helicobacter pylori eradication therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Enzyme Inhibitors; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Pharmacogenetics; Polymorphism, Genetic; Proton Pump Inhibitors; Treatment Failure | 2005 |
High grade B-cell gastric lymphoma with complete pathologic remission after eradication of Helicobacter pylori infection: report of a case and review of the literature.
Topics: Adult; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Omeprazole; Proton Pump Inhibitors; Remission Induction; Stomach Neoplasms | 2008 |
What is new in the management of Helicobacter pylori?
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Practice Guidelines as Topic; Probiotics; Proton Pump Inhibitors; Rifabutin; Tetracycline | 2008 |
Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Proton Pump Inhibitors; Ranitidine; Tinidazole; Treatment Outcome | 2009 |
Efficacy and Safety of Vonoprazan and Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Pyrroles; Treatment Outcome | 2023 |
662 trial(s) available for amoxicillin and omeprazole
| Article | Year |
|---|---|
Two weeks treatment with amoxicillin/omeprazole for eradication of Helicobacter pylori.
Topics: Amoxicillin; Biopsy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Ranitidine | 1992 |
[Short-term therapy with high dosage omeprazole and amoxicillin for Helicobacter pylori eradication. A pilot study].
Topics: Amoxicillin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Pilot Projects | 1992 |
The role of omeprazole (40 mg) in the treatment of gastric Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Salicylates | 1991 |
Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? A pilot study.
Topics: Adult; Amoxicillin; Campylobacter Infections; Double-Blind Method; Drug Therapy, Combination; Female; Gastritis; Humans; Male; Omeprazole; Pilot Projects | 1989 |
No effect of omeprazole-induced hypoacidity on the bioavailability of amoxycillin or bacampicillin.
Topics: Adult; Amoxicillin; Ampicillin; Biological Availability; Female; Gastric Acid; Half-Life; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole | 1989 |
Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Ranitidine; Recurrence; Salicylates; Tetracycline; Treatment Outcome | 1995 |
[Comparison of 2 treatment schemes to eradicate Helicobacter pylori].
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Dyspepsia; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Recurrence | 1995 |
Clinical efficacy of lansoprazole-amoxicillin treatment in eradicating Helicobacter pylori: evaluation by the polymerase chain reaction method.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Base Sequence; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Molecular Sequence Data; Omeprazole; Penicillins; Peptic Ulcer; Polymerase Chain Reaction; Proton Pump Inhibitors | 1995 |
Lansoprazole versus lansoprazole plus amoxicillin treatment for eradication of Helicobacter pylori in patients with gastric ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Penicillins; Proton Pump Inhibitors; Stomach Ulcer | 1995 |
Effects of lansoprazole with or without amoxicillin on ulcer healing: relation to eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Duodenal Ulcer; Gastric Juice; Gastric Mucosa; Gastrins; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Penicillins; Pepsinogens; Peptic Ulcer; Proton Pump Inhibitors; Stomach Ulcer | 1995 |
Clinical efficacy of lansoprazole in eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Stomach Ulcer | 1995 |
Efficacy of lansoprazole and amoxicillin in eradicating Helicobacter pylori: evaluation using 13C-UBT and Monoclonal H. pylori antibody testing.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Breath Tests; Drug Therapy, Combination; Duodenal Ulcer; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Monitoring, Physiologic; Omeprazole; Penicillins; Pepsinogens; Stomach Ulcer; Urea | 1995 |
Eradication of Helicobacter pylori with lansoprazole, amoxicillin, and plaunotol in duodenal ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Diterpenes; Drug Therapy, Combination; Duodenal Ulcer; Fatty Alcohols; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors | 1995 |
Combination therapies with a proton pump inhibitor for Helicobacter pylori-infected gastric ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diterpenes; Fatty Alcohols; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Recurrence; Stomach Ulcer | 1995 |
Therapeutic effects of lansoprazole on peptic ulcers in elderly patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Anti-Ulcer Agents; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors | 1995 |
A randomized prospective comparison of clarithromycin versus amoxycillin in combination with omeprazole for eradication of Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Amoxicillin; Clarithromycin; Dizziness; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Pruritus | 1995 |
Omeprazole-amoxycillin therapy for eradication of Helicobacter pylori in duodenal ulcer bleeding: preliminary results of a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Colony Count, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Pilot Projects; Treatment Outcome | 1995 |
Two-year follow-up of duodenal ulcer patients treated with omeprazole and amoxicillin.
Topics: Amoxicillin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Recurrence; Time Factors | 1995 |
Limited efficacy of omeprazole-based dual and triple therapy for Helicobacter pylori: a randomized trial employing "optimal" dosing.
Topics: Adult; Amoxicillin; Breath Tests; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Patient Compliance; Prospective Studies; Tetracycline; Time Factors | 1995 |
Treatment of Helicobacter pylori infection with omeprazole-amoxicillin combination therapy versus ranitidine/sodium bicarbonate-amoxicillin.
Topics: Amoxicillin; Biopsy; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Ranitidine; Reproducibility of Results; Sodium Bicarbonate | 1995 |
Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Biopsy; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Patient Compliance; Treatment Failure | 1995 |
Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized
Topics: Adult; Amoxicillin; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Nitrates; Omeprazole; Prospective Studies; Ranitidine; Recurrence; Tetracycline; Time Factors; Tinidazole | 1995 |
Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Recurrence; Stomach Ulcer; Treatment Outcome | 1995 |
Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease.
Topics: Adult; Amoxicillin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Recurrence | 1995 |
Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Recurrence | 1995 |
Efficacy of omeprazole combined with antibiotics for Helicobacter pylori eradication and duodenal ulcer recurrence.
Topics: Adult; Aged; Amoxicillin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Recurrence | 1995 |
Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers.
Topics: Adolescent; Adult; Aged; Amoxicillin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Germany; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Recurrence | 1995 |
Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Stomach Ulcer; Tetracycline; Treatment Outcome | 1994 |
Rapid eradication of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Chi-Square Distribution; Cost-Benefit Analysis; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Drug Tolerance; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole | 1995 |
Successful Helicobacter pylori eradication incorporating a one-week antibiotic regimen.
Topics: Adult; Amoxicillin; Drug Synergism; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Stomach Ulcer | 1995 |
Intravenous omeprazole/amoxicillin and omeprazole pretreatment in Helicobacter pylori-positive acute peptide ulcer bleeding. A pilot study.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Breath Tests; Carbon Radioisotopes; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Injections, Intravenous; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Pilot Projects; Prospective Studies; Stomach Ulcer; Time Factors; Urea; Urease | 1994 |
Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after Helicobacter pylori eradication.
Topics: Adult; Age Factors; Amoxicillin; Chronic Disease; Drug Therapy, Combination; Dyspepsia; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Middle Aged; Omeprazole; Prevalence; Sex Factors; Time Factors | 1994 |
[Helicobacter pylori eradication therapy with omeprazole and amoxicillin: current status].
Topics: Amoxicillin; Double-Blind Method; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Multicenter Studies as Topic; Omeprazole; Randomized Controlled Trials as Topic | 1994 |
Scintigraphic assessment of the intragastric distribution and gastric emptying of an encapsulated drug: the effect of feeding and of a proton pump inhibitor.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Capsules; Cross-Over Studies; Dietary Proteins; Double-Blind Method; Drug Carriers; Eating; Female; Food; Gastric Emptying; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Indium Radioisotopes; Male; Omeprazole; Pentetic Acid; Proton Pump Inhibitors; Radionuclide Imaging; Stomach; Technetium | 1994 |
Amoxycillin capsules with omeprazole for the eradication of Helicobacter pylori. Assessment of the importance of antibiotic dose timing in relation to meals.
Topics: Adolescent; Adult; Aged; Amoxicillin; Drug Administration Schedule; Duodenal Ulcer; Eating; Female; Food; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Stomach Ulcer | 1994 |
Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors influencing the treatment success.
Topics: Adult; Aged; Amoxicillin; Analysis of Variance; Clinical Trials as Topic; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Prospective Studies; Stomach Ulcer; Treatment Outcome | 1994 |
High-dose omeprazole plus amoxicillin or clarithromycin cures Helicobacter pylori infection in duodenal ulcer disease.
Topics: Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies | 1995 |
Duodenal ulcer healing drugs.
Topics: Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Omeprazole | 1994 |
Causal role of Helicobacter pylori in peptic ulcer relapse.
Topics: Aged; Amoxicillin; Bismuth; Chi-Square Distribution; Drug Therapy, Combination; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Leukocytes; Male; Metronidazole; Omeprazole; Peptic Ulcer; Prospective Studies; Proton Pumps; Recurrence | 1994 |
Omeprazole 40 mg o.m. combined with amoxycillin alone or with amoxycillin and metronidazole in the eradication of Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies | 1994 |
Bismuth-free triple therapy for eradicating Helicobacter pylori and reducing the gastric ulcer recurrence rate.
Topics: Amoxicillin; Anti-Ulcer Agents; Diterpenes; Drug Therapy, Combination; Fatty Alcohols; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Recurrence; Stomach Ulcer | 1994 |
Medium- and high-dose omeprazole plus amoxicillin for eradication of Helicobacter pylori in duodenal ulcer disease.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole | 1994 |
Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients.
Topics: Amoxicillin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metaplasia; Metronidazole; Omeprazole | 1994 |
[Eradication of metronidazole-resistant Helicobacter pylori: is omeprazole/amoxicillin a therapeutic alternative?].
Topics: Adult; Aged; Amoxicillin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies | 1994 |
[Omeprazole/amoxicillin: improved eradication of Helicobacter pylori in smokers because of N-acetylcysteine].
Topics: Acetylcysteine; Adult; Aged; Amoxicillin; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies | 1994 |
[Omeprazole/amoxicillin: impaired eradication of Helicobacter pylori in smoking but not in premedication with omeprazole].
Topics: Adult; Aged; Amoxicillin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Premedication; Prospective Studies; Smoking | 1994 |
Medium- or high-dose omeprazole plus amoxicillin eradicates Helicobacter pylori in gastric ulcer disease.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Stomach Ulcer | 1994 |
Lansoprazole and Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulins; Lansoprazole; Middle Aged; Omeprazole | 1993 |
Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens.
Topics: Aged; Amoxicillin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole | 1993 |
Medium-term results of oral and intravenous omeprazole/amoxicillin Helicobacter pylori eradication therapy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Breath Tests; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Injections, Intravenous; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Stomach Ulcer; Urea | 1994 |
Long-term follow-up after eradication of Helicobacter pylori with a combination of omeprazole and amoxycillin.
Topics: Adolescent; Adult; Aged; Amoxicillin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Recurrence | 1993 |
Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study.
Topics: Adult; Aged; Amoxicillin; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Salicylates; Tetracycline | 1993 |
Omeprazole plus amoxicillin: efficacy of various treatment regimens to eradicate Helicobacter pylori.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole | 1993 |
Triple therapy vs. amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: a multicenter, prospective, randomized, controlled study of efficacy and side effects.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Colloids; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Penicillins; Prospective Studies; Tetracycline; Time Factors | 1996 |
Cure of Helicobacter pylori infection: role of duration of treatment with omeprazole and amoxicillin.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Time Factors | 1996 |
[Ulcer healing through the elimination of Helicobacter pylori: is a week of therapy enough?].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Remission Induction; Stomach Ulcer; Tetracycline; Time Factors | 1996 |
Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid, and ulceration.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Duodenum; Female; Gastric Acid; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metaplasia; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins | 1996 |
Omeprazole-based antimicrobial therapies: results in 198 Helicobacter pylori-positive patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Endoscopy, Digestive System; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer | 1995 |
Lansoprazole capsules and amoxicillin oral suspension in the treatment of peptic ulcer disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Amoxicillin; Anti-Ulcer Agents; Capsules; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Pharyngitis; Stomatitis; Suspensions | 1995 |
Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double-blind, randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Antitrichomonal Agents; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 1995 |
Prevention and treatment of low-grade B-cell primary gastric lymphoma by anti-H. pylori therapy.
Topics: Adolescent; Adult; Aged; Amoxicillin; Antitrichomonal Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Omeprazole; Penicillins; Stomach Neoplasms; Tinidazole | 1995 |
Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Duodenal Ulcer; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Smoking; Stomach Ulcer; Time Factors | 1996 |
Dual therapy versus triple therapy for Helicobacter pylori-associated duodenal ulcers.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chi-Square Distribution; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Single-Blind Method; Tetracycline; Time Factors | 1996 |
Low eradication rates of Helicobacter pylori with omeprazole plus amoxycillin combination in a Turkish population.
Topics: Amoxicillin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Turkey | 1996 |
Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Recurrence; Time Factors | 1996 |
The use of azithromycin in short-term low-dose triple therapies for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Time Factors; Tinidazole | 1996 |
Low H. pylori reinfection rate after triple therapy in Chilean duodenal ulcer patients.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Chile; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Recurrence; Salicylates; Single-Blind Method; Time Factors | 1996 |
Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cross-Over Studies; Double-Blind Method; Gastric Acid; Gastric Juice; Gastric Mucosa; Humans; Male; Metronidazole; Omeprazole; Penicillins; Saliva; Tissue Distribution | 1996 |
Effects of permanent eradication or transient clearance of Helicobacter pylori on histology of gastric mucosa using omeprazole with or without antibiotics.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Recurrence; Time Factors | 1996 |
Treatment of Helicobacter pylori infection with low or high dose omeprazole combined with amoxycillin and the effect of early retreatment.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Treatment Outcome | 1996 |
Comparison of two lansoprazole-antibiotic combinations (amoxycillin or classical triple therapy) for treatment of H. pylori infection in duodenal ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Antitrichomonal Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Penicillins; Tinidazole | 1996 |
Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer Hemorrhage; Prospective Studies; Ranitidine; Recurrence; Stomach Ulcer; Time Factors | 1996 |
One week treatment with omeprazole, clarithromycin and tinidazole or lansoprazole, amoxicillin and metronidazole for cure of Helicobacter pylori infection in duodenal ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Acidity Determination; Gastric Mucosa; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Tinidazole | 1996 |
Cure of gastric ulcer disease after cure of Helicobacter pylori infection--German Gastric Ulcer Study.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Biopsy; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Recurrence; Salicylates; Stomach Ulcer; Time Factors; Tinidazole | 1996 |
Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Bismuth; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Tetracycline | 1995 |
Omeprazole-amoxycillin versus omeprazole-amoxycillin-clarithromycin in the eradication of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance | 1996 |
Prospective evaluation of the macrolide antibiotic dirithromycin for the treatment of Helicobacter pylori.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Drug Combinations; Erythromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Macrolides; Male; Metronidazole; Middle Aged; Omeprazole; Pilot Projects; Prospective Studies; Urea | 1996 |
Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Tinidazole | 1996 |
Pharmacokinetic and pharmacodynamic interactions between omeprazole and amoxycillin in Helicobacter pylori-positive healthy subjects.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Area Under Curve; Breath Tests; Cross-Over Studies; Double-Blind Method; Drug Interactions; Gastric Acidity Determination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Urea | 1996 |
Dose-response of omeprazole combined with amoxycillin on duodenal ulcer healing and eradication of Helicobacter pylori.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Urea | 1996 |
[Eradication of Helicobacter pylori in patients with end-stage renal disease undergoing dialysis treatment].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ammonia; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Diterpenes; Drug Therapy, Combination; Fatty Alcohols; Female; Gastric Juice; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis | 1996 |
Helicobacter pylori eradication--evaluation of triple therapy containing omeprazole.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Prospective Studies; Time Factors | 1996 |
One-week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer | 1996 |
Enhanced eradication of Helicobacter pylori by pre- versus post-prandial amoxycillin suspension with omeprazole: implications for antibiotic delivery.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Eating; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins | 1996 |
Symptomatic and endoscopic duodenal ulcer relapse rates 12 months following Helicobacter pylori eradication treatment with omeprazole and amoxycillin with or without metronidazole.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins; Recurrence | 1996 |
Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
Topics: Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Random Allocation; Recurrence; Wound Healing | 1996 |
Effects of lansoprazole plus amoxycillin on the cure of Helicobacter pylori infection in Japanese peptic ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Synergism; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Recurrence; Stomach Ulcer | 1996 |
One-week therapy for Helicobacter pylori. A randomized trial of two treatment regimens.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Salicylates | 1996 |
Chemoprevention trial on precancerous lesions of the stomach in Venezuela: summary of study design and baseline data.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anticarcinogenic Agents; Antioxidants; Clarithromycin; Double-Blind Method; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Placebos; Precancerous Conditions; Stomach Neoplasms; Vitamins | 1996 |
Therapeutic options after failed Helicobacter pylori eradication therapy.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Retreatment; Treatment Failure | 1996 |
Omeprazole plus amoxicillin versus triple therapy eradicates Helicobacter pylori in the Chinese with peptic ulcer disease.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Salicylates; Salicylic Acid | 1996 |
[Effect of treatment with lansoprazole and amoxicillin in combination on healing process of duodenal ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors | 1996 |
Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cross-Over Studies; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Stomach Ulcer | 1996 |
Ecabet sodium eradicates Helicobacter pylori infection in gastric ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diterpenes; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Pepsin A; Protease Inhibitors; Stomach Ulcer | 1996 |
Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and either clarithromycin or azithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Proton Pump Inhibitors | 1996 |
High-dose proton pump inhibitor plus amoxycillin for the treatment or retreatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors | 1996 |
Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins | 1996 |
Reinfection and duodenal ulcer relapse in south-east Asian patients following successful Helicobacter pylori eradication: results of a 2-year follow-up.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Malaysia; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Recurrence; Time Factors | 1996 |
Evaluation of the efficacy and tolerability of four different therapeutic regimens for the Helicobacter pylori eradication.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Tinidazole | 1996 |
Effects of omeprazole and amoxycillin on the human oral and gastrointestinal microflora in patients with Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; beta-Lactamases; Biopsy; Dental Plaque; Double-Blind Method; Drug Therapy, Combination; Feces; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Intestines; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Omeprazole; Penicillins; Placebos; Polymerase Chain Reaction; Saliva; Stomach | 1996 |
Omeprazole, amoxicillin and bismuth for peptic ulcer healing and Helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Drug Interactions; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer | 1997 |
Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Norway; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Stomach Ulcer | 1997 |
Efficacy and tolerability of a one-week triple therapy consisting of pantoprazole, clarithromycin and amoxycillin for cure of Helicobacter pylori infection in patients with duodenal ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Diarrhea; Drug Hypersensitivity; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Sulfoxides | 1997 |
Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Ulcer Agents; Biopsy; Double-Blind Method; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Recurrence; Stomach Neoplasms; Stomach Ulcer; Wound Healing | 1997 |
Is the polymerase chain reaction or cure of Helicobacter pylori infection of help in the differential diagnosis of early gastric mucosa-associated lymphatic tissue lymphoma?
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Cross-Over Studies; Diagnosis, Differential; Double-Blind Method; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Omeprazole; Penicillins; Polymerase Chain Reaction | 1997 |
Lansoprazole and amoxycillin: observations on the treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Recurrence; Treatment Outcome | 1997 |
A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Oxytetracycline; Penicillins; Prospective Studies; Recurrence; Time Factors | 1997 |
One-week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection: the significance of imidazole resistance.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Imidazoles; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Tinidazole | 1997 |
Immediate repeat course of amoxycillin, metronidazole and omeprazole to eradicate Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer | 1997 |
Randomized study comparing omeprazole plus amoxycillin versus omeprazole plus clarithromycin for eradication of Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer | 1997 |
An increasing dose of omeprazole combined with amoxycillin cures Helicobacter pylori infection more effectively.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors | 1997 |
Does pretreatment with omeprazole decrease the chance of eradication of Helicobacter pylori in peptic ulcer patients?
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Treatment Outcome | 1997 |
Clarithromycin in the combination therapy for the eradication of Helicobacter pylori in peptic ulcer disease.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Nizatidine; Omeprazole; Organometallic Compounds; Penicillins; Ranitidine; Salicylates | 1997 |
Another therapeutic schedule in eradication of Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Ulcer Agents; Clavulanic Acids; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole | 1997 |
Helicobacter pylori eradication for the treatment of low-grade gastric MALT lymphoma: follow-up together with sequential molecular studies.
Topics: Aged; Amoxicillin; Drug Therapy, Combination; Follow-Up Studies; Gastrointestinal Neoplasms; Genes, Immunoglobulin; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Middle Aged; Omeprazole; Polymerase Chain Reaction; Prospective Studies | 1997 |
Doubling the omeprazole dose (40 mg b.d. vs. 20 mg b.d.) in dual therapy with amoxycillin increases the cure rate of Helicobacter pylori infection in duodenal ulcer patients.
Topics: Amoxicillin; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 1997 |
[Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Smoking; Treatment Outcome | 1997 |
Eradication of Helicobacter pylori in peptic ulcer disease with amoxycillin, 2.0 g, and omeprazole, 80 or 120 mg: a prospective randomized trial.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Biopsy; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Single-Blind Method; Treatment Outcome | 1997 |
Helicobacter pylori eradication--comparison of three drug regimens and symptomatic assessment in duodenitis and antral gastritis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Treatment Outcome | 1997 |
Age-dependent eradication of Helicobacter pylori with dual therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Age Factors; Aged; Amoxicillin; Anti-Ulcer Agents; Area Under Curve; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastric Acid; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Metabolic Clearance Rate; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Ranitidine | 1997 |
Cure with omeprazole plus amoxicillin versus long-term ranitidine therapy in Helicobacter pylori-associated peptic ulcer bleeding.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer Hemorrhage; Prognosis; Prospective Studies; Ranitidine; Secondary Prevention | 1997 |
Endoscopic ultrasonography for the initial staging and follow-up in patients with low-grade gastric lymphoma of mucosa-associated lymphoid tissue treated medically.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Antineoplastic Agents, Alkylating; Clarithromycin; Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combination; Endosonography; Female; Follow-Up Studies; Gastric Mucosa; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Neoplasm Staging; Omeprazole; Sensitivity and Specificity; Treatment Outcome | 1997 |
A United States multicentre trial of dual and proton pump inhibitor-based triple therapies for Helicobacter pylori.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; United States | 1997 |
Two omeprazole-based Helicobacter pylori eradication regimens for the treatment of duodenal ulcer disease in general practice.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Quality of Life | 1997 |
Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Canada; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Europe; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors | 1997 |
Triple therapy with lansoprazole, clarithromycin, and amoxicillin for the cure of Helicobacter pylori infection: a short report.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Treatment Outcome | 1996 |
Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Diarrhea; Double-Blind Method; Drug Eruptions; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hypertension; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prevalence; Proton Pump Inhibitors; Research Design; Treatment Outcome | 1996 |
Comparison of one or two weeks of lansoprazole, amoxicillin, and clarithromycin in the treatment of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alcohol Drinking; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Duodenitis; Esophagitis; Female; Helicobacter Infections; Helicobacter pylori; Hernia, Hiatal; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Smoking; Treatment Outcome | 1996 |
Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Treatment Outcome | 1996 |
No additional value of bismuth subcitrate to combination omeprazole/amoxicillin therapy in the eradication of Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Atrophy; Biopsy; Data Interpretation, Statistical; Diarrhea; Digestive System; Drug Therapy, Combination; Female; Gastroenteritis; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Male; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Pyloric Antrum; Time Factors; Treatment Outcome | 1997 |
[Hormonal changes and secretion and stomach mucosal microstructure in the course of H. pylori in patients with duodenal ulcer].
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Epidermal Growth Factor; Gastric Juice; Gastric Mucosa; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Somatostatin | 1997 |
[Endocrine and exocrine gastric mucosal secretion in the course of H. pylori eradication in patients with non-ulcer dyspepsia].
Topics: Amoxicillin; Bismuth; Dyspepsia; Epidermal Growth Factor; Gastric Juice; Gastric Mucosa; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Somatostatin; Stomach Ulcer | 1997 |
Omeprazole-based dual and triple therapy for the treatment of Helicobacter pylori infection in peptic ulcer disease: a randomized trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 1997 |
Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Evaluation; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Organometallic Compounds; Oxytetracycline; Prospective Studies | 1997 |
Multicenter evaluation of dual-therapy (omeprazol and amoxycillin) for Helicobacter pylori-associated duodenal and gastric ulcer (two years of the observation).
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Stomach Ulcer | 1997 |
Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Metronidazole; Omeprazole; Penicillins; Placebos; Proton Pump Inhibitors; Ranitidine; Tetracycline | 1998 |
Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Chronic Disease; Confidence Intervals; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Endoscopy; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Penicillins; Placebos; Stomach; Time Factors | 1998 |
Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Data Interpretation, Statistical; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Time Factors | 1998 |
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Single-Blind Method | 1997 |
Double-blind trial of omeprazole and amoxicillin in the cure of Helicobacter pylori infection in gastric ulcer patients. The Ulcer Study Group, Germany.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Stomach Ulcer; Treatment Outcome | 1998 |
Helicobacter pylori, efficacy of the new triple therapy in six and twelve-day schedules.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Penicillins; Time Factors; Tinidazole | 1997 |
Does Helicobacter pylori eradication depend on the period of amoxicillin treatment? A retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Diterpenes; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Fatty Alcohols; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Retrospective Studies | 1998 |
Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Alanine; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Antioxidants; Chemokines; Cytokines; Drug Therapy, Combination; Gastric Mucosa; Helicobacter Infections; Humans; Lansoprazole; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Quinolones | 1998 |
Dual therapy with high or low doses of omeprazole does not achieve an acceptable rate of Helicobacter pylori eradication in duodenal ulcer patients. A multicentre randomized long-term detailed study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Multivariate Analysis; Omeprazole; Penicillins; Prognosis; Pyloric Antrum; Recurrence; Regression Analysis; Treatment Outcome | 1997 |
[new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins | 1998 |
[Effects of the triple therapy in the eradication of Helicobacter pylori: comparison of 3 different antibiotics].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Clarithromycin; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Time Factors | 1997 |
Eradicating Helicobacter pylori reduces hypergastrinaemia during long-term omeprazole treatment.
Topics: Adult; Alginates; Aluminum Hydroxide; Amoxicillin; Antacids; Anti-Ulcer Agents; Drug Combinations; Drug Therapy, Combination; Esophagitis; Female; Gastrins; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Silicic Acid; Sodium Bicarbonate | 1998 |
Accuracy of CLOtest after Helicobacter pylori therapy.
Topics: Amoxicillin; Anti-Ulcer Agents; Biopsy; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Sensitivity and Specificity; Urease | 1998 |
Short duration therapy for Helicobacter pylori in Western Australia: the impact of metronidazole resistance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Penicillins; Tetracycline; Western Australia | 1998 |
Amoxicillin/metronidazole/omeprazole/clarithromycin: a new, short quadruple therapy for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pilot Projects; Prospective Studies | 1998 |
Lansoprazole, amoxicillin, and clarithromycin triple therapy in vagotomized patients with dyspeptic complaints. A randomized, double-blind, placebo-controlled, clinical study without pretreatment diagnostic upper endoscopy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Recurrence; Vagotomy | 1998 |
A prospective randomized study of amoxycillin and omeprazole with and without metronidazole in the eradication treatment of Helicobacter pylori.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Stomach Ulcer; Treatment Outcome | 1998 |
Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Penicillins; Recurrence | 1998 |
[Omeprazole, clarithromycin and amoxicillin therapy for Helicobacter pylori infection].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Penicillins | 1996 |
Miconazole gel increases the cure rate of Helicobacter pylori infection when added to lansoprazole and amoxicillin in a randomized trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gels; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Miconazole; Middle Aged; Omeprazole; Penicillins | 1998 |
Amount of Helicobacter pylori in gastric mucus during anti-H. pylori treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Polymerase Chain Reaction; Treatment Outcome | 1998 |
Helicobacter pylori eradication in the healing and recurrence of benign gastric ulcer: a two-year, double-blind, placebo controlled study.
Topics: Amoxicillin; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Proportional Hazards Models; Recurrence; Statistics, Nonparametric; Stomach Ulcer | 1997 |
Eradication of Helicobacter pylori reduces the rate of duodenal ulcer rebleeding: a long-term follow-up study.
Topics: Adult; Amoxicillin; Antacids; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer Hemorrhage; Prospective Studies; Recurrence | 1998 |
Two-day quadruple therapy for cure of Helicobacter pylori infection: a comparative, randomized trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Treatment Outcome | 1998 |
Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Stomach Ulcer | 1998 |
Omeprazole, azithromycin and either amoxycillin or metronidazole in eradication of Helicobacter pylori in duodenal ulcer patients.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins | 1998 |
Comparison of two 1-week low-dose omeprazole triple therapies--optimal treatment for Helicobacter pylori infection?
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Single-Blind Method; Treatment Outcome | 1997 |
Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Wound Healing | 1997 |
[Helicobacter pylori: 6-day triple therapy in duodenal ulcer].
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole | 1998 |
Relationship between the results of pre-treatment urea breath test and efficacy of eradication of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Tinidazole; Treatment Outcome; Urea | 1998 |
Two-week course of pantoprazole combined with 1 week of amoxycillin and clarithromycin is effective in Helicobacter pylori eradication and duodenal ulcer healing.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Patient Compliance; Penicillins; Single-Blind Method; Sulfoxides; Treatment Outcome | 1998 |
Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Developing Countries; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Pefloxacin; Proton Pump Inhibitors | 1998 |
Addition of bismuth subnitrate to omeprazole plus amoxycillin improves eradication of Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Ranitidine; Stomach Ulcer | 1998 |
Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Ascorbic Acid; China; Double-Blind Method; Drug Therapy, Combination; Garlic; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Omeprazole; Penicillins; Phytotherapy; Plant Extracts; Plants, Medicinal; Precancerous Conditions; Selenium; Stomach Neoplasms; Vitamin E | 1998 |
Spiramycin as an alternative to amoxicillin treatment associated with lansoprazole/metronidazole for Helicobacter pylori infection in children.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Penicillins; Spiramycin | 1998 |
US double-blind, controlled trials of omeprazole and amoxycillin for treatment of Helicobacter pylori.
Topics: Administration, Oral; Adult; Amoxicillin; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 1998 |
One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Treatment Outcome | 1998 |
Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Protocols; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Ranitidine; Single-Blind Method | 1998 |
Randomized comparison of 1-hour topical method vs. amoxycillin plus omeprazole for eradication of Helicobacter pylori in duodenal ulcer patients.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clinical Protocols; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter pylori; Humans; Intubation, Gastrointestinal; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Pronase; Ranitidine | 1998 |
[Eradication therapies for Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Tinidazole | 1998 |
Amoxycillin resistance is one reason for failure of amoxycillin-omeprazole treatment of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Patient Compliance; Penicillin Resistance; Penicillins; Prospective Studies; Surveys and Questionnaires | 1998 |
Factors influencing Helicobacter pylori eradication with 2 week combination therapy of lansoprazole and amoxycillin: intragastric distribution of colonization and gastric mucosal atrophy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Time Factors | 1998 |
One-week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Combined Modality Therapy; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Proton Pumps; Ranitidine; Single-Blind Method; Treatment Outcome | 1998 |
Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Combined Modality Therapy; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Treatment Outcome | 1998 |
Cure of H. pylori infection using a 7-day triple therapy combining pantoprazole with two antibiotics.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Patient Compliance; Penicillins; Peptic Ulcer; Sulfoxides; Treatment Outcome | 1998 |
Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: results of a prospective randomized open study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Prospective Studies; Stomach Ulcer | 1998 |
Evaluation of a selective transport medium for gastric biopsy specimens to be cultured for Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; China; Clarithromycin; Culture Media; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Pilot Projects; Prospective Studies; Rural Health; Stomach | 1998 |
Effects of rebamipide in combination with lansoprazole and amoxicillin on Helicobacter pylori-infected gastric ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Alanine; Amoxicillin; Anti-Ulcer Agents; Diterpenes; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Quinolones; Stomach Ulcer; Treatment Outcome | 1998 |
Effect of rebamipide on Helicobacter pylori infection in patients with peptic ulcer.
Topics: Adult; Aged; Alanine; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Quinolones; Stomach Ulcer; Treatment Outcome | 1998 |
The value of different detection methods of Helicobacter pylori during treatment.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Bacteriological Techniques; Biopsy; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Polymerase Chain Reaction; Predictive Value of Tests | 1998 |
Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Life Tables; Male; Middle Aged; Omeprazole; Peptic Ulcer; Recurrence; Risk Factors | 1998 |
Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Treatment Outcome | 1998 |
Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton-Translocating ATPases; Rabeprazole; Time Factors; Treatment Outcome | 1998 |
A new quadruple therapy for the eradication of Helicobacter pylori. Effect of pretreatment with omeprazole on the cure rate.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Roxithromycin; Treatment Outcome | 1998 |
Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; United States | 1998 |
Continuous and more effective duodenal ulcer healing under therapy with bismuth and two antibiotics than with dual therapy comprising omeprazole and amoxicillin.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Duodenum; Female; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Tetracycline; Treatment Outcome | 1998 |
Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Diterpenes; Drug Therapy, Combination; Female; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Hyperplasia; Immunoglobulin G; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Polyps; Proton Pump Inhibitors; Single-Blind Method; Statistics, Nonparametric; Stomach Neoplasms | 1998 |
Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Treatment Outcome | 1998 |
[Omeprazole plus 2 antibiotics for the eradication of H. pylori, are 5 days of treatment sufficient?].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies | 1998 |
Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Omeprazole; Tetracycline | 1998 |
Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Quality of Life; Treatment Outcome | 1998 |
Preliminary study on a novel quadruple eradication therapy with a mucoprotective drug, sofalcone, for Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chalcone; Chalcones; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Treatment Outcome | 1998 |
[Effectiveness of the eradication of Helicobacter pylori by treatment with omeprazol, amoxicillin, and clarithromycin according to dosage and administration schedule].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Retrospective Studies | 1998 |
[Previous treatment with omeprazole and H. pylori: does it diminish the eradication efficacy of the "new" triple therapies of one week's duration?].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Odds Ratio; Omeprazole; Penicillins; Prognosis; Prospective Studies; Time Factors | 1998 |
[Treatment with omeprazole, clarithromycin and amoxicillin for one week. Their efficacy and tolerance in eradicating Helicobacter pylori in primary care].
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Primary Health Care; Prospective Studies; Remission Induction; Time Factors | 1998 |
The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Treatment Outcome | 1999 |
Omeprazole, azithromycin and amoxicillin or amoxicillin plus clavulanic acid in eradication of Helicobacter pylori in duodenal ulcer disease.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Clavulanic Acid; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins | 1998 |
[Recurrence rate of H. pylori after successful eradication and second eradication therapy after initial failure of treatment].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Recurrence; Time Factors; Treatment Failure | 1999 |
[Evaluation of the efficacy and the cost-effectiveness of proton pump inhibitor-based dual and triple therapy regimens for H. pylori eradication in peptic ulcer disease].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Drug Evaluation; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Treatment Outcome | 1999 |
[Four kinds of new triple therapy regiments for Helicobacter pylori eradication in patients with peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Evaluation; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 1999 |
[A comparative study; one week treatment versus two weeks treatment with lansoprazol, amoxycillin and clarythromycin for the eradication of Helicobacter pylori in patient with gastric and duodenal ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Recurrence; Treatment Outcome | 1999 |
Enhancing compliance not a prerequisite for effective eradication of Helicobacter pylori: the HelP Study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Prospective Studies; Single-Blind Method | 1999 |
[Treatment with omeprazole, clarithromycin and amoxicillin over 6 days in patients with Helicobacter pylori-infected duodenal ulcer].
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Recurrence; Time Factors | 1999 |
Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Treatment Outcome | 1999 |
Helicobacter pylori gastritis in children: efficacy of 2 weeks of treatment with clarithromycin, amoxicillin and omeprazole.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Penicillins; Prospective Studies; Time Factors | 1999 |
The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy.
Topics: Acute Disease; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins | 1999 |
Once-daily therapy for H. pylori infection: a randomized comparison of four regimens.
Topics: Adult; Amoxicillin; Azithromycin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Pilot Projects | 1999 |
Efficacy of 1 week omeprazole or lansoprazole-amoxycillin-clarithromycin therapy for Helicobacter pylori infection in the Japanese population.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Time Factors | 1999 |
Rapid elimination of Helicobacter pylori and reduction of histocompatibility leucocyte antigen-DR expression 12 h after a single dose of omeprazole, amoxycillin and metronidazole triple therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; HLA-DR Antigens; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Pyloric Antrum; Time Factors | 1999 |
Polaprezinc, a mucosal protective agent, in combination with lansoprazole, amoxycillin and clarithromycin increases the cure rate of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Carnosine; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Penicillins; Prospective Studies; Protective Agents; Zinc Compounds | 1999 |
Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 1999 |
The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Single-Blind Method; Treatment Outcome | 1999 |
[Antral biopsy is sufficient to confirm Helicobacter pylori eradication with the "new" one-week long triple treatments].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Penicillins; Prospective Studies; Pyloric Antrum; Stomach Ulcer; Time Factors | 1999 |
Eradication of Helicobacter pylori with a Chinese herbal medicine without emergence of resistant colonies.
Topics: Amoxicillin; Anti-Ulcer Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Plant Extracts | 1999 |
Helicobacter pylori-positive functional dyspepsia in elderly patients: comparison of two treatments.
Topics: Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 1999 |
Helicobacter pylori as a possible bacterial focus of chronic urticaria.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Chronic Disease; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Urticaria | 1999 |
Chronic idiopathic urticaria: natural course and association with Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Chronic Disease; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Urticaria | 1999 |
Resolution of gastritis induced by Helicobacter pylori 4-5 weeks after successful eradication of infection using a triple therapy regimen of pantoprazole, amoxycillin and clarithromycin for one week.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Biopsy; Clarithromycin; Colony Count, Microbial; Drug Therapy, Combination; Follow-Up Studies; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Severity of Illness Index; Sulfoxides; Treatment Outcome | 1999 |
One-week triple regime therapy consisting of pantoprazole, amoxicillin and clarithromycin for cure of Helicobacter pylori-associated upper gastrointestinal diseases.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Biopsy; Clarithromycin; Colony Count, Microbial; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Follow-Up Studies; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Male; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome | 1999 |
High dose omeprazole plus amoxicillin and azithromycin in eradication of Helicobacter pylori in duodenal ulcers.
Topics: Adult; Aged; Amoxicillin; Azithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Treatment Outcome | 1999 |
Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Amoxicillin; Antibodies, Bacterial; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Treatment Outcome | 1999 |
Helicobacter pylori eradication: comparison of three treatment regimens in India.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Pilot Projects; Treatment Outcome | 1999 |
Dual versus triple therapy of Helicobacter pylori infection: results of a multicentre trial.
Topics: Adolescent; Amoxicillin; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Prospective Studies | 1999 |
Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and azithromycin: failure of a "promising" association.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Treatment Failure; Treatment Outcome | 1999 |
H. pylori and nonulcer dyspepsia: not guilty as charged.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Treatment Failure | 1999 |
Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Doxycycline; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Tetracycline; Treatment Failure | 1999 |
Colloidal bismuth pectin: an alternative to bismuth subcitrate for the treatment of Helicobacter pylori--positive duodenal ulcer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; China; Colloids; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Pectins | 1999 |
Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Rabeprazole | 1999 |
Two-week dual vs. one-week triple therapy for cure of Helicobacter pylori infection in primary care: a multicentre, randomized trial.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Primary Health Care | 1999 |
Short-term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 1999 |
Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Ranitidine; Treatment Outcome | 1999 |
Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Single-Blind Method | 1999 |
Eradication of Helicobacter pylori infection with proton pump-based triple therapy in patients in whom bismuth-based triple therapy failed.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Proton Pump Inhibitors; Salicylates; Treatment Outcome | 1999 |
[Is lack of stomach carcinoma prevention by Helicobacter pylori eradication unethical?].
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Ethics, Medical; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Risk Factors; Stomach Neoplasms | 1999 |
Comparative treatment of Helicobacter pylori-positive duodenal ulcer using pantoprazole at low and high doses versus omeprazole in triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Sulfoxides; Treatment Outcome | 1999 |
Effect of smoking and histological gastritis severity on the rate of H. pylori eradication with omeprazole, amoxicillin, and clarithromycin.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Smoking | 1999 |
Morphometric estimation of acid output in duodenal ulcer associated with Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Parietal Cells, Gastric; Penicillins; Sulfoxides | 1999 |
Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Peptic Ulcer; Prospective Studies; Statistics, Nonparametric; Sulfoxides; Treatment Failure | 1999 |
The OAC and OMC options.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Multicenter Studies as Topic; Omeprazole; Randomized Controlled Trials as Topic; Treatment Outcome | 1999 |
Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Quality of Life; Treatment Outcome | 1999 |
Assessment of decisions in the treatment of Helicobacter pylori-related duodenal ulcer: a cost-effectiveness study.
Topics: Adolescent; Adult; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; China; Cimetidine; Cost-Benefit Analysis; Disease Management; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Recurrence; Treatment Outcome | 1999 |
Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Ranitidine; Tetracycline; Treatment Failure | 1999 |
Functional (non-ulcer) dyspepsia and Helicobacter pylori infection. To treat or not to treat?
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Humans; Omeprazole; Penicillins; Prognosis; Treatment Outcome | 1999 |
Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intestines; Male; Metronidazole; Middle Aged; Mouth; Omeprazole; Penicillins; Stomach | 1999 |
Cost effectiveness of Helicobacter pylori eradication therapies in patients with duodenal ulcer. An analysis of triple therapy versus two dual therapy alternatives.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Cost-Benefit Analysis; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins | 1999 |
The outcome of a 2-week treatment of Helicobacter pylori-positive duodenal ulcer with omeprazole-based antibiotic regimen in a region with high metronidazole resistance rate.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Biopsy; Clarithromycin; Contraindications; Drug Resistance, Microbial; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Treatment Outcome | 1999 |
Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Patient Compliance; Penicillins; Sulfoxides | 1999 |
[Reinfection with Helicobacter pylori in patients with duodenal ulcer after successful eradication].
Topics: Adult; Amoxicillin; Bismuth; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Recurrence; Wound Healing | 1999 |
Improvement in lipid and haemostasis patterns after Helicobacter pylori infection eradication in type 1 diabetic patients.
Topics: Adult; Amoxicillin; Analysis of Variance; Body Mass Index; Breath Tests; Cholesterol; Clarithromycin; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Glycated Hemoglobin; Helicobacter Infections; Helicobacter pylori; Hemostasis; Humans; Lipids; Male; Middle Aged; Omeprazole; Tissue Plasminogen Activator | 1999 |
Efficacy of two different dosage regimens of omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Drug Resistance; Drug Therapy, Combination; Endoscopy; Europe; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Pyloric Antrum; Pylorus; Time Factors; Urea | 1999 |
Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Esophagitis; Female; Food; Gastric Acid; Gastric Emptying; Gastric Mucosa; Gastrins; Gastritis; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Monitoring, Physiologic; Omeprazole; Penicillins; Polyethylene Glycols; Postprandial Period; Solvents | 1999 |
Eradication of Helicobacter pylori using 30 mg or 60 mg lansoprazole combined with amoxicillin and metronidazole: one and two weeks of a new triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Carbon Isotopes; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Time Factors; Treatment Outcome; Urea | 1999 |
Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Single-Blind Method; Time Factors; Treatment Outcome | 1999 |
Pantoprazole, amoxycillin and either azithromycin or clarithromycin for eradication of Helicobacter pylori in duodenal ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Sulfoxides | 2000 |
Salvage therapies after failure of Helicobacter pylori eradication with ranitidine bismuth citrate-based therapies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Prospective Studies; Proton Pump Inhibitors; Ranitidine; Salvage Therapy | 2000 |
Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Asia; Breath Tests; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Risk Factors; Urea | 2000 |
Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: results of a multicentre study in South-East Asia. South-East Asia Multicenter Study Group.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Asia, Southeastern; Biopsy; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Single-Blind Method | 2000 |
Helicobacter pylori eradication with dual and low-dose triple therapy in patients with liver cirrhosis.
Topics: Amoxicillin; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Liver Cirrhosis; Male; Middle Aged; Omeprazole; Prospective Studies | 1999 |
Four-day, twice daily, quadruple therapy with amoxicillin, clarithromycin, tinidazole and omeprazole to cure Helicobacter pylori infection: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diarrhea; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nausea; Omeprazole; Organometallic Compounds; Patient Compliance; Pilot Projects; Tetracycline; Time Factors; Tinidazole; Treatment Outcome | 2000 |
Response to triple treatment with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori infections in continuous ambulatory peritoneal dialysis patients.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peritoneal Dialysis, Continuous Ambulatory | 1999 |
[The MACH2 Study: value of inhibiting gastric acid secretion in eradication of Helicobacter pylori with a one week triple therapy protocol].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Treatment Outcome | 2000 |
Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection: comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Proton-Translocating ATPases; Rabeprazole | 2000 |
Effect of ornidazole and clarithromycin resistance on eradication of Helicobacter pylori in peptic ulcer disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Combinations; Drug Resistance, Microbial; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Ornidazole; Penicillins; Peptic Ulcer; Treatment Outcome | 2000 |
Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients-a double-blind placebo-controlled study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Time Factors; Treatment Outcome | 2000 |
Seven-day triple therapy with ranitidine bismuth citrate or omeprazole and two antibiotics for eradication of Helicobacter pylori in duodenal ulcer: a multicentre, randomized, single-blind study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Prospective Studies; Ranitidine; Single-Blind Method | 2000 |
A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Digestive System; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Lansoprazole; Male; Omeprazole; Prospective Studies | 2000 |
Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Case-Control Studies; Clarithromycin; Esophagitis, Peptic; Female; Gastritis, Atrophic; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies | 2000 |
Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Clarithromycin; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Pantoprazole; Ranitidine; Sulfoxides; Tinidazole | 2000 |
Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyspepsia; Female; Follow-Up Studies; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Salicylates; Tetracycline; Treatment Outcome | 2000 |
Eradication of Helicobacter pylori with lansoprazole based triple therapy in peptic ulcer disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Antitrichomonal Agents; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Thailand; Tinidazole; Treatment Outcome | 2000 |
One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Prospective Studies; Ranitidine; Sulfoxides; Treatment Outcome | 2000 |
Helicobacter pylori eradication with lansoprazole, amoxycillin and clarithromycin: testing an ideal regimen in a multicultural south east Asian population and examining factors potentially influencing eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; China; Clarithromycin; Drug Therapy, Combination; Ethnicity; Female; Helicobacter Infections; Helicobacter pylori; Humans; India; Lansoprazole; Likelihood Functions; Logistic Models; Malaysia; Male; Middle Aged; Omeprazole; Prospective Studies; Singapore | 2000 |
Endoscopic biopsy requirements for post-treatment diagnosis of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Double-Blind Method; Endoscopy, Gastrointestinal; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Sensitivity and Specificity | 2000 |
[Effectiveness of omeprazole, clarithromycin and amoxycillin therapy to eradicate Helicobacter pylori in patients with active peptic ulcer. Preliminary results of GENPY study].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Treatment Outcome | 2000 |
A new highly effective short-term therapy schedule for Helicobacter pylori eradication.
Topics: Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Stomach Ulcer; Tinidazole; Treatment Outcome | 2000 |
Randomized trial of omeprazole and metronidazole with amoxycillin or clarithromycin for Helicobacter pylori eradication, in a region of high primary metronidazole resistance: the HERO study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 2000 |
Comparison of seven and fourteen days of lansoprazole, clarithromycin, and amoxicillin therapy for eradication of Helicobacter pylori: a report from India.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; India; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins | 2000 |
Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Rabeprazole; Treatment Outcome | 2000 |
[Effect of pantoprazole, amoxicillin and metronidazole treatment on the level of H. pylori eradication and the histological image of antral gastritis in patients with duodenal ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Pyloric Antrum; Sulfoxides | 2000 |
Effect of Helicobacter pylori eradication on malignant transformation of gastric adenoma.
Topics: Adenoma; Aged; Aged, 80 and over; Amoxicillin; Carcinoma; Cell Transformation, Neoplastic; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Omeprazole; Probability; Reference Values; Statistics, Nonparametric; Stomach Neoplasms; Treatment Outcome | 2000 |
Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Atrophy; Clarithromycin; Endoscopy; Female; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Intestines; Male; Metaplasia; Middle Aged; Omeprazole; Penicillins; Prospective Studies | 2000 |
[Treatment of Helicobacter pylori infection with lansoprazole 30 mg or 60 mg combined with two antibiotics for duodenal ulcers].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins | 2000 |
Comparison of the efficacy of 400mg and 800mg of clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection in a Japanese population.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Omeprazole; Penicillins; Prospective Studies; Sensitivity and Specificity | 2000 |
Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Aged; Aging; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Diseases; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Stomach Diseases; Sulfoxides | 2000 |
Rabeprazole, amoxycillin and low- or high-dose clarithromycin for cure of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Rabeprazole; Treatment Outcome | 2000 |
Cetraxate, a mucosal protective agent, combined with omeprazole, amoxycillin, and clarithromycin increases the eradication rate of helicobacter pylori in smokers.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Regional Blood Flow; Smoking; Tranexamic Acid; Treatment Outcome | 2000 |
Effect of omeprazole on gastric mucosa and serum levels of amoxicillin in patients with non-ulcer dyspepsia.
Topics: Adult; Amoxicillin; Drug Interactions; Dyspepsia; Enzyme Inhibitors; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Probability; Reference Values | 2000 |
[Cost-effectiveness analysis of 2 strategies of Helicobacter pylori eradication: results of a prospective and randomized study in primary care].
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Data Interpretation, Statistical; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Primary Health Care; Prospective Studies; Stomach Ulcer; Tetracycline; Time Factors | 2000 |
[Combination of ranitidine and bismuth citrate plus 2 antibiotics in the eradication of Helicobacter pylori].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Ranitidine; Time Factors | 2000 |
Eradication of Helicobacter pylori with pantoprazole and two antibiotics: a comparison of two short-term regimens.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Pantoprazole; Sulfoxides | 2000 |
Cure of Helicobacter pylori-positive active duodenal ulcer patients: a double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy. GISU (Interdisciplinary Group for Ulcer Study).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Antitrichomonal Agents; Biopsy; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Digestive System; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Recurrence; Tinidazole | 2000 |
Five-day triple therapy in Helicobacter pylori-positive duodenal ulcer: an eighteen-month follow-up.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Biopsy; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Stomach; Sulfoxides; Time Factors | 2000 |
Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Omeprazole; Prospective Studies; Treatment Outcome | 2000 |
[Triple therapy of short-term with azithromycin, amoxycillin and omeprazole for the eradication of Helicobacter pylori].
Topics: Amoxicillin; Anti-Ulcer Agents; Azithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Peptic Ulcer | 2000 |
Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Costs and Cost Analysis; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Proton Pump Inhibitors; Ranitidine; Treatment Outcome | 2000 |
Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Female; Follow-Up Studies; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Penicillins; Prospective Studies; Rabeprazole; Tinidazole | 2000 |
Does the depth of gastric ulceration influence a modified dual therapy with amoxicillin and lansoprazole for Helicobacter pylori-associated gastric ulcer?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Amoxicillin; Anti-Ulcer Agents; Diterpenes; Drug Therapy, Combination; Endosonography; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Pepsin A; Proton Pump Inhibitors; Stomach Ulcer; Time Factors; Wound Healing | 2000 |
Relationship between Helicobacter pylori and rosacea: it may be a myth.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Cohort Studies; Erythema; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prevalence; Rosacea | 2000 |
High-dose ecabet sodium improves the eradication rate of helicobacter pylori in dual therapy with lansoprazole and amoxicillin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Diterpenes; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Single-Blind Method; Treatment Outcome | 2000 |
Triple therapy with clarithromycin, omeprazole, and amoxicillin for eradication of Helicobacter pylori in duodenal ulcer patients in Asia and Africa.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Hong Kong; Humans; Omeprazole; Pakistan; Penicillins; South Africa; Taiwan; Treatment Outcome | 2000 |
Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. A randomized trial with 2-year follow-up. The Danish Ulcer Study Group.
Topics: Amoxicillin; Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Female; Follow-Up Studies; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Quality of Life | 2000 |
One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Stereoisomerism | 2000 |
5-day vs. 7-day triple therapy with rabeprazole, clarithromycin and amoxicillin for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Rabeprazole | 2000 |
A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter pylori; Humans; Lactobacillus acidophilus; Male; Middle Aged; Omeprazole; Patient Compliance; Prospective Studies; Rabeprazole | 2000 |
A multicentre study on eradication of Helicobacter pylori using four 1-week triple therapies in China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Furazolidone; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies | 2001 |
Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastrointestinal Agents; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Failure | 2000 |
The HOMER Study: the effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Infant, Newborn; Male; Metronidazole; Middle Aged; Omeprazole; Treatment Outcome | 2000 |
Curing Helicobacter pylori infection in patients with duodenal ulcer does not provoke gastroesophageal reflux disease.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins | 2000 |
Limited usefulness of a seven-day twice-a-day quadruple therapy.
Topics: Adult; Aged; Amoxicillin; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Organometallic Compounds; Pilot Projects; Stomach Ulcer; Tinidazole; Treatment Outcome | 2000 |
A short-term eradication therapy for Helicobacter pylori acute gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adolescent; Adult; Alanine; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Quinolones; Stomach; Time Factors | 2000 |
Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Biopsy, Needle; Confidence Intervals; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Pantoprazole; Probability; Prospective Studies; Rifabutin; Sulfoxides; Tetracycline; Treatment Failure | 2001 |
Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Iran; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Treatment Outcome | 2001 |
Five-day proton pump inhibitor-based quadruple therapy regimen is more effective than 7-day triple therapy regimen for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Rabeprazole; Treatment Outcome | 2001 |
[Usefulness of new triple therapy containing PPI].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Proton Pump Inhibitors | 2001 |
Comparison of the efficacy and safety of different formulations of omeprazole-based triple therapies in the treatment of Helicobacter pylori-positive peptic ulcer.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Capsules; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Tablets | 2001 |
Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Logistic Models; Male; Middle Aged; Omeprazole; Prognosis; Prospective Studies; Proton Pump Inhibitors; Time Factors | 2001 |
Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Duodenal Ulcer; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Logistic Models; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Penicillins; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Treatment Outcome | 2001 |
Two weeks triple therapy with lansoprazole, amoxycillin and roxythromycin is better than dual therapy with lansoprazole and amoxycillin for H. pylori infection: a randomised, clinical trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Penicillins; Roxithromycin | 2000 |
Comparison of two regimens on eradication of Helicobacter pylori.
Topics: Amoxicillin; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Tinidazole | 2000 |
A randomised trial of amoxycillin versus clarithromycin in combination with omeprazole for eradication of Helicobacter pylori infection in Singapore.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Omeprazole; Penicillins; Singapore; Treatment Outcome | 2000 |
cagA Status and eradication treatment outcome of anti-Helicobacter pylori triple therapies in patients with nonulcer dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Benzimidazoles; Clarithromycin; Double-Blind Method; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Polymerase Chain Reaction; Sulfoxides; Treatment Outcome | 2001 |
The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Organometallic Compounds; Patient Selection; Penicillins; Peptic Ulcer; Time Factors; Treatment Failure | 2001 |
Antibiotic resistance and antibiotic sensitivity based treatment in Helicobacter pylori infection: advantages and outcome.
Topics: Adolescent; Amoxicillin; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Omeprazole; Ranitidine; Treatment Outcome | 2001 |
Ranitidine bismuth citrate or omeprazole-based triple therapy for Helicobacter pylori eradication in Helicobacter pylori-infected non-ulcer dyspepsia.
Topics: Adult; Amoxicillin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Probability; Ranitidine; Reference Values; Treatment Outcome | 2001 |
Randomised study of the efficacy of omeprazole and clarithromycin with either amoxycillin or metronidazole in the eradication of Helicobacter pylori in screened primary care patients.
Topics: Adult; Amoxicillin; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Mass Screening; Metronidazole; Middle Aged; Omeprazole; Probability; Reference Values; Treatment Outcome | 2001 |
Effect of Helicobacter pylori eradication on cyclooxygenase 2 (COX-2) and inducible nitric oxide synthase (iNOS) expression during gastric adaptation to aspirin (ASA) in humans.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blotting, Western; Clarithromycin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Electrophoresis, Polyacrylamide Gel; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Isoenzymes; Lansoprazole; Membrane Proteins; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Omeprazole; Prostaglandin-Endoperoxide Synthases | 2001 |
[The effect of cigarette smoking and alcohol consumption on efficacy of Helicobacter pylori eradication].
Topics: Adult; Alcohol Drinking; Amoxicillin; Clarithromycin; Comorbidity; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Smoking; Tinidazole; Treatment Outcome | 2000 |
Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Analysis of Variance; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Female; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Omeprazole; Recurrence; Treatment Outcome | 2001 |
Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Benzimidazoles; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Ranitidine; Recurrence; Sulfoxides; Tinidazole; Treatment Outcome; Urea | 2001 |
Predictors of failure of Helicobacter pylori eradication with the standard 'Maastricht triple therapy'.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Biopsy; Breath Tests; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Endoscopy; Helicobacter Infections; Humans; Omeprazole; Pantoprazole; Penicillins; Prospective Studies; Proton Pump Inhibitors; Risk Factors; Smoking; Sulfoxides; Urea | 2001 |
Cure of Helicobacter pylori infection in elderly patients: comparison of low versus high doses of clarithromycin in combination with amoxicillin and pantoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Aged; Aged, 80 and over; Aging; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Biopsy; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Sulfoxides; Treatment Outcome | 2001 |
Is a one-week course of triple anti-Helicobacter pylori therapy sufficient to control active duodenal ulcer?
Topics: Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Placebos; Treatment Outcome | 2001 |
Is eradication of Helicobacter pylori with colloidal bismuth subcitrate quadruple therapy safe?
Topics: Adult; Amoxicillin; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Safety | 2001 |
Clarithromycin-based triple therapy for non-resistant Helicobacter pylori infection. How long should it be given?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Polymerase Chain Reaction; Time Factors | 2001 |
Noninvasive stool antigen assay can effectively screen Helicobacter pylori Infection and assess success of eradication therapy in hemodialysis patients.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Antigens, Bacterial; Clarithromycin; Constipation; Diarrhea; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Kidney Failure, Chronic; Male; Middle Aged; Nausea; Omeprazole; Penicillins; Renal Dialysis; Treatment Outcome; Vomiting | 2001 |
An intervention trial to inhibit the progression of precancerous gastric lesions: compliance, serum micronutrients and S-allyl cysteine levels, and toxicity.
Topics: Adult; Aged; Amoxicillin; Antioxidants; Ascorbic Acid; beta Carotene; China; Double-Blind Method; Drug Therapy, Combination; Female; Garlic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Phytotherapy; Plants, Medicinal; Precancerous Conditions; Prevalence; Selenium; Stomach Neoplasms; Treatment Outcome; Vitamin E | 2001 |
The AMOR study: a randomized, double-blinded trial of omeprazole versus ranitidine together with amoxycillin and metronidazole for eradication of Helicobacter pylori.
Topics: Adolescent; Aged; Aged, 80 and over; Amoxicillin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Ranitidine; Treatment Outcome | 2001 |
Helicobacter pylori and iron deficiency anaemia in children.
Topics: Adolescent; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Hemoglobins; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Urea | 2001 |
A randomized open trial for comparison of proton pump inhibitors, omeprazole versus rabeprazole, in dual therapy for Helicobacter pylori infection in relation to CYP2C19 genetic polymorphism.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome | 2001 |
Is untargeted outreach visiting in primary care effective? A pragmatic randomized controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Community Pharmacy Services; Community-Institutional Relations; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization Review; Education, Medical, Continuing; England; Family Practice; Female; Guideline Adherence; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medical Audit; Metronidazole; Omeprazole; Penicillins; Practice Guidelines as Topic; Practice Patterns, Physicians'; Primary Health Care; Program Evaluation; Proton Pump Inhibitors | 2001 |
Efficacy of ecabet sodium for Helicobacter pylori eradication triple therapy in comparison with a lansoprazole-based regimen.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Diterpenes; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Pepsin A; Prospective Studies; Treatment Outcome; Urea; Urease | 2001 |
Famotidine versus omeprazole, in combination with amoxycillin and tinidazole, for eradication of Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Enzyme Inhibitors; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Tinidazole | 2001 |
Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Absenteeism; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Health Status; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Patient Satisfaction; Penicillins; Referral and Consultation | 2001 |
Prolonging proton pump inhibitor-based anti-Helicobacter pylori treatment from one to two weeks in duodenal ulcer: is it worthwhile?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 2000 |
[Comparative study of the eradication of Helicobacter pylori: ranitidine bismuth citrate versus omeprazole plus two antibiotics for seven days].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine | 2001 |
A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors | 2001 |
Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection and CYP2C19 genetic polymorphism.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Proton Pump Inhibitors; Rabeprazole; Stomach Ulcer | 2001 |
A multicenter study on eradication of Helicobacter pylori infection in patients with duodenal ulcer by lansoprazole-antibiotics combined therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies | 1999 |
Ultrashort regimen of lansoprazole-amoxicillin-azithromycin for eradicating Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lebanon; Omeprazole; Penicillins; Research Design; Safety; Treatment Outcome | 2001 |
A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia.
Topics: Administration, Oral; Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Penicillins; Treatment Outcome; Urea | 2001 |
A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Microbial Sensitivity Tests; Middle Aged; Multicenter Studies as Topic; Omeprazole; Peptic Ulcer | 2001 |
Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Sickness Impact Profile | 2001 |
Omeprazole combined with amoxicillin and clarithromycin in the eradication of Helicobacter pylori in children with gastritis: A prospective randomized double-blind trial.
Topics: Adolescent; Amoxicillin; Breath Tests; Child; Child, Preschool; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Prospective Studies; Treatment Outcome | 2001 |
One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Time Factors; Treatment Outcome | 2001 |
[Modern means of anti-Helicobacter therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Proton-Translocating ATPases; Rabeprazole | 2001 |
Effects of CYP2C19 gene polymorphism on cure rates for Helicobacter pylori infection by triple therapy with proton pump inhibitor (omeprazole or rabeprazole), amoxycillin and clarithromycin in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Female; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Prospective Studies; Proton-Translocating ATPases; Rabeprazole; Treatment Outcome | 2001 |
Two new treatment regimens for Helicobacter pylori eradication: a randomised study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Tinidazole; Treatment Outcome | 2001 |
Amoxycillin, clarithromycin and either sucralfate or pantoprazole for eradication of Helicobacter pylori in duodenal ulcer (a randomized controlled trial).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Sucralfate; Sulfoxides | 2001 |
Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Regression Analysis; Treatment Outcome | 2002 |
Helicobacter pylori eradication with beta carotene, ascorbic acid and allicin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antioxidants; Ascorbic Acid; beta Carotene; Clarithromycin; Disulfides; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Sulfinic Acids | 2001 |
Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study).
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Stomach Neoplasms | 2001 |
[Treatment of perforated gastroduodenal ulcer by simple suture followed by Helicobacter pylori eradication].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer Perforation; Prevalence; Stomach Ulcer; Suture Techniques; Treatment Outcome; Vietnam | 2002 |
Therapeutic effects of antibacterial treatment for intractable skin diseases in Helicobacter pylori-positive Japanese patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Child; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Lansoprazole; Male; Middle Aged; Omeprazole; Skin Diseases; Treatment Outcome | 2002 |
Efficacy of low-dose clarithromycin triple therapy and tinidazole-containing triple therapy for Helicobacter pylori eradication.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Breath Tests; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Tinidazole; Treatment Outcome; Urea | 2002 |
Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Costs; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 2002 |
Effect of Helicobacter pylori eradication on duodenal ulcer scar in patients with no clinical history of duodenal ulcer.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Recurrence | 2002 |
Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole-based triple therapies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Taiwan | 2002 |
High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Nitroimidazoles; Omeprazole; Treatment Outcome | 2002 |
Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
Topics: Adult; Aged; Amoxicillin; Antineoplastic Agents, Alkylating; Biopsy, Needle; Chlorambucil; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Omeprazole; Predictive Value of Tests; Prospective Studies; Stomach Neoplasms; Treatment Outcome | 2002 |
Effect of Helicobacter pylori eradication on oesophageal acid exposure in patients with reflux oesophagitis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Esophagitis, Peptic; Female; Gastric Acid; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Treatment Outcome | 2002 |
Influence of Helicobacter pylori infection and eradication on blood lipids and fibrinogen.
Topics: Adult; Aged; Amoxicillin; Biomarkers; Clarithromycin; Female; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Lipids; Male; Middle Aged; Omeprazole; Risk Factors | 2002 |
One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapies.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents, Local; Anti-Ulcer Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pilot Projects; Treatment Failure | 2002 |
Relation between alcohol consumption and the success of Helicobacter pylori eradication therapy using omeprazole, clarithromycin and amoxicillin for 1 week.
Topics: Adult; Aged; Alcohol Drinking; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Smoking; Time Factors | 2002 |
Amoxicillin/tetracycline combinations are inadequate as alternative therapies for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Doxycycline; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Ranitidine; Tetracycline; Treatment Failure | 2002 |
[Triple therapy with faropenem, proton pump inhibitor (PPI), and amoxicillin for clarithromycin-resistant H. pylori eradication].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactams; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Treatment Outcome | 2002 |
Helicobacter pylori eradication does not worsen quality of life related to reflux symptoms: a prospective trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastroesophageal Reflux; Helicobacter Infections; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Quality of Life; Urea | 2002 |
Duodenal ulcer healing with 1-week eradication triple therapy followed, or not, by anti-secretory treatment: a multicentre double-blind placebo-controlled trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Placebos; Proton Pump Inhibitors; Treatment Outcome; Urea | 2002 |
Amoxicillin and ampicillin are not transferred to gastric juice irrespective of Helicobacter pylori status or acid blockade by omeprazole.
Topics: Adult; Amoxicillin; Ampicillin; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Cross-Over Studies; Enzyme Inhibitors; Female; Gastric Juice; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Penicillins; Proton Pump Inhibitors; Saliva | 2002 |
[Microflora of gastric juice in patients after eradication of Helicobacter pylori and treatment with a proton pump inhibitor].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Benzimidazoles; Candida albicans; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Escherichia coli; Esophagitis, Peptic; Female; Gastric Juice; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Staphylococcus aureus; Sulfoxides | 2002 |
Additive effect of pronase on the efficacy of eradication therapy against Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pronase; Treatment Outcome | 2002 |
Randomized open trial for comparison of proton pump inhibitors in triple therapy for Helicobacter pylori infection in relation to CYP2C19 genotype.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; DNA; Drug Therapy, Combination; Enzyme Inhibitors; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Peptic Ulcer; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome | 2002 |
Genotyping of Helicobacter pylori in paraffin-embedded gastric biopsy specimens: relation to histological parameters and effects on therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Typing Techniques; Biopsy; Clarithromycin; Gastroesophageal Reflux; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Paraffin Embedding; Stomach | 2002 |
One-week triple vs. quadruple therapy for Helicobacter pylori infection - a randomized trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Tetracycline; Treatment Outcome | 2002 |
Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hydrocortisone; Lansoprazole; Liver Function Tests; Male; Middle Aged; Omeprazole; Oxidoreductases, N-Demethylating; Penicillins; Protein Synthesis Inhibitors | 2002 |
Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.
Topics: Adult; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Diclofenac; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pain; Peptic Ulcer; Treatment Outcome | 2002 |
Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Chronic Disease; Drug Therapy, Combination; Dyspepsia; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Urease | 2002 |
Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Bifidobacterium; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus; Lansoprazole; Male; Middle Aged; Omeprazole; Patient Compliance; Probiotics; Yogurt | 2002 |
Azithromycin in a triple therapy for H.pylori eradication in active duodenal ulcer.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 2002 |
Eradication rate of Helicobacter pylori in a Mexican population at high risk for gastric cancer and use of serology to assess cure.
Topics: Adenocarcinoma; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Gastrins; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Middle Aged; Omeprazole; Penicillins; Precancerous Conditions; Recurrence; Risk Factors; ROC Curve; Stomach Neoplasms | 2002 |
Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Stomach Ulcer | 2002 |
Vitamin C and E supplements to lansoprazole-amoxicillin-metronidazole triple therapy may reduce the eradication rate of metronidazole-susceptible Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Ascorbic Acid; Dietary Supplements; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Lansoprazole; Male; Metronidazole; Omeprazole; Severity of Illness Index; Stomach Diseases; Treatment Outcome; Vitamin E | 2002 |
Pharmacokinetics of lansoprazole, amoxicillin and clarithromycin after simultaneous and single administration.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Area Under Curve; Clarithromycin; Confidence Intervals; Cross-Over Studies; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Humans; Lansoprazole; Male; Omeprazole | 2002 |
The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Ranitidine; Treatment Outcome | 2002 |
[Comparison of pantoprazole and omeprazole-based triple therapy regimens in the treatment of Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Time Factors; Treatment Outcome | 2002 |
Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Tetracycline; Wound Healing | 2002 |
Seven-day triple therapy with omeprazole, amoxycillin and clarithromycin for Helicobacter pylori infection in haemodialysis patients.
Topics: Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Diseases; Male; Middle Aged; Omeprazole; Renal Dialysis; Retreatment; Sex Factors; Time Factors; Treatment Outcome; Urea | 2002 |
Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Quality of Life; Treatment Failure | 2003 |
Eradication therapy with rabeprazole versus omeprazole in the treatment of active duodenal ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Patient Compliance; Prospective Studies; Proton-Translocating ATPases; Rabeprazole | 2002 |
The effects of nocturnal acid breakthrough on Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Circadian Rhythm; Clarithromycin; Drug Therapy, Combination; Female; Gastric Acid; Gastric Acidity Determination; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Treatment Outcome | 2002 |
Oxidative stress in gastric mucosa of asymptomatic humans infected with Helicobacter pylori: effect of bacterial eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biomarkers; Biopsy; Catalase; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-8; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Omeprazole; Oxidative Stress; Superoxide Dismutase | 2002 |
Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second-line Helicobacter pylori eradication in Japan, and the influence of metronidazole resistance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Rabeprazole | 2003 |
Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Cytochrome P-450 Enzyme System; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Rabeprazole; Treatment Outcome | 2003 |
Impact of clarithromycin resistance and CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with lansoprazole- or rabeprazole-based triple therapy in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Logistic Models; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Peptic Ulcer; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Treatment Failure; Treatment Outcome | 2003 |
[New triple therapy for Helicobacter pylori infection in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole | 2003 |
High eradication rates of Helicobacter pylori with a new sequential treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Rabeprazole; Tinidazole; Treatment Outcome | 2003 |
Omeprazole plus azithromycin and either amoxicillin or tinidazole for eradication of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Azithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Probability; Prospective Studies; Tinidazole; Treatment Outcome | 2003 |
Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a
Topics: Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Capsules; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; North America; Omeprazole; Organometallic Compounds; Tetracycline; Treatment Outcome | 2003 |
Clinical and pathological implications of IgG antibody responses to Helicobacter pylori and its virulence factors in non-ulcer dyspepsia.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Antibodies, Bacterial; Double-Blind Method; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Middle Aged; Omeprazole; Penicillins | 2003 |
Lafutidine, a novel histamine H2-receptor antagonist, vs lansoprazole in combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Penicillins; Piperidines; Prospective Studies; Pyridines | 2003 |
Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Safety | 2003 |
Helicobacter pylori stimulates inducible nitric oxide synthase in diverse topographical patterns in various gastroduodenal disorders.
Topics: Amoxicillin; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Digestive System; Enzyme Induction; Gastric Mucosa; Gastritis; Gene Expression Regulation, Enzymologic; Helicobacter pylori; Humans; Immunoenzyme Techniques; Intestinal Mucosa; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Omeprazole; Pyloric Antrum; RNA, Messenger | 2003 |
Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Randomized Controlled Trials as Topic; Recurrence; Treatment Outcome | 2003 |
Helicobacter pylori eradication and gastric ulcer healing--comparison of three pantoprazole-based triple therapies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Stomach Ulcer; Sulfoxides | 2003 |
The selection of triple therapy for Helicobacter pylori eradication in chronic renal insufficiency.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Failure, Chronic; Lansoprazole; Male; Middle Aged; Omeprazole; Treatment Outcome | 2003 |
Validation of the 13c-urea breath test for the initial diagnosis of helicobacter pylori infection and to confirm eradication after treatment.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Confidence Intervals; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Likelihood Functions; Male; Middle Aged; Omeprazole; Penicillins; ROC Curve; Sensitivity and Specificity; Time Factors; Urea | 2003 |
Do Japanese and Swedish peptic ulcer patients respond differently to Helicobacter pylori eradication therapies and what are their histological features?
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Asian People; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Sweden; White People | 2003 |
Effect of different doses of furazolidone with amoxicillin and omeprazole on eradication of Helicobacter pylori.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Treatment Outcome | 2003 |
High-dose rabeprazole-amoxicillin versus rabeprazole-amoxicillin-metronidazole as second-line treatment after failure of the Japanese standard regimen for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Rabeprazole; Treatment Outcome | 2003 |
Density of Helicobacter pylori may affect the efficacy of eradication therapy and ulcer healing in patients with active duodenal ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Colony Count, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Wound Healing | 2003 |
Helicobacter pylori eradication therapy for the remnant stomach after gastrectomy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Biomarkers; Biopsy; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastrectomy; Gastric Stump; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Lansoprazole; Male; Middle Aged; Omeprazole; Pepsinogen A; Pepsinogen C; Proton Pump Inhibitors; Proton Pumps; Randomized Controlled Trials as Topic; Severity of Illness Index; Time Factors; Treatment Outcome | 2003 |
The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Female; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 2003 |
Gastric juice, gastric tissue and blood antibiotic concentrations following omeprazole, amoxicillin and clarithromycin triple therapy.
Topics: Adult; Amoxicillin; Clarithromycin; Cross-Over Studies; Drug Therapy, Combination; Gastric Juice; Gastric Mucosa; Humans; Male; Omeprazole | 2003 |
A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Tetracycline; Urea | 2003 |
Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 2003 |
Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmacotherapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Antacids; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Rabeprazole; Tinidazole; Treatment Outcome | 2003 |
Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Clarithromycin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Probability; Reference Values; Severity of Illness Index; Treatment Outcome | 2003 |
One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Breath Tests; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Salicylates; Severity of Illness Index; Treatment Outcome | 2003 |
[A prospective study on rabeprazole-based triple therapy for Helicobacter pylori eradication in patients with peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Rabeprazole | 2003 |
A randomized trial comparing seven-day ranitidine bismuth citrate and clarithromycin dual therapy to seven-day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Satisfaction; Ranitidine; Time Factors; Urea | 2003 |
Second-line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Treatment Failure | 2003 |
Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Pantoprazole; Prospective Studies; Ranitidine; Sulfoxides; Tinidazole; Treatment Failure; Urea | 2003 |
Role of antibiotic sensitivity testing before first-line Helicobacter pylori eradication treatments.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Ranitidine; Tinidazole; Treatment Outcome | 2003 |
Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users--a randomized trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Dyspepsia; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Patient Compliance; Peptic Ulcer; Secondary Prevention; Treatment Outcome | 2003 |
Low and high doses of rabeprazole vs. omeprazole for cure of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Combinations; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Rabeprazole; Treatment Outcome | 2003 |
Three-day intravenous triple therapy is not effective for the eradication of Helicobacter pylori infection in patients with bleeding gastro-duodenal ulcer.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Clavulanic Acids; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infusions, Intravenous; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Recurrence; Stomach Ulcer; Treatment Failure | 2003 |
Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Sulfoxides; Treatment Outcome | 2003 |
Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-1; Lansoprazole; Logistic Models; Male; Middle Aged; Mixed Function Oxygenases; Multivariate Analysis; Omeprazole; Polymorphism, Genetic; Probability; Proton Pump Inhibitors; Proton Pumps; Rabeprazole; Statistics, Nonparametric; Treatment Outcome | 2003 |
Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Stomach Neoplasms; Treatment Outcome | 2004 |
Low-dose furazolidone in triple and quadruple regimens for Helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Organometallic Compounds; Treatment Outcome | 2004 |
[Results of an open multicenter study of the efficiency of one-week anti-helicobacter therapy using omeprazole, clarithromycin, and amoxicillin in patients with duodenal peptic ulcer].
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Russia; Treatment Outcome | 2003 |
Effect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trial.
Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Chi-Square Distribution; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Gastric Mucosa; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Proportional Hazards Models; Statistics, Nonparametric; Treatment Failure | 2004 |
[Efficacy of Helicobacter pylori eradication in non-ulcer dyspepsia].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole | 2004 |
Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Benzimidazoles; Clarithromycin; DNA; Drug Evaluation; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Polymerase Chain Reaction; Rabeprazole; Risk Factors; Smoking; Tinidazole; Treatment Outcome | 2004 |
[Efficacy of anti-Helicobacter therapy in children with ulcer-like functional dyspepsia].
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors | 2003 |
Empirical Helicobacter pylori "rescue" therapy after failure of two eradication treatments.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Treatment Outcome | 2004 |
Comparison of rabeprazole-based four- and seven-day triple therapy and omeprazole-based seven-day triple therapy for Helicobacter pylori infection in patients with peptic ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Rabeprazole; Treatment Outcome | 2003 |
[Comparative analysis of the effectiveness of two Helicobacter pylori eradication plans based on omeprazole, clarithromycin and amoxicillin in patients with duodenal peptic ulcer: results of a randomized double-blind, controlled study].
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter pylori; Humans; Macrolides; Male; Middle Aged; Omeprazole | 2003 |
[Effect of CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with rabeprazole-based triple therapy in Chinese].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; China; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Rabeprazole; Treatment Outcome | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Stomach Ulcer; Tetracycline; Treatment Outcome; Turkey | 2004 |
Clinical evaluation of four one-week triple therapy regimens in eradicating Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Treatment Outcome | 2004 |
Polymorphism of interleukin-1beta affects the eradication rates of Helicobacter pylori by triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antibody Specificity; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastritis; Genetic Predisposition to Disease; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-1; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Mutation; Omeprazole; Patient Compliance; Peptic Ulcer; Polymorphism, Genetic; Proton Pump Inhibitors; Proton Pumps; Treatment Outcome | 2004 |
Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost Savings; Cost-Benefit Analysis; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Prevalence; Proton Pump Inhibitors; Proton Pumps; Statistics as Topic; Tetracycline; Treatment Outcome | 2003 |
[Eradication effect of lansoprazole-based triple therapy against H. pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Neoplasms; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Stomach Ulcer | 2004 |
[Comparative efficacy of proton pump inhibitors in children].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Child; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Gastric Acidity Determination; Gastric Juice; Gastroenteritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome | 2003 |
Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Imidazoles; Lansoprazole; Male; Middle Aged; Omeprazole; Pilot Projects; Prospective Studies; Time Factors; Tinidazole; Urea | 2004 |
Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Costs; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Rabeprazole; Tinidazole; Treatment Outcome | 2004 |
Helicobacter pylori eradication: efficacy of conventional therapy in India.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Agents; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Polymerase Chain Reaction; Tinidazole; Treatment Outcome | 2004 |
Does the 'test-and-treat' strategy work in primary health care for management of uninvestigated dyspepsia? A prospective two-year follow-up study of 1552 patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Dyspepsia; Endoscopy, Gastrointestinal; Family Practice; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Outcome and Process Assessment, Health Care; Peptic Ulcer; Prospective Studies; Quality of Life; Referral and Consultation | 2004 |
[Clinical effectiveness of omeprazole, azithromycin and amoxicillin in ulcer healing and eradication of Helicobacter pylori infection].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Treatment Outcome | 2003 |
Use of imidazole-based eradication regimens for Helicobacter pylori should be abandoned in North India regardless of in vitro antibiotic sensitivity.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; India; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Peptic Ulcer; Prospective Studies; Tinidazole; Treatment Outcome; Wound Healing | 2004 |
Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Treatment Outcome | 2004 |
Efficacy of two rabeprazole/gatifloxacin-based triple therapies for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Therapy, Combination; Female; Fluoroquinolones; Gatifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Peptic Ulcer; Rabeprazole; Treatment Outcome | 2004 |
The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: a prospective, randomised study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Multivariate Analysis; Omeprazole; Patient Compliance; Peptic Ulcer; Prospective Studies; Rabeprazole; Smoking; Tinidazole; Treatment Outcome | 2004 |
Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Coronary Disease; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Treatment Outcome | 2004 |
Seven-day therapy for Helicobacter pylori in the United States.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Rabeprazole; Treatment Outcome | 2004 |
Comparison of cetraxate-based and pantoprazole-based triple therapies in the treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dizziness; Drug Therapy, Combination; Endoscopes, Gastrointestinal; Exanthema; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Multivariate Analysis; Omeprazole; Pantoprazole; Pilot Projects; Prospective Studies; Sulfoxides; Tranexamic Acid; Treatment Outcome | 2004 |
In treatment of active duodenal ulcer and Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Sulfoxides; Treatment Outcome | 2003 |
[Long-term therapeutic effect of triple therapy consisted of omeperazole, clarithromycin and amoxycillin in children with Helicobacter pylori infection and approach to re-treatment after failure of the treatment].
Topics: Adolescent; Amoxicillin; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Recurrence; Time Factors; Treatment Outcome | 2004 |
Total family unit Helicobacter pylori eradication and pediatric re-infection rates.
Topics: Adolescent; Amoxicillin; Breath Tests; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Family Health; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Recurrence; Urea | 2004 |
Dual vs. triple therapy for childhood Helicobacter pylori gastritis: a double-blind randomized multicentre trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Breath Tests; Child; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Recurrence; Tinidazole; Urea | 2004 |
Helicobacter pylori eradication decreases blood neutrophil and monocyte counts.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Leukocyte Count; Leukocytes, Mononuclear; Male; Middle Aged; Neutrophils; Omeprazole; Peptic Ulcer; Retrospective Studies | 2004 |
Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Disease Progression; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metaplasia; Middle Aged; Omeprazole; Precancerous Conditions; Prospective Studies; Risk Factors; Stomach Neoplasms | 2004 |
Symptomatic response to Helicobacter pylori eradication in children with recurrent abdominal pain: double blind randomized placebo-controlled trial.
Topics: Abdominal Pain; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Double-Blind Method; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Prospective Studies; Recurrence; Time Factors | 2004 |
The efficacy, safety and tolerability of pantoprazole-based one-week triple therapy in H. pylori eradication and duodenal ulcer healing.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Duodenal Ulcer; Duodenoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome; Wound Healing | 2004 |
Open, randomized multicenter comparative trial of rabeprazole, ofloxacin and amoxicillin therapy for Helicobacter pylori eradication: 7 vs. 14 day treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mexico; Middle Aged; Ofloxacin; Omeprazole; Rabeprazole; Time Factors; Treatment Outcome | 2004 |
The effect of Helicobacter pylori eradication on gastroesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Endoscopes, Gastrointestinal; Female; Gastroesophageal Reflux; Heartburn; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Monitoring, Physiologic; Omeprazole; Treatment Outcome; Urease | 2004 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pilot Projects; Ranitidine; Tetracycline; Treatment Outcome | 2004 |
Comparison of the efficacy of 250 mg and 500 mg clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Patient Care Management; Treatment Outcome | 2004 |
[Effects of different triple therapies on duodenal ulcer-associated Helicobacter pylori infection and a one-year follow-up study].
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Recurrence | 2004 |
Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Infective Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Omeprazole; Platelet Count; Purpura, Thrombocytopenic, Idiopathic | 2004 |
Lewis and Secretor status and Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Phenotype; Tinidazole; Treatment Outcome; Urea | 2004 |
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Organometallic Compounds; Pantoprazole; Prospective Studies; Sulfoxides; Treatment Outcome | 2004 |
Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bacillus; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Probiotics; Prospective Studies; Rabeprazole | 2004 |
Effects of Helicobacter pylori eradication on platelet activation and disease recurrence in patients with acute coronary syndromes.
Topics: Acute Disease; Amoxicillin; Antigens, CD; Coronary Disease; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; P-Selectin; Platelet Activation; Platelet Membrane Glycoprotein IIb; Platelet Membrane Glycoproteins; Recurrence; Tetraspanin 30 | 2004 |
Gastric acid and salivary bicarbonate. Is there a relationship in duodenal ulcer patients?
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bicarbonates; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Acid; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Saliva; Tinidazole; Treatment Outcome | 2004 |
Esomeprazole 40 mg twice daily in triple therapy and the efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Chi-Square Distribution; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Follow-Up Studies; Gastric Mucosa; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mixed Function Oxygenases; Omeprazole; Risk | 2005 |
Comparison of two management strategies for Helicobacter pylori treatment: clinical study and cost-effectiveness analysis.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Clinical Protocols; Cost-Benefit Analysis; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Tetracycline; Treatment Outcome | 2005 |
Response of blood endothelin-1 and nitric oxide activity in duodenal ulcer patients undergoing Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Biomarkers; Drug Therapy, Combination; Duodenal Ulcer; Endothelin-1; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nitrates; Nitric Oxide; Nitrites; Omeprazole; Rabeprazole | 2005 |
Effects of killing Helicobacter pylori quadruple therapy on peptic ulcer: a randomized double-blind clinical trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Recurrence; Wound Healing | 2005 |
First-line eradication therapy for Helicobacter pylori in primary health care based on antibiotic resistance: results of three eradication regimens.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Multivariate Analysis; Omeprazole; Ranitidine; Risk Factors | 2005 |
Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Chalcone; Chalcones; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Rabeprazole | 2005 |
One-year follow-up study of Helicobacter pylori eradication rate with 13C-urea breath test after 3-d and 7-d rabeprazole-based triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Carbon Isotopes; Clarithromycin; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Rabeprazole; Treatment Outcome; Urea | 2005 |
[Effect of the Helicobacter pylori eradication in patients with functional dyspepsia: randomised placebo-controlled trial].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Confidence Intervals; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Odds Ratio; Omeprazole; Treatment Outcome | 2005 |
Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Tetracycline; Treatment Outcome; Turkey | 2005 |
Effect of high-dose aspirin on Helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aspirin; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Pilot Projects | 2005 |
Treatment regimens for Helicobacter pylori infection in children: is in vitro susceptibility testing helpful?
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Treatment Outcome | 2005 |
Helicobacter pylori eradication does not cause reflux oesophagitis in functional dyspeptic patients: a randomized, investigator-blinded, placebo-controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Esophagitis, Peptic; Follow-Up Studies; Heartburn; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Middle Aged; Omeprazole; Risk Assessment; Single-Blind Method | 2005 |
Low-dose rabeprazole, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Biopsy; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prevalence; Proton-Translocating ATPases; Pyloric Antrum; Rabeprazole; Retrospective Studies; Treatment Outcome | 2005 |
Quality of gastric ulcer healing evaluated by endoscopic ultrasonography.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Endosonography; Female; Helicobacter Infections; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Stomach Ulcer; Wound Healing | 2005 |
High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Patient Compliance; Peptic Ulcer; Prospective Studies; Rabeprazole; Treatment Outcome | 2005 |
Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels?
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; C-Reactive Protein; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Omeprazole | 2005 |
Randomized study of Helicobacter pylori eradication therapy and proton pump inhibitor monotherapy for idiopathic thrombocytopenic purpura.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Purpura, Thrombocytopenic, Idiopathic; Remission Induction; Treatment Outcome | 2005 |
Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole | 2005 |
Role of chronic infection and inflammation in the gastrointestinal tract in the etiology and pathogenesis of idiopathic parkinsonism. Part 2: response of facets of clinical idiopathic parkinsonism to Helicobacter pylori eradication. A randomized, double-b
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Omeprazole; Parkinson Disease; Treatment Outcome | 2005 |
[Comparison of esomeprazole- and omeprazole-based triple therapy regimens for duodenal ulcer with Helicobacter pylori infection].
Topics: Adolescent; Adult; Aged; Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole | 2005 |
A follow-up study on the effect of Helicobacter pylori eradication on the severity of gastric histology.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Atrophy; Female; Follow-Up Studies; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Intestines; Lansoprazole; Male; Metaplasia; Metronidazole; Middle Aged; Omeprazole; Severity of Illness Index; Stomach; Treatment Outcome | 2005 |
The results of Helicobacter pylori eradication on repeated bleeding in patients with stomach ulcer.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Recurrence; Stomach Ulcer; Treatment Outcome | 2005 |
Esomeprazole-based therapy in Helicobacter pylori eradication: any effect by increasing the dose of esomeprazole or prolonging the treatment?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole | 2005 |
A randomized trial of triple therapy for pediatric Helicobacter pylori infection and risk factors for treatment failure in a population with a high prevalence of infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Child; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Omeprazole; Prevalence; Prospective Studies; Risk Factors; Treatment Failure | 2005 |
Helicobacter pylori eradication in childhood after failure of initial treatment: advantage of quadruple therapy with nifuratel to furazolidone.
Topics: Adolescent; Amoxicillin; Antacids; Anti-Bacterial Agents; Child; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Nifuratel; Omeprazole; Organometallic Compounds; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2005 |
Recent success of pantoprazole -or lansoprazole- based clarithromycin plus amoxicillin treatment in the eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Single-Blind Method; Sulfoxides; Treatment Outcome | 2004 |
Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Remission Induction; Tinidazole; Treatment Outcome | 2005 |
[H. pylori eradication package set (Lansap)].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Packaging; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Patient Compliance; Proton Pump Inhibitors; Surveys and Questionnaires; Treatment Outcome | 2005 |
[PPI plus bismuth-based quintuple therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Minocycline; Omeprazole; Patient Compliance; Proton Pump Inhibitors; Treatment Outcome | 2005 |
[Cetraxate hydrochloride (Neuer) induces the effectiveness of new triple therapy in H. pylori eradication].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Tranexamic Acid; Treatment Outcome | 2005 |
Should we eradicate Helicobacter pylori before prescribing an NSAID? Result of a placebo-controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Needs Assessment; Omeprazole; Peptic Ulcer; Probability; Reference Values; Rheumatic Diseases; Risk Assessment; Statistics, Nonparametric; Treatment Outcome | 2005 |
Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Biopsy; Brazil; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Prevalence; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2006 |
Clarithromycin-resistant genotypes and eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Point Mutation; Rabeprazole; Treatment Outcome | 2006 |
Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Lansoprazole; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Organometallic Compounds; Tetracycline; Treatment Outcome | 2006 |
Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Cadherins; Chronic Disease; Clarithromycin; DNA Methylation; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Intestines; Male; Metaplasia; Middle Aged; Omeprazole; Promoter Regions, Genetic; Prospective Studies | 2006 |
Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy--a randomized, double-blind, placebo-controlled multicentre trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Omeprazole; Prospective Studies; Treatment Outcome | 2006 |
Third-line rescue therapy with levofloxacin after two H. pylori treatment failures.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Protein Synthesis Inhibitors; Tetracycline; Treatment Failure | 2006 |
Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Minocycline; Omeprazole; Peptic Ulcer; Rabeprazole; Treatment Outcome | 2006 |
[Lipid peroxidation and antioxidant system in treatment dynamics of patients with chronic gastritis].
Topics: Adult; Aged; alpha-Tocopherol; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Antioxidants; Chronic Disease; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lipid Peroxidation; Lipid Peroxides; Male; Metronidazole; Middle Aged; Omeprazole; Tocopherols; Treatment Outcome | 2005 |
[Comparison of the effectiveness of tri- and quadricomponent eradication therapy in patients with peptic ulcer].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Russia; Tetracycline; Treatment Outcome | 2005 |
Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Esophagitis, Peptic; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome | 2006 |
Evaluation of triple and quadruple Helicobacter pylori eradication therapies in Iranian children: a randomized clinical trial.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Iran; Male; Metronidazole; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Treatment Outcome | 2006 |
Design and planned analyses of an ongoing randomized trial assessing the preventive effect of Helicobacter pylori eradication on occurrence of new gastric carcinomas after endoscopic resection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Clinical Protocols; Combined Modality Therapy; Endoscopy; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Lansoprazole; Middle Aged; Omeprazole; Proportional Hazards Models; Research Design; Sample Size; Stomach Neoplasms | 2006 |
Role of Helicobacter pylori virulence factor and genotypes in non-ulcer dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; Dyspepsia; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Treatment Outcome; Virulence; Virulence Factors | 2006 |
Efficacy of one-day quadruple therapy for H pylori infection in Chinese patients.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Asian People; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Organometallic Compounds; Pyloric Antrum; Time Factors | 2006 |
Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Denmark; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Linear Models; Male; Middle Aged; Omeprazole; Prevalence; Prospective Studies; Statistics, Nonparametric; Surveys and Questionnaires; Treatment Outcome | 2006 |
Eradication of H pylori infection in a rural population: one-day quadruple therapy versus 7-day triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Pilot Projects; Prospective Studies; Rural Population | 2006 |
Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cross-Over Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Rifabutin; Treatment Outcome | 2006 |
Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions.
Topics: Adult; Amoxicillin; Ascorbic Acid; China; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Factor Analysis, Statistical; Female; Garlic; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Phytotherapy; Precancerous Conditions; Prevalence; Selenium; Severity of Illness Index; Stomach Neoplasms; Vitamin E | 2006 |
Azithromycin in one week quadruple therapy for H pylori eradication in Iran.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Azithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance | 2006 |
Efficacy and safety of rabeprazole, amoxicillin, and gatifloxacin after treatment failure of initial Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; Benzimidazoles; Breath Tests; Drug Therapy, Combination; Female; Fluoroquinolones; Gatifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Rabeprazole; Smoking; Treatment Outcome; Urease | 2006 |
Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds | 2006 |
A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; China; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dietary Supplements; Double-Blind Method; Drug Administration Schedule; Factor Analysis, Statistical; Female; Garlic; Helicobacter Infections; Helicobacter pylori; Humans; Lipoproteins; Male; Micronutrients; Middle Aged; Omeprazole; Rural Population | 2006 |
Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER Study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Treatment Outcome | 2007 |
Pharmacoeconomic comparison of Helicobacter pylori eradication regimens.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Infective Agents; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Economics, Pharmaceutical; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Melena; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Ranitidine; Taste Disorders; Time Factors; Treatment Outcome | 2006 |
2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
Topics: Administration, Oral; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Proton Pumps | 2006 |
Efficacy and safety of Helicobacter pylori eradication therapy with omeprazole, amoxicillin and high- and low-dose clarithromycin in Japanese patients: a randomised, double-blind, multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Double-Blind Method; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mixed Function Oxygenases; Omeprazole | 2006 |
Improvement of the eradication rate of Helicobacter pylori gastritis in children is by adjunction of omeprazole to a dual antibiotherapy.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Treatment Outcome; Urease | 2007 |
Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Proton Pumps; Treatment Outcome | 2007 |
Oral health status and oral hygiene practices of patients with peptic ulcer and how these affect Helicobacter pylori eradication from the stomach.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mouth Mucosa; Omeprazole; Oral Hygiene; Peptic Ulcer; Tinidazole; Treatment Outcome | 2007 |
Omeprazole-based triple therapy with low-versus high-dose of clarithromycin plus amoxicillin for H pylori eradication in Iranian population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Iran; Male; Middle Aged; Omeprazole | 2007 |
Effect of cranberry juice on eradication of Helicobacter pylori in patients treated with antibiotics and a proton pump inhibitor.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Beverages; Clarithromycin; Double-Blind Method; Female; Fruit; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Phytotherapy; Placebos; Proton Pump Inhibitors; Vaccinium macrocarpon | 2007 |
H. pylori infection in childhood chronic immune thrombocytopenic purpura.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Chronic Disease; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Netherlands; Omeprazole; Platelet Count; Prevalence; Prospective Studies; Purpura, Thrombocytopenic, Idiopathic; Remission Induction | 2007 |
Efficacy of low-dose proton pump inhibitor (PPI) in the eradication of Helicobacter pylori following combination PPI/AC therapy in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Phenotype; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Retreatment; Stomach Diseases; Treatment Outcome | 2007 |
Optimal length of triple therapy for H pylori eradication in a population with high prevalence of infection in Chile.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Chile; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prevalence; Treatment Outcome | 2007 |
Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Rifabutin; Tetracycline; Treatment Outcome | 2007 |
Reversal of migraine symptoms by Helicobacter pylori eradication therapy in patients with hepatitis-B-related liver cirrhosis.
Topics: Adult; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Hepatitis B; Humans; Liver Cirrhosis; Male; Middle Aged; Migraine Disorders; Omeprazole; Time Factors; Treatment Outcome | 2007 |
Evidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Drug Administration Schedule; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Gastric Juice; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lipopolysaccharides; Male; Membrane Glycoproteins; Middle Aged; Omeprazole; Receptors, Immunologic; Severity of Illness Index; Stomach Ulcer; Tissue Culture Techniques; Triggering Receptor Expressed on Myeloid Cells-1; Tumor Necrosis Factor-alpha | 2007 |
Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Middle Aged; Omeprazole; Peptic Ulcer; Time Factors; Treatment Outcome | 2007 |
Eradication of Helicobacter pylori infection equally improves chronic urticaria with positive and negative autologous serum skin test.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Autoantibodies; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Skin Tests; Treatment Outcome; Urticaria | 2007 |
Garlic, vitamin, and antibiotic treatment for Helicobacter pylori: a randomized factorial controlled trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Garlic; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Omeprazole; Plant Extracts; Treatment Outcome; Vitamins | 2007 |
Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Failure; Urea | 2008 |
Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients.
Topics: Amoxicillin; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Breath Tests; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Ranitidine; Rifabutin; Tetracycline; Treatment Failure | 2008 |
Double-dose, new-generation proton pump inhibitors do not improve Helicobacter pylori eradication rate.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole | 2007 |
Effect of eradication of Helicobacter pylori on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura: a controlled trial.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunosuppressive Agents; Iran; Male; Middle Aged; Omeprazole; Prospective Studies; Purpura, Thrombocytopenic, Idiopathic; Splenectomy | 2008 |
Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Infective Agents; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Retreatment; Treatment Outcome | 2008 |
The effect of Helicobacter pylori eradication treatment on the MUC 1 and Lewis antigens level in human gastric juice: a preliminary study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Epithelial Cells; Female; Gastric Juice; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lewis Blood Group Antigens; Male; Middle Aged; Mucin-1; Omeprazole | 2008 |
Effect of a community screening for Helicobacter pylori: a 5-Yr follow-up study.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Community Health Services; Cost-Benefit Analysis; Cross-Sectional Studies; Denmark; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Screening; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer | 2008 |
Is a 7-day Helicobater pylori treatment enough for eradication and inactivation of gastric inflammatory activity?
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ecuador; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Treatment Outcome | 2008 |
Prevalence of A2143G mutation of H. pylori-23S rRNA in Chinese subjects with and without clarithromycin use history.
Topics: Adult; Amoxicillin; China; Clarithromycin; DNA Mutational Analysis; DNA, Bacterial; Double-Blind Method; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastric Juice; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Point Mutation; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 23S | 2008 |
[Effectiveness of 10 day-sequential therapy for Helicobacter pylori eradication in Korea].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Male; Metronidazole; Middle Aged; Omeprazole; Time Factors; Treatment Outcome | 2008 |
A randomized, open trial evaluating the effect of Saccharomyces boulardii on the eradication rate of Helicobacter pylori infection in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Probiotics; Prospective Studies; Proton Pump Inhibitors; Saccharomyces | 2009 |
Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.
Topics: Aged; Amoxicillin; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Severity of Illness Index; Time Factors; Treatment Outcome | 2009 |
Quadruple therapy with furazolidone for retreatment in patients with peptic ulcer disease.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Proton Pump Inhibitors; Recurrence; Salvage Therapy; Treatment Outcome; Young Adult | 2008 |
Efficacy of the standard quadruple therapy versus triple therapies containing proton pump inhibitor plus amoxicillin and clarithromycin or amoxicillin-clavulanic acid and metronidazole for Helicobacter pylori eradication in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Clavulanic Acid; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Single-Blind Method; Treatment Outcome; Urea | 2009 |
Long-term garlic or micronutrient supplementation, but not anti-Helicobacter pylori therapy, increases serum folate or glutathione without affecting serum vitamin B-12 or homocysteine in a rural Chinese population.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Asian People; Dietary Supplements; Dose-Response Relationship, Drug; Female; Folic Acid; Garlic; Glutathione; Helicobacter Infections; Helicobacter pylori; Homocysteine; Humans; Male; Micronutrients; Middle Aged; Omeprazole; Rural Population; Vitamin B 12 | 2009 |
Effect of Helicobacter pylori eradication on ulcer recurrence after simple closure of perforated duodenal ulcer.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer Perforation; Prevalence; Secondary Prevention | 2009 |
[Interleukin-1beta gene polymorphism as a predictor of eradication treatment efficacy in gastric and duodenal ulcer associated with Helicobacter pylori].
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Endoscopy, Digestive System; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-1beta; Middle Aged; Omeprazole; Peptic Ulcer; Polymorphism, Single Nucleotide; Predictive Value of Tests; Prospective Studies; Treatment Outcome; Young Adult | 2008 |
Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Cognition Disorders; Comorbidity; Endpoint Determination; Female; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Neuropsychological Tests; Omeprazole; Prevalence; Treatment Outcome; Urease | 2009 |
Randomized, double-blind, placebo-controlled trial: effect of lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Combined Modality Therapy; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus; Male; Omeprazole; Placebos; Probiotics | 2009 |
The efficacy of Helicobacter pylori eradication regimen with and without vitamin C supplementation.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Ascorbic Acid; Bismuth; Dietary Supplements; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Young Adult | 2009 |
Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Female; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Stomach Neoplasms; Young Adult | 2009 |
[Effect of CYP2C19 gene polymorphism on eradication treatment efficacy of Helicobacter pylori infection].
Topics: Adult; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Breath Tests; Clarithromycin; Cohort Studies; Cytochrome P-450 CYP2C19; DNA; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metabolic Clearance Rate; Moscow; Omeprazole; Peptic Ulcer; Polymorphism, Single Nucleotide; Prospective Studies | 2009 |
[Anti-Helicobacter pylori treatment in patients with idiopathic thrombocytopenic purpura].
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Purpura, Thrombocytopenic, Idiopathic; Retrospective Studies; Young Adult | 2009 |
Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Treatment Outcome; Young Adult | 2010 |
Effect of eradication of Helicobacter pylori and iron supplementation on the iron status of children with iron deficiency.
Topics: Adolescent; Amoxicillin; Anemia, Iron-Deficiency; Child; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iron; Male; Mexico; Omeprazole; Placebos | 2010 |
Investigation of the anti-inflammatory effect of Curcuma longa in Helicobacter pylori-infected patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bacterial Load; Curcumin; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-8; Male; Metronidazole; Middle Aged; Omeprazole | 2010 |
High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Time Factors; Treatment Outcome; Young Adult | 2010 |
Eradication of Helicobacter spp. by using medicated diet in mice deficient in functional natural killer cells and complement factor D.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Antigens, CD1; Clarithromycin; Complement Factor D; Drug Combinations; Female; Helicobacter; Helicobacter Infections; Immunocompromised Host; Male; Metronidazole; Mice; Mice, Inbred Strains; Mice, Knockout; Omeprazole; Rodent Diseases | 2010 |
Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Medication Adherence; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Single-Blind Method; Young Adult | 2010 |
Standard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradication.
Topics: Adult; Aged; Amoxicillin; Bismuth; Clarithromycin; Double-Blind Method; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Middle Aged; Omeprazole; Pectins; Prospective Studies | 2010 |
Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Blood Platelets; Child; Chronic Disease; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Platelet Count; Purpura, Thrombocytopenic, Idiopathic | 2011 |
Comparison of the efficacy of triple versus quadruple therapy on the eradication of Helicobacter pylori and antibiotic resistance.
Topics: Adolescent; Adult; Aged; Amoxicillin; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Tetracycline | 2010 |
Clarithromycin-based triple therapy for Helicobacter pylori treatment in peptic ulcer patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Brazil; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Stomach Ulcer; Treatment Outcome | 2010 |
Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Combinations; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Tablets; Tetracycline; Young Adult | 2011 |
Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Sex Factors; Taiwan; Treatment Outcome; Young Adult | 2011 |
Sequential therapy compared with standard triple therapy for Helicobacter pylori eradication in children: a double-blind, randomized, controlled trial.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Omeprazole; Proton Pump Inhibitors; Tinidazole; Urea | 2011 |
Helicobacter pylori chronic gastritis in children: to eradicate or not to eradicate?
Topics: Adolescent; Aluminum Hydroxide; Amoxicillin; Antacids; Anti-Bacterial Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter Infections; Humans; Magnesium Hydroxide; Male; Metronidazole; Omeprazole; Proton Pump Inhibitors; Severity of Illness Index; Urea | 2011 |
Furazolidone, amoxicillin and omeprazole with or without bismuth for eradication of Helicobacter pylori in peptic ulcer disease.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Peptic Ulcer; Treatment Outcome | 2011 |
High eradication rates of Helicobacter pylori infection following sequential therapy: the Israeli experience treating naïve patients.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Male; Middle Aged; Omeprazole; Prospective Studies; Tinidazole; Treatment Outcome | 2011 |
Sequential therapy versus standard triple drug therapy for eradication of Helicobacter pylori in patients with perforated duodenal ulcer following simple closure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer Perforation; Young Adult | 2011 |
Efficacy of levofloxacin and rifaximin based quadruple therapy in Helicobacter pylori associated gastroduodenal disease: a double-blind, randomized controlled trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Peptic Ulcer; Prospective Studies; Rifamycins; Rifaximin | 2011 |
Sequential therapy versus tailored triple therapies for Helicobacter pylori infection in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Prospective Studies; Treatment Outcome | 2011 |
Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Middle Aged; Omeprazole; Quinolones; Stomach Ulcer; Treatment Outcome; Wound Healing; Young Adult | 2011 |
Increasing the duration of dual amoxicillin plus omeprazole Helicobacter pylori eradication to 6 weeks: a pilot study.
Topics: Amoxicillin; Anti-Bacterial Agents; Breath Tests; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Middle Aged; Omeprazole; Pilot Projects; Prospective Studies; Proton Pumps; Texas; Time Factors; Treatment Outcome | 2012 |
Second-line levofloxacin-based triple therapy's efficiency for Helicobacter pylori eradication in patients with peptic ulcer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Peptic Ulcer; Treatment Outcome; Young Adult | 2011 |
Effect of Helicobacter pylori eradication therapy in iron deficiency anaemia of pregnancy - a pilot study.
Topics: Adolescent; Adult; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Clarithromycin; Disease Eradication; Double-Blind Method; Drug Therapy, Combination; Female; Folic Acid; Helicobacter Infections; Helicobacter pylori; Humans; Iron, Dietary; Omeprazole; Pilot Projects; Pregnancy; Pregnancy Complications | 2011 |
Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Celecoxib; Clarithromycin; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Precancerous Conditions; Pyrazoles; Stomach; Stomach Neoplasms; Sulfonamides | 2012 |
[Effect of anti-Helicobacter pylori on the prognosis in patients with acute cerebral infarction].
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; C-Reactive Protein; Cerebral Infarction; Female; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prognosis; Risk Factors; Triglycerides | 2011 |
A randomized study comparing levofloxacin, omeprazole, nitazoxanide, and doxycycline versus triple therapy for the eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Lansoprazole; Levofloxacin; Male; Middle Aged; Nitro Compounds; Ofloxacin; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Recurrence; Thiazoles; Young Adult | 2011 |
Correlation between creatinine clearance and Helicobacter pylori infection eradication with sequential and triple therapeutic regimens: A randomised clinical trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Ciprofloxacin; Creatinine; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Treatment Outcome; Uremia | 2011 |
Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Ascorbic Acid; China; Confounding Factors, Epidemiologic; Dietary Supplements; Factor Analysis, Statistical; Female; Follow-Up Studies; Garlic; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Logistic Models; Male; Middle Aged; Odds Ratio; Omeprazole; Precancerous Conditions; Proportional Hazards Models; Stomach Neoplasms; Vitamin E; Vitamins | 2012 |
Clarithromycin versus metronidazole in first-line Helicobacter pylori eradication. Prospective randomized study of 85 Tunisian adults.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Metronidazole; Omeprazole; Prospective Studies | 2012 |
Randomised clinical trial: simvastatin as adjuvant therapy improves significantly the Helicobacter pylori eradication rate--a placebo-controlled study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Simvastatin; Treatment Outcome | 2012 |
Helicobacter pylori infection: sequential therapy followed by levofloxacin-containing triple therapy provides a good cumulative eradication rate.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Treatment Outcome; Young Adult | 2012 |
Lycopene an adjunctive therapy for Helicobacter pylori eradication: a quasi-control trial.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Antioxidants; Bismuth; Carotenoids; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lycopene; Male; Metronidazole; Middle Aged; Omeprazole; Treatment Outcome | 2012 |
[A 10-day sequential therapy for eradication of Helicobacter pylori infection in children].
Topics: Administration, Oral; Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Time Factors; Treatment Outcome | 2012 |
[Use of the immunopotentiator N-acetyl-glucosamine-N-acetylmuramyl dipeptide during triple anti-Helicobacter pylori therapy].
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Clinical Protocols; Drug Costs; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Treatment Outcome | 2012 |
Penbactam for Helicobacter pylori eradication: a randomised comparison of quadruple and triple treatment schedules in an Iranian population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Analysis of Variance; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Proton Pump Inhibitors; Sulbactam; Urea; Young Adult | 2013 |
Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Treatment Outcome; Urea; Young Adult | 2014 |
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a prospective randomized study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies | 2013 |
Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study.
Topics: Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Omeprazole; Pilot Projects; Proton Pump Inhibitors; Tinidazole; Urea | 2013 |
Azithromycin based triple therapy versus standard clarithromycin based triple therapy in eradication of Helicobacter pylori infection in Iran: a randomized controlled clinical trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Omeprazole; Treatment Outcome | 2013 |
Randomised controlled trial: sequential vs. standard triple therapy for Helicobacter pylori infection in Chinese children-a multicentre, open-labelled study.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Asian People; Child; Child, Preschool; China; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2013 |
Expression comparison of azithromycin and clarithromycin in triple-therapy regimens for eradication of Helicobacter pylori in hemodialysis patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Azithromycin; Breath Tests; Chi-Square Distribution; Clarithromycin; Double-Blind Method; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Renal Dialysis; Time Factors; Treatment Outcome | 2014 |
The efficacy of levofloxacin-based triple therapy for first-line helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Time Factors; Treatment Outcome; Young Adult | 2013 |
[Clinical effect of triple therapy combined with Saccharomyces boulardii in the treatment of Helicobacter pylori infection in children].
Topics: Amoxicillin; Child; Child, Preschool; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Probiotics; Prospective Studies; Saccharomyces | 2014 |
Modified sequential Helicobacter pylori eradication therapy using high dose omeprazole and amoxicillin in the initial phase in the extensive metaboliser Turkish patients for CYP2C19 polymorphism is ineffective.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Polymorphism, Genetic; Treatment Failure; Turkey | 2014 |
Relationship of Helicobacter pylori eradication with gastric cancer and gastric mucosal histological changes: a 10-year follow-up study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Female; Follow-Up Studies; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Stomach Neoplasms | 2014 |
Helicobacter pylori eradication in renal recipient: triple or quadruple therapy?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Breath Tests; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunocompromised Host; Iran; Kidney Transplantation; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 2014 |
Clarithromycin for first-line treatment of Helicobacter pylori infection after culture in high-resistance regions.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Predictive Value of Tests; Prospective Studies; Proton Pump Inhibitors; Remission Induction; Spain; Time Factors; Treatment Outcome | 2014 |
Replacement of clarithromycin with azithromycin in triple therapy regimens for the eradication of Helicobacter pylori: A randomized clinical trial.
Topics: Amoxicillin; Azithromycin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Omeprazole; Stomach Ulcer | 2014 |
Low dose furazolidone for eradication of H- pylori instead of clarithromycin: a clinical trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Treatment Outcome | 2014 |
Probiotics for standard triple Helicobacter pylori eradication: a randomized, double-blind, placebo-controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bifidobacterium; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lacticaseibacillus rhamnosus; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Placebos; Probiotics; Prospective Studies; Proton Pump Inhibitors; Surveys and Questionnaires; Treatment Outcome | 2015 |
A randomized-controlled study to compare the efficacy of sequential therapy with standard triple therapy for Helicobacter pylori eradication in an Irish population.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Ireland; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome; Urea; Young Adult | 2015 |
Phytomedicine-based and Quadruple Therapies in Helicobacter pylori Infection: A Comparative, Randomized Trial.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Phytotherapy; Plant Extracts; Treatment Outcome; Young Adult | 2015 |
Helicobacter pylori, cyclooxygenase-2 and evolution of gastric lesions: results from an intervention trial in China.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Celecoxib; China; Clarithromycin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Double-Blind Method; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Precancerous Conditions; Stomach; Stomach Neoplasms | 2015 |
Impact of creatinine clearance on Helicobacter pylori eradication rate in patients with peptic ulcer disease.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Creatinine; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Failure, Chronic; Male; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Treatment Outcome | 2015 |
A 2-week Nitazoxanide-based quadruple treatment as a rescue therapy for Helicobacter pylori eradication: A single center experience.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Nitro Compounds; Omeprazole; Proton Pump Inhibitors; Retrospective Studies; Thiazoles; Treatment Outcome | 2016 |
High efficacy of gemifloxacin-containing therapy in Helicobacter Pylori eradication: A pilot empirical second-line rescue therapy.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoroquinolones; Follow-Up Studies; Gastric Mucosa; Gastroscopy; Gemifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Male; Naphthyridines; Omeprazole; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Stomach Diseases; Treatment Outcome | 2016 |
Effect of treatment failure on the CagA EPIYA motif in
Topics: Adult; Amino Acid Motifs; Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Biopsy; Breath Tests; Clarithromycin; Colombia; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Phylogeny; Prevalence; Proton Pump Inhibitors; Random Amplified Polymorphic DNA Technique; Treatment Failure; Treatment Outcome; Virulence Factors | 2017 |
Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial.
Topics: Adult; Amoxicillin; Carnosine; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Treatment Outcome; Zinc Compounds | 2017 |
Dietary PUFA Increase Apoptosis in Stomach of Patients with Dyspeptic Symptoms and Infected with H. pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Apoptosis; Caspase 3; Clarithromycin; Dietary Fats, Unsaturated; Double-Blind Method; Dyspepsia; Fatty Acids, Unsaturated; Female; Gene Expression Regulation; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Proto-Oncogene Proteins c-bcl-2; Stomach | 2017 |
Therapeutic success with bismuth-containing sequential and quadruple regimens in Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Doxycycline; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Smoking; Tetracycline; Treatment Outcome; Young Adult | 2017 |
Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pilot Projects; Prospective Studies; Rifamycins; Rifaximin; Treatment Outcome; Young Adult | 2017 |
New single capsule of bismuth, metronidazole and tetracycline given with omeprazole versus quadruple therapy consisting of bismuth, omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a Chinese pro
Topics: Adolescent; Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Capsules; China; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Tetracycline; Young Adult | 2018 |
Efficacies of different proton pump inhibitor-based 14-day bismuth-furazolidone quadruple regimens for the initial eradication of Helicobacter pylori in the southeast coastal region of China: an open-label, randomized clinical trial.
Topics: Adult; Amoxicillin; Bismuth; Breath Tests; China; Drug Administration Schedule; Drug Therapy, Combination; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2018 |
Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Tetracycline | 2018 |
Efficacy of Helicobacter pylori eradication regimens in Rwanda: a randomized controlled trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Disease Eradication; Doxycycline; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Quality of Life; Rwanda; Treatment Failure | 2018 |
Saccharomyces boulardii CNCM I-745 plus sequential therapy for Helicobacter pylori infections: a randomized, open-label trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Probiotics; Prospective Studies; Proton Pump Inhibitors; Random Allocation; Saccharomyces boulardii | 2019 |
Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study.
Topics: Adult; Alanine; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Peptic Ulcer; Prospective Studies; Quinolones; Treatment Outcome | 2018 |
Evaluation of the efficacy and safety of the hybrid scheme for eradication therapy of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Peptic Ulcer; Prospective Studies; Treatment Outcome | 2018 |
Personalized therapy for Helicobacter pylori: CYP2C19 genotype effect on first-line triple therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Polymorphism, Genetic; Precision Medicine | 2019 |
H. pylori eradication with antibiotic treatment causes changes in glucose homeostasis related to modifications in the gut microbiota.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Gastrointestinal Microbiome; Glucose; Helicobacter Infections; Helicobacter pylori; Homeostasis; Humans; Male; Middle Aged; Omeprazole; RNA, Bacterial; RNA, Ribosomal, 16S; Sequence Analysis, RNA | 2019 |
Potential roles of Helicobacter pylori treatment, body mass index and waist circumference in the causation of erosive esophagitis: a randomized clinical trial (HEROES-GERD).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Body Mass Index; Clarithromycin; Esophagitis; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Waist Circumference; Young Adult | 2020 |
Efficacy of Omeprazole, Tetracycline, and 4 Times Daily Dosing of Amoxicillin in Helicobacter pylori Eradication in Limited Resource Area in Bhutan: A Prospective Randomized Trial (BHUTAN Study).
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bhutan; Developing Countries; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prognosis; Prospective Studies; Socioeconomic Factors; Tetracycline; Young Adult | 2020 |
Rifabutin-Based Triple Therapy (RHB-105) for
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Rifabutin; Young Adult | 2020 |
Positive Effect of Helicobacter pylori Treatment on Outcome of Patients With Chronic Spontaneous Urticaria.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Chronic Urticaria; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pilot Projects; Proton Pump Inhibitors; Treatment Outcome; Young Adult | 2021 |
Comparing the Efficacy of Sequential and Standard Quadruple Therapy for Eradication of H. Pylori Infection.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Omeprazole; Organometallic Compounds; Tinidazole | 2020 |
Randomized clinical trial: 7-day vonoprazan-based versus 14-day omeprazole-based triple therapy for Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2021 |
[A prospective randomized comparative study of the efficacy and safety of a two-week bismuth-based quadrotherapy of
Topics: Amoxicillin; Anti-Bacterial Agents; Bifidobacterium longum; Bismuth; Clarithromycin; Drug Therapy, Combination; Enterococcus faecium; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin A, Secretory; Omeprazole; Probiotics; Prospective Studies; Urease | 2021 |
Effect and safety of anaprazole in the treatment of duodenal ulcers: a randomized, rabeprazole-controlled, phase III non-inferiority study.
Topics: Amoxicillin; Anti-Ulcer Agents; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Proton Pump Inhibitors; Rabeprazole | 2022 |
479 other study(ies) available for amoxicillin and omeprazole
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Sitafloxacin and garenoxacin may overcome the antibiotic resistance of Helicobacter pylori with gyrA mutation.
Topics: Anti-Infective Agents; DNA Gyrase; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Helicobacter pylori; Mutation | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Modified combined omeprazole/amoxicillin therapy for Helicobacter pylori eradication: a pilot study].
Topics: Adult; Aged; Amoxicillin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Pilot Projects | 1992 |
Prevalence of Helicobacter pylori infection in patients with large gastric folds: evaluation and follow-up with endoscopic ultrasound before and after antimicrobial therapy.
Topics: Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prevalence; Stomach; Ultrasonography | 1995 |
[Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Ranitidine; Salicylates; Tetracycline | 1995 |
Schönlein-Henoch purpura associated with gastric Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Biopsy; Breath Tests; Chronic Disease; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; IgA Vasculitis; Omeprazole; Penicillins; Proteinuria; Recurrence | 1995 |
90% cure: which anti-Helicobacter therapy can achieve this treatment goal?
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Randomized Controlled Trials as Topic; Tetracycline | 1995 |
[Therapy of Helicobacter pylori associated diseases].
Topics: Amoxicillin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer | 1995 |
[Helicobacter heilmannii: new spiral shaped bacterium that may be responsible for ulcerated gastritis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Gastritis; Helicobacter; Helicobacter Infections; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Stomach Ulcer; Tinidazole | 1995 |
The long-term management of patients with bleeding ulcers: Helicobacter pylori eradication instead of maintenance antisecretory therapy.
Topics: Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer Hemorrhage | 1995 |
New insight in the mechanism of omeprazole antimicrobial combinations to eradicate Helicobacter pylori.
Topics: Amoxicillin; Circadian Rhythm; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Omeprazole | 1995 |
Additive effect of clarithromycin combined with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pylori.
Topics: Amoxicillin; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Erythromycin; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Metronidazole; Microbial Sensitivity Tests; Omeprazole | 1994 |
Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Omeprazole; Stomach Neoplasms | 1995 |
Helicobacter pylori eradication in the treatment and differential diagnosis of giant folds in the corpus and fundus of the stomach.
Topics: Aged; Amoxicillin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Gastritis, Hypertrophic; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Treatment Outcome | 1995 |
Helicobacter pylori in patients with systemic sclerosis: detection with the 13C-urea breath test and eradication.
Topics: Adult; Aged; Amoxicillin; Breath Tests; Carbon Isotopes; Drug Therapy, Combination; Dyspepsia; Esophagitis, Peptic; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Risk Factors; Scleroderma, Systemic; Stomach Diseases; Urea | 1994 |
Treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Tetracycline | 1995 |
[Low malignancy MALT lymphoma of the stomach: H. pyloric eradication as a therapeutic concept?].
Topics: Amoxicillin; Drug Therapy, Combination; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Omeprazole; Stomach Neoplasms | 1994 |
Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori eradication.
Topics: Amoxicillin; Biopsy; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Omeprazole; Remission Induction; Stomach Neoplasms | 1995 |
Duodenal ulcer healing drugs.
Topics: Amoxicillin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Omeprazole | 1994 |
Effective treatment after failure of omeprazole plus amoxycillin to eradicate Helicobacter pylori infection in peptic ulcer disease.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Ranitidine; Recurrence; Salicylates; Tetracycline; Treatment Failure; Treatment Outcome | 1994 |
[A Norwegian conference on updating of the treatment of Helicobacter pylori in peptic ulcer. Interessegruppe for Gastroenterologi].
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Norway; Omeprazole; Oxytetracycline; Peptic Ulcer | 1994 |
Resolution of protein-losing hypertrophic lymphocytic gastritis with therapeutic eradication of Helicobacter pylori.
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis, Hypertrophic; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Protein-Losing Enteropathies; Salicylates | 1994 |
Short-term omeprazole oral/amoxicillin intravenous therapy for Helicobacter pylori eradication: a lack of therapeutic effect.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Drug Administration Schedule; Drug Therapy, Combination; Duodenitis; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Time Factors | 1994 |
Healing gastric MALT lymphomas by eradicating H pylori?
Topics: Amoxicillin; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Omeprazole; Stomach Neoplasms | 1993 |
Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Peptic Ulcer Hemorrhage; Prospective Studies; Ranitidine; Recurrence; Salicylates; Stomach Ulcer | 1994 |
[Quality assurance in everyday routines].
Topics: Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Quality Assurance, Health Care | 1994 |
Omeprazole/amoxicillin versus ranitidine/triple therapy for duodenal ulcer: when is the "same" the same?
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Ranitidine; Salicylates; Tetracycline | 1994 |
Healing of protein losing hypertrophic gastropathy by eradication of Helicobacter pylori--is Helicobacter pylori a pathogenic factor in Ménétrier's disease?
Topics: Adult; Amoxicillin; Drug Therapy, Combination; Female; Gastritis, Hypertrophic; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Protein-Losing Enteropathies | 1994 |
Acid inhibition and amoxicillin activity against Helicobacter pylori.
Topics: Amoxicillin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole | 1993 |
Combined intravenous and oral omeprazole/amoxicillin therapy in patients with Helicobacter pylori-positive acute peptic ulcer bleeding.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage | 1993 |
Proton-pump inhibitor-refractory gastric ulcer and Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Ranitidine; Stomach Ulcer | 1993 |
Helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer | 1993 |
[Helicobacter pylori infection and ulcer disease].
Topics: Amoxicillin; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Stomach Ulcer | 1993 |
One-day therapy for treatment of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Chronic Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Treatment Outcome | 1993 |
Short report: high-dose omeprazole and amoxycillin in the treatment of Helicobacter pylori-associated duodenal ulcer.
Topics: Adult; Aged; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance | 1993 |
pH and Hp--gastric acid secretion and Helicobacter pylori: implications for ulcer healing and eradication of the organism.
Topics: Amoxicillin; Duodenal Ulcer; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Omeprazole | 1993 |
Successful Helicobacter pylori eradication: a systemic effect of antibiotics?
Topics: Adult; Amoxicillin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Peptic Ulcer | 1993 |
Two-week eradication regimen for metronidazole-resistant Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Breath Tests; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds | 1993 |
Sucralfate affects the susceptibility of Helicobacter pylori to antimicrobial agents.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Interactions; Erythromycin; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Penicillins; Sucralfate; Tetracycline | 1995 |
Deterioration of renal function in a nephropathic diabetic patient during omeprazole plus amoxicillin therapy for Helicobacter pylori-associated duodenal ulcer.
Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Diabetic Nephropathies; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Kidney; Omeprazole; Penicillins | 1995 |
Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Pilot Projects; Treatment Outcome | 1995 |
Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Cost-Benefit Analysis; Costs and Cost Analysis; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Omeprazole; Patient Compliance; Penicillins; Recurrence; Tetracycline; Time Factors | 1996 |
Factors affecting growth and antibiotic susceptibility of Helicobacter pylori: effect of pH and urea on the survival of a wild-type strain and a urease-deficient mutant.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzamides; Clarithromycin; Drug Interactions; Duodenal Ulcer; Enzyme Inhibitors; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Metronidazole; Microbial Sensitivity Tests; Mutation; Omeprazole; Penicillins; Urea; Urease | 1996 |
[What factors influence healing of duodenal ulcer when Helicobacter pylori eradication treatment is used?].
Topics: Adult; Age Factors; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Evaluation Studies as Topic; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Multivariate Analysis; Omeprazole; Penicillins; Sex Factors; Smoking; Tetracycline; Time Factors; Wound Healing | 1996 |
[New guidelines from the Medical Products Agency: the triple regime against Helicobacter pylori is necessary. Treat only if the ulcer is verified].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Stomach Ulcer; Tetracycline | 1996 |
[Is the omeprazole and amoxicillin combination useful in the treatment eradicating Helicobacter pylori in Spain?].
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Penicillins | 1996 |
One-day combined therapy of children with Helicobacter pylori-associated peptic disease.
Topics: Adolescent; Amoxicillin; Anti-Ulcer Agents; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins | 1996 |
[Effectiveness of triple therapy to eradicate H. pylori in patients after failed therapy with omeprazole/amoxicillin].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Tetracycline; Treatment Outcome | 1996 |
Pharmacology of the gastric mucosa: a rational approach to Helicobacter polytherapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastric Acid; Gastric Juice; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins | 1996 |
A comparative trial of short term therapy with omeprazole plus either amoxycillin or azithromycin for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 1996 |
Use of PCR and culture to detect Helicobacter pylori in naturally infected cats following triple antimicrobial therapy.
Topics: Amoxicillin; Animals; Bacteriological Techniques; Cats; Cells, Cultured; Drug Therapy, Combination; Gastric Juice; Helicobacter Infections; Helicobacter pylori; Male; Metronidazole; Omeprazole; Polymerase Chain Reaction; Saliva | 1996 |
One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies | 1996 |
The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Antibodies, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Primary Health Care; Prospective Studies; Serologic Tests | 1996 |
[Dynamic imaging of gastric ulcer healing using the most modern Morph-Software].
Topics: Amoxicillin; Anti-Ulcer Agents; Computer Systems; Drug Therapy, Combination; Gastroscopes; Helicobacter Infections; Helicobacter pylori; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Omeprazole; Software; Stomach Ulcer; Video Recording; Wound Healing | 1996 |
Short-term low-dose triple therapy with lansoprazole plus amoxycillin and clarithromycin for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole | 1996 |
[Which factors influence the success of the classical triple therapy in the eradication of Helicobacter pylori?].
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Pyloric Antrum; Stomach; Tetracycline | 1996 |
The influence of isolated doses of drugs, feeding and colonic bacterial ureolysis on urea breath test results.
Topics: Adult; Amoxicillin; Bacteria; Bismuth; Breath Tests; Colon; Drug Therapy, Combination; Eating; False Negative Reactions; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Sucralfate; Urea | 1995 |
Etiological involvement of Helicobacter pylori in "reflux" gastritis after gastrectomy.
Topics: Amoxicillin; Anti-Ulcer Agents; Chalcone; Chalcones; Drug Therapy, Combination; Female; Gastric Mucosa; Gastric Stump; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Postgastrectomy Syndromes; Prevalence; Risk Factors | 1996 |
[Association of chronic urticaria with Helicobacter pylori-induced antrum gastritis].
Topics: Adult; Amoxicillin; Chronic Disease; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pyloric Antrum; Urticaria | 1996 |
Helicobacter pylori eradication helps resolve pyloric and duodenal stenosis.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Obstruction; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pyloric Stenosis | 1996 |
[Is there a correlation between the values of breath tests and the response to the treatment for the eradication of Helicobacter pylori?].
Topics: Amoxicillin; Anti-Ulcer Agents; Breath Tests; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Retrospective Studies; Urea | 1996 |
Relevance of the ferret model of Helicobacter-induced gastritis to evaluation of antibacterial therapies.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Female; Ferrets; Gastric Mucosa; Gastritis; Helicobacter; Helicobacter Infections; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Penicillins; Time Factors | 1996 |
Effect of lansoprazole in mono-, dual-, or triple therapy on Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Penicillins; Proton Pump Inhibitors; Stomach Ulcer; Tinidazole | 1996 |
Endoscopic topical therapy for the treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Topical; Amoxicillin; Antacids; Anti-Ulcer Agents; Bismuth; Drug Combinations; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Instillation, Drug; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Pronase | 1996 |
Eradication of Helicobacter pylori followed by reinfection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Blotting, Southern; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Penicillins; Peptic Ulcer; Polymorphism, Restriction Fragment Length; Proton Pump Inhibitors; Recurrence | 1996 |
Proton-pump inhibition and gastric giardiasis: a causal or casual association?
Topics: Aged; Amoxicillin; Animals; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Gastric Mucosa; Giardia lamblia; Giardiasis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Stomach Diseases; Stomach Ulcer; Time Factors | 1995 |
[Erradicating treatment of Helicobacter pylori with lansoprazole and amoxicillin in duodenal ulcer patients].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies | 1996 |
Helicobacter pylori reinfection is rare in peptic ulcer patients cured by antimicrobial therapy.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Recurrence; Salicylates; Stomach Ulcer; Time Factors; Tinidazole | 1996 |
Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antineoplastic Combined Chemotherapy Protocols; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Immunoproliferative Small Intestinal Disease; Lymphoma, B-Cell, Marginal Zone; Male; Omeprazole; Penicillins | 1997 |
Percentage changes in serum pepsinogens are useful as indices of eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Pepsinogens; Stomach Ulcer | 1997 |
Eradication of Helicobacter pylori in patients with end-stage renal disease under dialysis treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Combined Modality Therapy; Diterpenes; Drug Evaluation; Drug Therapy, Combination; Fatty Alcohols; Female; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Failure, Chronic; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Renal Dialysis; Time Factors | 1997 |
[Breath test in the diagnosis of Helicobacter pylori infection: concordance with histological methods and correlation with anatomopathological lesions of the gastric mucosa].
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Tetracycline | 1996 |
[A case of gastric MALT lymphoma regressed endoscopically and pathologically after eradication of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Omeprazole; Stomach Neoplasms | 1997 |
In vitro activity of omeprazole in combination with several antimicrobial agents against clinical isolates of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Ceftibuten; Cephalosporins; Clarithromycin; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Endoscopy; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Omeprazole; Penicillins; Stomach | 1996 |
Ongoing gastric acid inhibition is a confounding factor in Helicobacter pylori diagnosis.
Topics: Amoxicillin; Anti-Ulcer Agents; Biopsy; Endoscopy, Digestive System; Female; Gastric Acid; Gastric Juice; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Immunohistochemistry; Male; Middle Aged; Omeprazole; Penicillins; Retrospective Studies | 1997 |
The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Buffers; Chromatography, High Pressure Liquid; Clarithromycin; Gastric Juice; Half-Life; Helicobacter; Helicobacter Infections; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Metronidazole; Omeprazole; Penicillins; Solutions | 1997 |
Does smoking predispose to peptic ulcer relapse after eradication of Helicobacter pylori?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Recurrence; Risk Factors; Smoking; Stomach Ulcer; Sucralfate; Wound Healing | 1997 |
[Helicobacter pylori eradication: finally clarity].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer | 1996 |
Resolution of protein-losing hypertrophic gastropathy by eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child, Preschool; Drug Therapy, Combination; Gastric Mucosa; Gastritis, Hypertrophic; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Omeprazole; Penicillins; Protein-Losing Enteropathies | 1997 |
Helicobacter pylori infection accelerates human gastric mucosal cell proliferation.
Topics: Amoxicillin; Anti-Ulcer Agents; Biopsy; Case-Control Studies; Cell Division; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins | 1997 |
Susceptibility of Helicobacter pylori isolates against agents commonly administered for eradication therapy and the efficacy of chemotherapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole | 1997 |
Bactericidal activity and synergy studies of proton pump inhibitors and antibiotics against Helicobacter pylori in vitro.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Drug Synergism; Enzyme Inhibitors; Erythromycin; Helicobacter pylori; Lansoprazole; Microbial Sensitivity Tests; Omeprazole; Proton Pump Inhibitors | 1997 |
[The efficacy of using a short course of 6-day duration (OCA-6) in the treatment to eradicate Helicobacter pylori infection. Omeprazole, clarithromycin, amoxicillin].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Evaluation; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Time Factors | 1997 |
Regression of a large gastric MALT lymphoma with antibiotic treatment to eradicate Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, Non-Hodgkin; Male; Metronidazole; Middle Aged; Omeprazole; Stomach Neoplasms | 1997 |
Urticaria during triple therapy for Helicobacter pylori infection: clinical implications.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Eruptions; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Omeprazole; Tinidazole; Urticaria | 1997 |
Gastric metaplasia and Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Duodenal Ulcer; Female; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Metaplasia; Metronidazole; Middle Aged; Omeprazole; Penicillins; Stomach; Treatment Outcome | 1997 |
[One-week treatment with omeprazole, clarithromycin and amoxicillin: high efficacy in the eradication of Helicobacter pylori and cicatrization of duodenal ulcer].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Multivariate Analysis; Omeprazole; Penicillins; Prospective Studies; Time Factors; Wound Healing | 1997 |
Evaluation of the dyspeptic patient: a cost-utility study.
Topics: Adult; Ambulatory Care; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Barium Sulfate; Clarithromycin; Contrast Media; Cost-Benefit Analysis; Decision Support Techniques; Dyspepsia; Endoscopy, Gastrointestinal; Evaluation Studies as Topic; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Peptic Ulcer; Probability; Quality of Life; Recurrence; Survival Rate; Treatment Outcome; Value of Life | 1997 |
Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study.
Topics: Amoxicillin; Antigens, Bacterial; Bacterial Proteins; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Time Factors | 1997 |
Serum 13C-bicarbonate assay for the diagnosis of gastric Helicobacter pylori infection and response to treatment.
Topics: Amoxicillin; Bicarbonates; Bismuth; Carbon Isotopes; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Spectrometry; Metronidazole; Middle Aged; Omeprazole; Sensitivity and Specificity; Tetracycline | 1997 |
[Toxic megacolon after Helicobacter pylori eradication therapy].
Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Colon; Diagnosis, Differential; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Helicobacter Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Megacolon, Toxic; Omeprazole; Penicillins; Peptic Ulcer | 1997 |
Successful low-dose amoxycillin, metronidazole and omeprazole combination therapy in a population with a high frequency of metronidazole-resistant Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins | 1997 |
Helicobacter pylori eradication using a 7-day regimen of low-dose clarithromycin, lansoprazole and amoxycillin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole | 1997 |
Regression of mucosa-associated lymphoid-tissue lymphoma of rectum after eradication of Helicobacter pylori.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Omeprazole; Penicillins; Proctoscopy; Rectal Neoplasms; Remission Induction | 1997 |
Pharmacological therapy of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Costs; Drug Resistance, Microbial; Drug Therapy, Combination; Guidelines as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Patient Compliance; Penicillins; Proton Pump Inhibitors; Tetracycline; Treatment Outcome; Vaccination | 1997 |
Unhealed duodenal ulcers despite Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Case-Control Studies; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Risk Factors; Tetracyclines; Time Factors; Treatment Outcome; Wound Healing | 1997 |
Duodenal stenosis may not regress after eradication of Helicobacter pylori.
Topics: Amoxicillin; Anti-Ulcer Agents; Constriction, Pathologic; Drug Therapy, Combination; Duodenal Ulcer; Duodenum; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Radiography; Recurrence | 1997 |
Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Biopsy; Clarithromycin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy; Female; Follow-Up Studies; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Neoplasm Recurrence, Local; Omeprazole; Precancerous Conditions; Stomach Neoplasms | 1997 |
Development of duodenal ulcer concomitant with successful Helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Peptic Ulcer; Recurrence; Retreatment; Sucralfate | 1997 |
Short-term eradication therapy for Helicobacter pylori does not reduce the incidence of gastric metaplasia in duodenal ulcer patients.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metaplasia; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Stomach | 1997 |
[Two step therapy for education of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors | 1997 |
Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Sequence; Amoxicillin; Anti-Ulcer Agents; Disease-Free Survival; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Molecular Sequence Data; Neoplasm, Residual; Omeprazole; Penicillins; Polymerase Chain Reaction; Remission Induction; Stomach Neoplasms; Survival Analysis; Treatment Outcome | 1997 |
Regression of mucosa-associated lymphoid-tissue lymphoma after eradication of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Omeprazole; Penicillins | 1997 |
Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Endoscopy; Endosonography; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Neoplasm Staging; Omeprazole; Penicillins; Predictive Value of Tests; Stomach Neoplasms; Time Factors | 1997 |
Clinical application of gastric histology to monitor treatment of dual therapy in H. pylori eradication.
Topics: Amoxicillin; Anti-Ulcer Agents; Biopsy; Colony Count, Microbial; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Penicillins; Predictive Value of Tests; Treatment Outcome | 1997 |
H. pylori eradication by LAC.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Food-Drug Interactions; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole | 1997 |
One-day high-dose combined therapy of Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Evaluation; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Time Factors | 1997 |
Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
Topics: Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastric Emptying; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Pepsinogens; Stomach; Stomach Ulcer | 1997 |
Duodenal ulcer healing after 7-day treatment: a pilot study with lansoprazole, amoxicillin, and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Pilot Projects; Tetracycline; Treatment Outcome | 1996 |
Treatment of Helicobacter pylori infection: summary of a meeting at the Fourth United European Gastroenterology Week, September 20, 1995.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enzyme Inhibitors; Europe; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tetracycline; Tinidazole | 1996 |
Cure of Helicobacter pylori: a hidden curse?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Duodenal Ulcer; Esophagitis, Peptic; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Risk Factors; Salicylates; Sex Factors; Weight Gain | 1997 |
Time of Helicobacter pylori eradication assessment following treatment.
Topics: Amoxicillin; Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Multicenter Studies as Topic; Omeprazole; Penicillins; Randomized Controlled Trials as Topic | 1997 |
Disappearance of multiple hyperplastic polyps after the eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hyperplasia; Lansoprazole; Middle Aged; Omeprazole; Stomach; Time Factors | 1997 |
Interaction of drugs for eradication therapy against antibiotic-resistant strains of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Drug Resistance, Microbial; Drug Synergism; Helicobacter Infections; Helicobacter pylori; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Penicillins | 1997 |
Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Biopsy; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Pyloric Antrum | 1998 |
[Gastric lymphoma--a case report].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Diterpenes; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Omeprazole; Penicillins; Stomach; Stomach Neoplasms | 1998 |
Regression of a primary gastric MALT lymphoma with extensive antrum lesions by Helicobacter pylori eradication.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Omeprazole; Penicillins; Polymerase Chain Reaction; Pyloric Antrum; Stomach Neoplasms; Stomach Ulcer | 1997 |
Enhancement of neutrophil infiltration in the corpus after failure of Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Drug Therapy, Combination; Duodenal Ulcer; Famotidine; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-8; Lansoprazole; Male; Middle Aged; Neutrophils; Omeprazole; Peroxidase; Proton Pump Inhibitors; Stomach Ulcer | 1997 |
[Reflux disease of the gastrointestinal tract. Acute therapy and long-term care in daily practice. 2. Therapeutic procedure--diagnosis--therapy-diagram].
Topics: Amoxicillin; Clarithromycin; Dose-Response Relationship, Drug; Gastroesophageal Reflux; Helicobacter pylori; Humans; Long-Term Care; Omeprazole | 1997 |
Prolonged and profound acid inhibition is crucial in Helicobacter pylori treatment with a proton pump inhibitor combined with amoxicillin.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Penicillins; Proton Pumps; Sex Factors; Treatment Outcome | 1998 |
[Efficacy of the triple therapy in the eradication of H. pylori in peptic ulcer].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Peptic Ulcer; Stomach Ulcer; Time Factors; Tinidazole | 1997 |
Evaluation of combined antibiotic-omeprazole therapies in Helicobacter pylori-infected Mongolian gerbils.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Clarithromycin; DNA Primers; Drug Therapy, Combination; Enzyme Inhibitors; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Male; Omeprazole; Penicillins; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Stomach Ulcer | 1998 |
Cure of Helicobacter pylori infection by omeprazole-clarithromycin-based therapy in non-human primates.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Gastritis; Helicobacter Infections; Helicobacter pylori; Macaca mulatta; Male; Omeprazole; Organometallic Compounds; Penicillins; Salicylates | 1998 |
Does Helicobacter pylori infection affect gastric emptying in patients with functional dyspepsia?
Topics: Adolescent; Adult; Amoxicillin; Anti-Ulcer Agents; Chronic Disease; Dyspepsia; Female; Gastric Emptying; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Reference Values | 1997 |
[Short-term triple therapy with pantoprazole, amoxicillin and metronidazole in Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Prospective Studies; Stomach Ulcer; Sulfoxides; Treatment Outcome | 1998 |
Assessment of a new triple agent regimen for the eradication of Helicobacter pylori and the nature of H. pylori resistance to this therapy in Japan.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Campylobacter Infections; Clarithromycin; Drug Resistance, Multiple; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter pylori; Humans; Japan; Male; Middle Aged; Omeprazole; Stomach Ulcer | 1998 |
[Seven-day omeprazole, clarithromycin, and amoxicillin for the therapy of Helicobacter pylori infection].
Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Combined Modality Therapy; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole | 1998 |
[Helicobacter pylori infection and recurrent abdominal pain in children. A proved relationship?].
Topics: Abdominal Pain; Adolescent; Adult; Age Factors; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Child; Chronic Disease; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Recurrence; Risk Factors; Stomach Ulcer | 1998 |
Effect of Helicobacter pylori infection on gastric juice pH.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ammonia; Amoxicillin; Anti-Ulcer Agents; Case-Control Studies; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Acid; Gastric Juice; Gastric Mucosa; Gastrins; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Stomach Ulcer | 1998 |
[Sensitivity of Helicobacter pylori to amoxicillin and clarythromycin with special reference to eradication therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Penicillin Resistance; Penicillins; Peptic Ulcer | 1998 |
Effect of metronidazole resistance on bacterial eradication of Helicobacter pylori in infected children.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Child; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Omeprazole; Prospective Studies; Spiramycin | 1998 |
Analysis of risk factors for chronic hepatic encephalopathy: the role of Helicobacter pylori infection.
Topics: Ammonia; Amoxicillin; Anti-Ulcer Agents; Ascites; Chronic Disease; Diuretics; Helicobacter Infections; Helicobacter pylori; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Risk Factors; Stomach Diseases | 1998 |
Weekend therapy for the treatment of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Tinidazole | 1998 |
Effectiveness of omeprazole-amoxicillin-clarithromycin (OAC) therapy for Helicobacter pylori infection in a Japanese population.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Humans; Japan; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Proton Pump Inhibitors; Time Factors | 1998 |
[Polyneuropathy caused by vitamin B12 deficiency secondary to chronic atrophic gastritis and giardiasis].
Topics: Amoxicillin; Anemia, Pernicious; Anti-Bacterial Agents; Antiprotozoal Agents; Bismuth; Duodenitis; Enzyme Inhibitors; Evoked Potentials, Somatosensory; Female; Gastritis, Atrophic; Giardiasis; Helicobacter Infections; Helicobacter pylori; Humans; Hydroxocobalamin; Malabsorption Syndromes; Metronidazole; Middle Aged; Neural Conduction; Omeprazole; Peripheral Nervous System Diseases; Remission Induction; Vitamin B 12 Deficiency | 1998 |
Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Breath Tests; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Predictive Value of Tests; Treatment Outcome | 1998 |
[Is dental plaque a normal Helicobacter pylori reservoir?].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Benzimidazoles; Clarithromycin; Dental Plaque; Disease Reservoirs; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Prevalence; Recurrence; Sulfoxides | 1998 |
Schönlein-Henoch purpura in association with duodenal ulcer and gastric Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; IgA Vasculitis; Male; Middle Aged; Omeprazole; Penicillins; Stomach Diseases | 1998 |
Analysis of the 13C-urea breath test for detection of Helicobacter pylori infection based on the kinetics of delta-13CO2 using laser spectroscopy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Predictive Value of Tests; Proton Pump Inhibitors; Sensitivity and Specificity; Spectrum Analysis; Urea | 1998 |
[An unusual course of low-malignancy non-Hodgkin lymphoma of the stomach].
Topics: Amoxicillin; Biopsy; Combined Modality Therapy; Female; Follow-Up Studies; Gastrectomy; Helicobacter Infections; Humans; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Multiple Primary; Nose Neoplasms; Omeprazole; Stomach Neoplasms | 1998 |
Cure of autoimmune gastritis by Helicobacter pylori eradication in a 21-year-old male.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Follow-Up Studies; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Pantoprazole; Sulfoxides; Treatment Outcome | 1998 |
[Efficacy of an ultrashort protocol in the eradication of Helicobacter pylori].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Stomach Ulcer | 1998 |
Helicobacter pylori eradication failure--'salvage' therapies needed.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Treatment Failure | 1998 |
Pre-treatment with misoprostol increases the efficacy of omeprazole plus amoxycillin to cure Helicobacter pylori infection. A pilot study.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Misoprostol; Omeprazole; Penicillins; Pilot Projects | 1998 |
Treating Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Combinations; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Ranitidine | 1998 |
Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Liver; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Penicillins; Peptic Ulcer; Phenotype; Prospective Studies | 1998 |
Relationship between the eradication of Helicobacter pylori and the healing pattern of peptic ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Recurrence; Stomach Ulcer; Treatment Outcome; Wound Healing | 1998 |
Gastric urease activity is inversely associated with the success of treatment for Helicobacter pylori: effect of sofalcone.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Breath Tests; Carbon Isotopes; Chalcone; Chalcones; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Stomach Ulcer; Treatment Outcome; Urea; Urease | 1998 |
[Eradication of Helicobacter pylori by triple therapy in ulcerous patients: the role of endoscopy and antibiotic sensitivity].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastrointestinal Agents; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer | 1998 |
[Triple treatment for the eradication of Helicobacter pylori infection].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins; Recurrence; Time Factors | 1998 |
Optimal treatment for duodenal ulcer disease: a cost-decision analysis in Malaysian patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Cost-Benefit Analysis; Decision Support Techniques; Drug Therapy, Combination; Duodenal Ulcer; Humans; Malaysia; Metronidazole; Models, Economic; Omeprazole; Tetracycline | 1999 |
Treatment of Helicobacter heilmannii-associated gastritis in a 14-year-old boy.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Gastritis; Granulocytes; Helicobacter; Helicobacter Infections; Humans; Male; Omeprazole; Penicillins | 1999 |
[Gastric MALT lymphoma, clinical features].
Topics: Amoxicillin; Anti-Ulcer Agents; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Omeprazole; Penicillins; Severity of Illness Index; Stomach Neoplasms | 1999 |
Decision analysis of Helicobacter pylori eradication therapy using omeprazole with either clarithromycin or amoxicillin.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Costs and Cost Analysis; Decision Support Techniques; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Models, Economic; Omeprazole | 1996 |
Resolution of thrombocytopenia after treatment for Helicobacter pylori: a case report.
Topics: Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; B-Lymphocytes; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Purpura, Thrombocytopenic, Idiopathic; Ranitidine; Splenectomy; Stomach Ulcer | 1999 |
The effect of antibiotic resistance on the outcome of three 1-week triple therapies against Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Sulfoxides | 1999 |
Helicobacter heilmannii associated erosive gastritis.
Topics: Abietanes; Aged; Amoxicillin; Anti-Ulcer Agents; Diterpenes; Drug Therapy, Combination; Endoscopy, Digestive System; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter; Helicobacter Infections; Humans; Male; Omeprazole; Penicillins; Pepsin A; Stomach Ulcer | 1999 |
Helicobacter pylori infection and persistent hyperemesis gravidarum.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Hyperemesis Gravidarum; Omeprazole; Penicillins; Peptic Ulcer; Pregnancy; Pregnancy Complications, Infectious; Proton Pump Inhibitors; Ranitidine | 1999 |
A new quadruple therapy for Helicobacter pylori: influence of resistant strains on treatment outcome.
Topics: Adult; Aged; Amoxicillin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Roxithromycin | 1999 |
Impact of clarithromycin resistance on the effectiveness of a regimen for Helicobacter pylori: a prospective study of 1-week lansoprazole, amoxycillin and clarithromycin in active peptic ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies | 1999 |
Treatment of Helicobacter pylori infection in functional dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Prospective Studies; Randomized Controlled Trials as Topic; Reproducibility of Results | 1999 |
[Are 5 days of omeprazole plus 2 antibiotics enough for eradication of H. pylori? Comments on sample size].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Confidence Intervals; Data Interpretation, Statistical; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Sample Size; Time Factors | 1999 |
A second-line anti-Helicobacter pylori therapy in patients with previously failed treatment.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Retreatment; Treatment Failure | 1999 |
Functional dyspepsia has a good prognosis irrespective of H. pylori status. Long-term follow-up of symptoms after anti H. pylori treatment.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prognosis; Prospective Studies | 1999 |
[Symptomatic improvement of patients with nonulcer dyspepsia after Helicobacter pylori eradication].
Topics: Amoxicillin; Anti-Ulcer Agents; Breath Tests; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Tetracycline; Treatment Outcome | 1999 |
Omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins; Treatment Outcome | 1999 |
Is there any difference in Helicobacter pylori eradication rates in patients with active peptic ulcer, inactive peptic ulcer and functional dyspepsia?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Remission, Spontaneous; Treatment Outcome | 1999 |
[A ration proposal for the eradicating treatment of Helicobacter pylori infection].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Combined Modality Therapy; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole | 1999 |
Ménétrier's disease and Helicobacter pylori: normalization of gastrointestinal protein loss after eradication therapy.
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis, Hypertrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Protein-Losing Enteropathies | 1999 |
CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Bismuth; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Enzyme Inhibitors; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Mixed Function Oxygenases; Omeprazole; Penicillins; Peptic Ulcer; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Protein Synthesis Inhibitors; Treatment Outcome | 1999 |
Duodenal ulcer relapse is not always associated with recurrence of H. pylori infection: a prospective three-year follow-up study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Recurrence | 1999 |
Proliferating cell nuclear antigen (PCNA) immunostaining in Helicobacter pylori infection: impact of eradication.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Biomarkers, Tumor; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Male; Middle Aged; Omeprazole; Penicillins; Proliferating Cell Nuclear Antigen; Risk Factors; Stomach Neoplasms | 1999 |
Sufficient effect of 1-week omeprazole and amoxicillin dual treatment for Helicobacter pylori eradication in cytochrome P450 2C19 poor metabolizers.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Asian People; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; DNA Primers; Drug Administration Schedule; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Sucralfate; Time Factors; Treatment Outcome | 1999 |
Relapse of duodenal ulcers after successful eradication of Helicobacter pylori in gastric ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Recurrence; Stomach Ulcer | 1999 |
Endoscopic and histological reversibility of gastric adenoma after eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Precancerous Conditions; Stomach Neoplasms | 1999 |
[Resolution of an autoimmune thrombocytopenic purpura after eradicating treatment of Helicobacter pylori].
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; Bismuth; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; L-Lactate Dehydrogenase; Metronidazole; Omeprazole; Organometallic Compounds; Purpura, Thrombocytopenic, Idiopathic; Salicylates; Tetracycline | 1999 |
Regression of high-grade gastric mucosa-associated lymphoid tissue lymphoma with Helicobacter pylori after triple antibiotic therapy.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Omeprazole; Penicillins; Stomach Neoplasms | 2000 |
[Eradication of Helicobacter pylori: what is the effect on symptoms of non-ulcerous dyspepsia?].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dyspepsia; Female; Helicobacter pylori; Humans; Male; Omeprazole; Prevalence | 1999 |
Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Proton Pump Inhibitors | 2000 |
The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Chile; Developing Countries; Drug Therapy, Combination; Duodenal Ulcer; Famotidine; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Recurrence; Tinidazole | 2000 |
Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer | 2000 |
Prevention of hemorrhage from intradiverticular ulcer in the duodenum by Helicobacter pylori eradication.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diverticulum; Drug Therapy, Combination; Duodenal Diseases; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Peptic Ulcer Hemorrhage | 2000 |
Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole, amoxicillin, and clarithromycin.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Risk Factors; Treatment Outcome | 2000 |
[Does eliminating Helicobacter pylori mean the healing of the duodenal ulcer? The results of a prospective study in Spain].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Prognosis; Prospective Studies; Remission Induction; Spain | 2000 |
Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Metronidazole; Middle Aged; Omeprazole; Reverse Transcriptase Polymerase Chain Reaction; Stomach; Stomach Neoplasms | 2000 |
[Analysis of indications and diagnosis of the gastroscopies requested by primary care physicians].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Duodenal Ulcer; Esophagitis; Female; Gastroscopy; Heartburn; Helicobacter Infections; Helicobacter pylori; Hernia, Diaphragmatic; Humans; Male; Omeprazole; Penicillins; Primary Health Care; Retrospective Studies; Stomach Ulcer | 2000 |
[Usefulness of Helicobacter pylori antigen detection in stools in the diagnosis of infection and confirming eradication after treatment].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Antigens, Bacterial; Clarithromycin; Data Interpretation, Statistical; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Middle Aged; Omeprazole; Penicillins; Sensitivity and Specificity | 2000 |
Influence of age on the steady state disposition of drugs commonly used for the eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Creatinine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Kidney; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Ranitidine | 2000 |
Histopathological features of gastritis before and after treatment for Helicobacter pylori.
Topics: Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Penicillins | 2000 |
Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer Hemorrhage; Stomach Ulcer; Treatment Outcome | 2000 |
OAM for cure of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Costs; Drug Therapy, Combination; Helicobacter Infections; Humans; Metronidazole; Omeprazole; Penicillins | 2000 |
[The role of omeprazole in the eradication of Helicobacter pylori in patients with duodenal ulcers].
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins | 2000 |
[Helicobacter pylori eradication in gastroduodenal ulcer: good, fine and not expensive].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Primary Health Care; Tetracycline | 2000 |
Helicobacter acinonychis eradication leading to the resolution of gastric lesions in tigers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Carnivora; Clarithromycin; DNA, Bacterial; Drug Therapy, Combination; Endoscopy; Female; Helicobacter; Helicobacter Infections; Lansoprazole; Male; Omeprazole; Penicillins; Polymerase Chain Reaction; Stomach; Stomach Ulcer | 2000 |
Treatment of Helicobacter pylori infection: is less more?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Sulfoxides; Time Factors | 2000 |
[Effects of Helicobacter pylori eradication on the recurrence of gastric ulcer during a 12-month follow up].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Recurrence; Stomach Ulcer; Time Factors | 2000 |
Two enzyme immunoassays and PCR for detection of Helicobacter pylori in stool specimens from pediatric patients before and after eradication therapy.
Topics: Adolescent; Amoxicillin; Antibodies, Bacterial; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Feces; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Immunoenzyme Techniques; Immunoglobulin G; Omeprazole; Polymerase Chain Reaction; Time Factors; Urea | 2000 |
Efficacy of a 1-week pantoprazole triple therapy in eradicating Helicobacter pylori in Asian patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Malaysia; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Sulfoxides; Treatment Outcome | 2000 |
Rifabutin-based triple therapy after failure of Helicobacter pylori eradication treatment: preliminary experience.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Pilot Projects; Rifabutin; Treatment Failure | 2000 |
Helicobacter pylori infection in recurrent abdominal pain.
Topics: Abdominal Pain; Adolescent; Amoxicillin; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Recurrence; Retrospective Studies; Stomach; Switzerland | 2000 |
CagA seropositivity and the severity of Helicobacter pylori infection in dyspeptic children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Bacterial Proteins; Child; Child, Preschool; Clarithromycin; Data Interpretation, Statistical; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunoenzyme Techniques; Immunoglobulin G; Male; Omeprazole; Penicillins | 2000 |
Endoscopic characteristics of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; B-Lymphocytes; Base Sequence; Biopsy; Clone Cells; Data Interpretation, Statistical; DNA, Complementary; DNA, Neoplasm; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Molecular Sequence Data; Omeprazole; Penicillins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Time Factors | 2000 |
Efficacy of omeprazole plus two antimicrobials for the eradication of Helicobacter pylori in a Turkish population.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins; Proton Pump Inhibitors | 2000 |
Helicobacter pylori infection in renal transplant recipients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Immunosuppressive Agents; Kidney Transplantation; Lansoprazole; Male; Middle Aged; Omeprazole; Postoperative Complications; Proton Pump Inhibitors; Time Factors | 2000 |
Helicobacter pylori, a frequent and potentially dangerous guest in the gastroduodenal mucosa of anticoagulated patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Aged; Amoxicillin; Anti-Ulcer Agents; Anticoagulants; Benzimidazoles; Cardiovascular Diseases; Duodenum; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; International Normalized Ratio; Intestinal Mucosa; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Prospective Studies; Sulfoxides | 2000 |
Effect of amoxicillin, clarithromycin, and rabeprazole, a new proton pump inhibitor, in eradication therapy for relapsing peptic ulcer diseases with Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Recurrence | 2000 |
[High eradication rates in Helicobacter pylori infection in patients with duodenal ulcer who failed previous eradication therapy].
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Treatment Failure | 2000 |
Lactobacillus acidophilus administration added to omeprazole/amoxycillin-based double therapy in Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Defensins; Drug Therapy, Combination; Gastrointestinal Agents; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus acidophilus; Omeprazole; Penicillins | 2000 |
The use of AP-PCR and flaA-RFLP typing to investigate treatment failure in Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; Drug Therapy, Combination; Flagellin; Genotype; Helicobacter Infections; Helicobacter pylori; Metronidazole; Omeprazole; Penicillins; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Recurrence; Treatment Failure; Virulence | 2000 |
Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Omeprazole; Penicillins; Prospective Studies; Remission Induction; Stomach Neoplasms | 2001 |
Antibiotic-resistance patterns of Helicobacter pylori in Croatia: cohort study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Benzimidazoles; Cohort Studies; Croatia; Drug Resistance; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Risk Factors; Sulfoxides | 2001 |
Effect of the treatment of Helicobacter pylori infection on gastric emptying and its influence on the glycaemic control in type 1 diabetes mellitus.
Topics: Adult; Aged; Amoxicillin; Antibodies, Bacterial; Blood Glucose; Clarithromycin; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Drug Therapy, Combination; Female; Gastric Emptying; Gastritis; Glycated Hemoglobin; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Middle Aged; Neurologic Examination; Omeprazole | 2001 |
Early stage gastric MALT lymphoma with high-grade component cured by Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Omeprazole; Proton Pump Inhibitors; Remission Induction; Stomach Neoplasms | 2001 |
A case of gastric plasmacytoma associated with Helicobacter pylori infection: improvement of abnormal endoscopic and EUS findings after H. pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Biopsy, Needle; Clarithromycin; Drug Therapy, Combination; Endosonography; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Plasmacytoma; Stomach Neoplasms; Treatment Outcome | 2001 |
[Prevalence and treatment of Helicobacter pylori in gastro-duodenal ulcers. An experience in Liege].
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Belgium; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prevalence; Prospective Studies; Treatment Outcome; Urban Population | 2001 |
Recurrence of Helicobacter pylori infection and duodenal ulcer relapse, following successful eradication in an urban east Asian population.
Topics: Adolescent; Adult; Age Distribution; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Hospitalization; Humans; Middle Aged; Omeprazole; Penicillins; Population Surveillance; Recurrence; Singapore; Time Factors; Urban Health | 2000 |
Effects of lansoprazole, clarithromycin and pH gradient on uptake of [14C]amoxycillin into rat gastric tissue.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Ulcer Agents; Biological Transport; Clarithromycin; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Duodenum; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Hydrogen-Ion Concentration; Lansoprazole; Male; Omeprazole; Penicillins; Peptic Ulcer; Rats; Rats, Wistar | 2001 |
Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Cell Transformation, Neoplastic; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Omeprazole; Penicillins; Remission Induction; Retrospective Studies; Stomach Neoplasms | 2001 |
Peptic ulcer occurrence in follow-up of chronic gastritis in patients with treated and not eradicated CagA-positive Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Chronic Disease; Esophagitis, Peptic; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Treatment Outcome | 2001 |
Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; DNA, Bacterial; Drug Resistance; Drug Therapy, Combination; Enzyme Inhibitors; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Polymerase Chain Reaction; Proton Pump Inhibitors | 2001 |
Eradication of Helicobacter pylori from the stomach and duodenum of patients with duodenal ulcers.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Duodenal Ulcer; Duodenum; Enzyme-Linked Immunosorbent Assay; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Stomach | 2001 |
Helicobacter pylori eradication therapy for high-grade mucosa-associated lymphoid tissue lymphomas of the stomach with analysis of p53 and K-ras alteration and microsatellite instability.
Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Female; Follow-Up Studies; Genetic Markers; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Microsatellite Repeats; Middle Aged; Omeprazole; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single-Stranded Conformational; Proto-Oncogene Proteins p21(ras); Stomach Neoplasms; Time Factors; Tumor Suppressor Protein p53 | 2001 |
4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease--A pilot study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Pilot Projects; Rabeprazole | 2001 |
Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Recurrence; Retrospective Studies; Treatment Failure | 2001 |
Regression of primary lymphoma of the ampulla of Vater after eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Ampulla of Vater; Biopsy; Clarithromycin; Common Bile Duct Neoplasms; Drug Therapy, Combination; Duodenal Neoplasms; Endosonography; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Lansoprazole; Lymphoma, Follicular; Male; Middle Aged; Omeprazole | 2001 |
A prospective study of a one-week nonbismuth quadruple therapy for childhood Helicobacter pylori infection.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins; Prospective Studies; Stomach Diseases | 2001 |
Effects of genotypic differences in CYP2C19 status on cure rates for Helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Alleles; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Heterozygote; Homozygote; Humans; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Penicillins; Polymorphism, Restriction Fragment Length; Proton Pump Inhibitors; Rabeprazole | 2001 |
CYP2C19 genotype related effect of omeprazole on intragastric pH and antimicrobial stability.
Topics: Amoxicillin; Anti-Ulcer Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Combinations; Drug Stability; Gastric Acidity Determination; Genotype; Helicobacter pylori; Hydrogen-Ion Concentration; Metronidazole; Mixed Function Oxygenases; Omeprazole; Reverse Transcriptase Polymerase Chain Reaction | 2001 |
The effectiveness of one-week triple eradication therapy for perforated duodenal ulcer patients treated with simple closure.
Topics: Adult; Amoxicillin; Clarithromycin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Peptic Ulcer Perforation; Postoperative Care; Recurrence; Treatment Outcome | 2001 |
Pseudomembranous colitis without diarrhoea following Helicobacter pylori eradication therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diarrhea; Enterocolitis, Pseudomembranous; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Occult Blood; Omeprazole; Penicillins | 2001 |
The relationship between gastric-oral Helicobacter pylori and oral hygiene in patients with vitamin B12-deficiency anemia.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anemia, Pernicious; Anti-Bacterial Agents; Anti-Ulcer Agents; Campylobacter; Chi-Square Distribution; Clarithromycin; Dental Calculus; Dental Plaque; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Oral Hygiene; Oral Hygiene Index; Penicillins; Recurrence; Statistics as Topic; Stomach Diseases; Vitamin B 12; Vitamin B 12 Deficiency | 2001 |
Short-term changes in Helicobacter pylori gastritis and bulbitis during and after 2 weeks of treatment with omeprazole and amoxicillin in duodenal ulcer patients.
Topics: Adult; Aged; Amoxicillin; Biopsy; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Endoscopy, Digestive System; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Male; Middle Aged; Omeprazole; Recurrence; Treatment Outcome | 2001 |
Gastric leptin and Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Biomarkers; Biopsy; Body Mass Index; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Leptin; Male; Middle Aged; Omeprazole; Reverse Transcriptase Polymerase Chain Reaction; Statistics, Nonparametric; Stomach Neoplasms | 2001 |
Resolution of Ménétrier's disease after Helicobacter pylori eradicating therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Gastritis, Hypertrophic; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 2001 |
Disappearance of both MALT lymphoma and hyperplastic polyps in the stomach after eradication of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hyperplasia; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Omeprazole; Penicillins; Polyps; Remission Induction; Stomach; Stomach Neoplasms | 2001 |
Noninvasive Helicobacter pylori testing for the "test-and-treat" strategy: a decision analysis to assess the effect of past infection on test choice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antibodies, Bacterial; Antigens, Bacterial; Breath Tests; Clarithromycin; Cohort Studies; Costs and Cost Analysis; Decision Support Techniques; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Predictive Value of Tests; Recurrence; Unnecessary Procedures | 2001 |
Remission of a high-grade gastric mucosa associated lymphoid tissue (MALT) lymphoma following Helicobacter pylori eradication and highly active antiretroviral therapy in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; HIV-1; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Omeprazole; Remission Induction; Stomach Neoplasms; Tinidazole | 2001 |
Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bangladesh; Body Mass Index; Breath Tests; Carbon Isotopes; Developing Countries; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Patient Compliance; Peptic Ulcer; Ranitidine; Recurrence; Tinidazole; Urea | 2001 |
Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Biopsy; Clarithromycin; DNA, Bacterial; Drug Resistance; Drug Resistance, Multiple; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Gastric Fundus; Gastric Mucosa; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Pyloric Antrum; Retrospective Studies; Stomach Neoplasms; Treatment Outcome | 2001 |
Evaluation of the cost-effectiveness of Helicobacter pylori eradication triple therapy vs. conventional therapy for ulcers in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Duodenal Ulcer; Health Care Costs; Helicobacter Infections; Humans; Lansoprazole; Markov Chains; Omeprazole; Penicillins; Stomach Ulcer; Treatment Outcome | 2001 |
The role of treatment with proton pump inhibitors and anti-Helicobacter therapy in functional dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors | 2001 |
Effects of lansoprazole and amoxicillin on uptake of [(14)C]clarithromycin into gastric tissue in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Interactions; Duodenum; Gastric Mucosa; Gastrointestinal Contents; In Vitro Techniques; Injections, Intravenous; Lansoprazole; Male; Omeprazole; Penicillins; Rats; Rats, Wistar; Stomach; Tissue Distribution | 2001 |
Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Neoplasm Staging; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Stomach Neoplasms; Treatment Outcome | 2001 |
Clarithromycin resistance, but not CYP2C-19 polymorphism, has a major impact on treatment success in 7-day treatment regimen for cure of H. pylori infection: a multiple logistic regression analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Penicillins; Peptic Ulcer; Polymorphism, Genetic; Prospective Studies; Proton Pump Inhibitors; Time Factors; Treatment Outcome | 2001 |
Duodenal mucosa-associated lymphoid tissue lymphoma treated by eradication of Helicobacter pylori: report of 2 cases including EUS findings.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Benzimidazoles; Biopsy, Needle; Clarithromycin; Drug Therapy, Combination; Duodenal Neoplasms; Duodenoscopy; Endosonography; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Middle Aged; Omeprazole; Rabeprazole; Treatment Outcome | 2001 |
Localization of [14C]amoxicillin in rat gastric tissue when administered with lansoprazole and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Carbon Radioisotopes; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Lansoprazole; Male; Omeprazole; Penicillins; Rats; Rats, Wistar | 2001 |
Fine-needle aspiration biopsy of an intra-abdominal inflammatory mass secondary to a penetrating duodenal ulcer mimicking neoplasm.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Biopsy, Needle; Clarithromycin; Diagnosis, Differential; Duodenal Ulcer; Duodenitis; Duodenum; Endoscopy, Digestive System; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pancreatic Neoplasms; Tomography, X-Ray Computed | 2001 |
The influence of commonly prescribed synthetic drugs for peptic ulcer on the pharmacokinetic fate of glycyrrhizin from Shaoyao-Gancao-tang.
Topics: Amoxicillin; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Area Under Curve; Butylscopolammonium Bromide; Chromatography, High Pressure Liquid; Cimetidine; Drug Combinations; Drug Therapy, Combination; Drugs, Chinese Herbal; Feces; Glycyrrhiza; Glycyrrhizic Acid; Hydrolysis; Male; Metronidazole; Muscarinic Antagonists; Omeprazole; Paeonia; Peptic Ulcer; Phytotherapy; Rats; Rats, Wistar | 2001 |
Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies | 2002 |
Regression of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: possible association with p16 hypermethylation.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; DNA Methylation; Drug Therapy, Combination; Female; Gene Expression; Genes, p16; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Omeprazole; Polymerase Chain Reaction; Prospective Studies; Remission Induction; Stomach Neoplasms; Treatment Outcome | 2002 |
[Successful treatment of refractory idiopathic thrombocytopenic purpura by eradication of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Middle Aged; Omeprazole; Penicillins; Purpura, Thrombocytopenic, Idiopathic | 2001 |
Second-line Helicobacter pylori eradication with a furazolidone-based regimen in patients who have failed a metronidazole-based regimen.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Drug Therapy, Combination; Enzyme Inhibitors; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Medical Records; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Retrospective Studies; Tetracycline; Treatment Failure; Treatment Outcome | 2001 |
Does Helicobacter pylori eradication reduce the long-term requirements for acid suppressants in patients with a history of peptic ulcer disease in general practice? Results from a four-year longitudinal study.
Topics: Amoxicillin; Antacids; Clarithromycin; Drug Therapy, Combination; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Longitudinal Studies; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors | 2002 |
Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Platelet Count; Purpura, Thrombocytopenic, Idiopathic | 2001 |
The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Drug Combinations; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Serologic Tests | 2002 |
[Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Data Interpretation, Statistical; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Lansoprazole; Male; Metronidazole; Omeprazole; Penicillin Resistance; Penicillins; Retrospective Studies | 2002 |
Evaluation of the Helicobacter pylori stool antigen test for monitoring eradication therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Antigens; Clarithromycin; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Prospective Studies; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2002 |
[Gastroduodenal ulcer in childhood].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Informed Consent; Japan; Lansoprazole; Male; Omeprazole; Peptic Ulcer; Practice Guidelines as Topic; Treatment Failure | 2002 |
Failure of Helicobacter pylori eradication: is poor compliance the main cause?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Peptic Ulcer; Treatment Failure | 2002 |
[Management of dyspepsia, gastroduodenal ulcer and Helicobacter pylori infection in primary care].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Endoscopy; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Peptic Ulcer; Primary Health Care; Surveys and Questionnaires | 2002 |
Detection of Helicobacter pylori colonization in dental plaques and tongue scrapings of patients with chronic gastritis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Chronic Disease; Clarithromycin; Coloring Agents; Dental Plaque; Drug Therapy, Combination; Female; Fluorescent Dyes; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Pyloric Antrum; Tongue | 2001 |
[Eradication of helicobacter pylori: symptomatic treatment of reflux disease?].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Esophagitis, Peptic; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Randomized Controlled Trials as Topic | 2002 |
Improvement of long-standing iron-deficiency anemia in adults after eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Hematologic Tests; Humans; Lansoprazole; Omeprazole; Penicillins; Treatment Outcome | 2002 |
Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Blood Platelets; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunosuppressive Agents; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Platelet Count; Purpura, Thrombocytopenic, Idiopathic | 2002 |
[Antibiotic resistance of Helicobacter pylori in Reunion Island: therapeutic consequences].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chi-Square Distribution; Ciprofloxacin; Clarithromycin; Confidence Intervals; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Random Amplified Polymorphic DNA Technique; Reunion; Stomach Ulcer; Tetracycline; Treatment Failure | 2002 |
Localization of [14C]clarithromycin in rat gastric tissue when administered with lansoprazole and amoxicillin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Amoxicillin; Animals; Carbon Radioisotopes; Clarithromycin; Drug Interactions; Gastric Mucosa; Injections, Intravenous; Intestinal Mucosa; Intubation, Gastrointestinal; Lansoprazole; Male; Omeprazole; Rats; Rats, Wistar; Stomach | 2002 |
Normalization of phospholipids concentration of the gastric mucosa was observed in patients with peptic ulcer after eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Phospholipids; Stomach Ulcer; Treatment Outcome | 2002 |
Chronic urticaria induced by eradication therapy of Helicobacter pylori: a case report.
Topics: Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Urticaria | 2002 |
Efficacy of a 1-week course of proton-pump inhibitor-based triple therapy for eradicating Helicobacter pylori in patients with and without chronic renal failure.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Famotidine; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Failure, Chronic; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2002 |
Effects of clarithromycin and amoxicillin on gastric emptying in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Infective Agents; Carbon Radioisotopes; Clarithromycin; Drug Therapy, Combination; Duodenum; Gastric Emptying; Gastric Mucosa; Lansoprazole; Male; Omeprazole; Rats; Rats, Wistar | 2002 |
Regression of CD5-positive and Helicobacter pylori-negative mucosa-associated lymphoid tissue lymphoma of the rectum after administration of antibiotics: report of a case.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; CD5 Antigens; Clarithromycin; Colonoscopy; Drug Therapy, Combination; Female; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Omeprazole; Penicillins; Rectal Neoplasms | 2002 |
[Seven-day antihelicobacter therapy of duodenal ulcer associated with Helicobacter pylori and prospects for treating patients].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Rabeprazole; Stomach Ulcer | 2002 |
Quantification of Helicobacter pylori resistance in functional and organic dyspepsia.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Cohort Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins | 2002 |
Sequential eradicating therapy: a treatment that does not discriminate Helicobacter pylori strains in patients with nonulcer dyspepsia?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Peptic Ulcer; Rabeprazole; Tinidazole | 2002 |
Thrombocytopenic purpura: an unusual complication of eradication therapy for Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Methylprednisolone; Middle Aged; Omeprazole; Penicillins; Platelet Count; Purpura, Thrombocytopenic | 2002 |
Effect of Helicobacter pylori infection on fibrinogen level in elderly patients with ischaemic heart disease.
Topics: Aged; Aged, 80 and over; Amoxicillin; Biomarkers; Breath Tests; Enzyme Inhibitors; Fibrinogen; Helicobacter Infections; Helicobacter pylori; Humans; Myocardial Ischemia; Omeprazole; Penicillins; Treatment Outcome | 2002 |
[Long-term curative effects of suture plus proximal gastric vagotomy or triad-therapy for duodenal ulcer with acute perforation].
Topics: Acute Disease; Adolescent; Adult; Aged; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer Perforation; Suture Techniques; Vagotomy, Proximal Gastric | 2002 |
A new serum antibody test kit (E plate) for evaluation of Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunologic Tests; Male; Middle Aged; Omeprazole; Pepsinogen A; Peptic Ulcer; Rabeprazole; Reagent Kits, Diagnostic; ROC Curve; Sensitivity and Specificity | 2002 |
[Microbiological factors that influence the eradication of Helicobacter pylori in adults and children].
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Child; Child, Preschool; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Virulence | 2002 |
Anti-Helicobacter pylori therapy in India: differences in eradication efficiency associated with particular alleles of vacuolating cytotoxin (vacA) gene.
Topics: Adult; Alleles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; Cytotoxins; DNA, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Female; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; India; Male; Omeprazole | 2003 |
[Patient with increased stomach cancer risk. Helicobacter can cause damage here].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Precancerous Conditions; Risk Factors; Stomach Neoplasms; Stomach Ulcer; Sulfoxides | 2002 |
Severe colchicine-macrolide interactions.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Colchicine; Cytochrome P-450 Enzyme System; Drug Interactions; Glycoproteins; Humans; Josamycin; Male; Omeprazole | 2003 |
Helicobacter pylori hiccup.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Esophagitis; Gastritis; Helicobacter Infections; Helicobacter pylori; Hiccup; Humans; Male; Omeprazole; Treatment Outcome | 2003 |
Long-term follow-up of gastric metaplasia after eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Cicatrix; Convalescence; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Follow-Up Studies; Gastric Acid; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Metaplasia; Metronidazole; Middle Aged; Mucus; Omeprazole; Severity of Illness Index | 2003 |
Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Cyclooxygenase 2; Drug Therapy, Combination; Female; Gastric Mucosa; Gastrins; Gastritis, Atrophic; Gene Expression; Helicobacter Infections; Helicobacter pylori; Humans; Isoenzymes; Male; Membrane Proteins; Middle Aged; Omeprazole; Ornithine Decarboxylase; Peroxidases; Prostaglandin-Endoperoxide Synthases; RNA, Messenger | 2003 |
[The state of immune system and effects of current therapy and immunomodulators].
Topics: Adjuvants, Immunologic; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter pylori; Humans; Immunity; Omeprazole; Organometallic Compounds; Tinidazole; Treatment Outcome | 2003 |
Utility and limitations of a method for detecting Helicobacter pylori-specific antigens in the stool.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Antigens, Bacterial; Breath Tests; Drug Therapy, Combination; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Sensitivity and Specificity | 2003 |
Triple eradication therapy counteracts functional impairment associated with Helicobacter pylori infection in Mongolian gerbils.
Topics: Amoxicillin; Animals; Anti-Ulcer Agents; Colony Count, Microbial; Drug Therapy, Combination; Gastric Mucosa; Gastrins; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Hyperplasia; Microcirculation; Omeprazole; Penicillins; Radioimmunoassay; Somatostatin; Stomach Ulcer; Tinidazole | 2003 |
Type 2 diabetes mellitus affects eradication rate of Helicobacter pylori.
Topics: Amoxicillin; Anti-Ulcer Agents; Case-Control Studies; Clarithromycin; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies | 2003 |
Smoking and polymorphisms of fucosyltransferase gene Le affect success of H. pylori eradication with lansoprazole, amoxicillin, and clarithromycin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Fucosyltransferases; Genotype; Helicobacter pylori; Humans; Lansoprazole; Lewis Blood Group Antigens; Male; Middle Aged; Omeprazole; Polymorphism, Genetic; Prospective Studies; Smoking | 2003 |
Isolated granulomatous gastritis successfully treated by Helicobacter pylori eradication: a possible association between granulomatous gastritis and Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Granuloma; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Middle Aged; Omeprazole | 2003 |
Seven-day proton pump inhibitor, amoxicillin and clarithromycin triple therapy. factors that influence Helicobacter pylori eradications success.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Stomach Ulcer; Sulfoxides | 2003 |
Acid exposure and altered acid clearance in GERD patients treated for Helicobacter pylori infection.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Esophagus; Female; Gastric Acid; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Manometry; Middle Aged; Monitoring, Physiologic; Multivariate Analysis; Omeprazole; Penicillins | 2003 |
A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Glossitis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Penicillins; Prospective Studies; Rabeprazole; Treatment Outcome; Urea | 2003 |
The clinical role of cytochrome p450 genotypes in Helicobacter pylori management.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; DNA; Drug Therapy, Combination; Female; Gastritis; Gastroscopy; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Penicillins; Peptic Ulcer; Pharmacogenetics; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Treatment Outcome | 2003 |
Gastric transitional zones, areas where Helicobacter treatment fails: results of a treatment trial using the Sydney strain mouse model.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Models, Animal; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Metronidazole; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Omeprazole; Organometallic Compounds; Penicillins; Pyloric Antrum | 2003 |
Long-term observation of reflux oesophagitis developing after Helicobacter pylori eradication therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Esophagitis, Peptic; Female; Follow-Up Studies; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies | 2003 |
[Pharmacotherapy in complex treatment of ulcerous stenosis].
Topics: Amoxicillin; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Cimetidine; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Omeprazole; Pyloric Stenosis; Ranitidine; Time Factors | 2003 |
Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Proton Pump Inhibitors; Stomach Ulcer; Treatment Outcome | 2003 |
A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure.
Topics: Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Creatinine; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Failure, Chronic; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Retrospective Studies | 2003 |
Effect of Helicobacter pylori eradicated therapy on water gastric emptying in patients with active duodenal ulcer.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Electric Impedance; Female; Gastric Emptying; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Tomography; Treatment Outcome; Water | 2003 |
Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy.
Topics: Adolescent; Adult; Amoxicillin; Anti-Ulcer Agents; Biopsy; Breath Tests; Clarithromycin; Cohort Studies; DNA, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Peru; Poverty; Random Amplified Polymorphic DNA Technique; Recurrence; Urban Population | 2003 |
Levofloxacin based triple therapy as a second-line treatment after failure of helicobacter pylori eradication with standard triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Failure | 2003 |
Asthma-like syndrome in a teenager.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Albuterol; Amoxicillin; Androstadienes; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Asthma; Benzimidazoles; Bronchi; Bronchodilator Agents; Bronchoscopy; Carcinoid Tumor; Diagnosis, Differential; Drug Therapy, Combination; Fluticasone; Forced Expiratory Flow Rates; Forced Expiratory Volume; Gastroesophageal Reflux; Humans; Immunoglobulin E; Lung Neoplasms; Male; Metronidazole; Omeprazole; Pantoprazole; Radioallergosorbent Test; Respiratory Sounds; Sulfoxides; Syndrome; Tomography, X-Ray Computed; Tuberculin Test; Vital Capacity | 2003 |
[Possible treatment with immune system modulators of patients with pathology of the digestive organs. Informational letter].
Topics: Adjuvants, Immunologic; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antiviral Agents; Drug Therapy, Combination; Gastrointestinal Tract; Humans; Metronidazole; Omeprazole | 2003 |
Retreatment of H. pylori with dual therapy using high doses of rabeprazole or lansoprazole can be effective.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Retreatment; Treatment Outcome | 2003 |
Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection in relation to CYP2C19 genotype.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Duodenal Ulcer; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Stomach Ulcer | 2003 |
Childhood Helicobacter pylori infection, clinical presentations, endoscopic, histologic features and results of treatment.
Topics: Adolescent; Amoxicillin; Child; Child, Preschool; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Metronidazole; Omeprazole; Ranitidine; Retrospective Studies; Treatment Outcome | 2003 |
Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer? Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Cell Transformation, Neoplastic; Clarithromycin; Female; Gastrectomy; Gastric Mucosa; Gastroenterostomy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Neoplasm Recurrence, Local; Omeprazole; Stomach Neoplasms; Treatment Outcome | 2004 |
[Long-term course of reflux symptoms following Helicobacter pylori eradication].
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Esophagitis, Peptic; Female; Follow-Up Studies; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Omeprazole; Peptic Ulcer; Prospective Studies; Time Factors | 2004 |
Helicobacter pylori eradication rate and glycemic control in young patients with type 1 diabetes.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Blood Glucose; Breath Tests; Child; Child, Preschool; Clarithromycin; Diabetes Mellitus, Type 1; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Rabeprazole; Time Factors | 2004 |
Application of Maastricht 2-2000 guidelines for the management of Helicobacter pylori among specialists and primary care physicians in israel: are we missing the malignant potential of Helicobacter pylori?
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Omeprazole; Physicians; Practice Guidelines as Topic; Primary Health Care; Surveys and Questionnaires | 2004 |
The effects of Helicobacter pylori eradication on chemokine production in patients with immune thrombocytopenic purpura.
Topics: Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; Chemokines; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Prednisolone; Purpura, Thrombocytopenic, Idiopathic | 2004 |
Helicobacter pylori: antibiotic resistance and eradication rates in Suffolk, UK, 1991-2001.
Topics: Adult; Age Factors; Amoxicillin; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Prospective Studies; Sex Factors; Time Factors; Treatment Outcome; United Kingdom | 2004 |
Do procalcitonin and C-reactive protein levels have a place in the diagnosis and follow-up of Helicobacter pylori infections?
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biomarkers; Biopsy; C-Reactive Protein; Calcitonin; Calcitonin Gene-Related Peptide; Clarithromycin; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Protein Precursors; Sensitivity and Specificity; Urease | 2004 |
Effect of antibacterial therapy and salivary secretion on the efficacy of Helicobacter pylori eradication in duodenal ulcer patients.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mouth; Omeprazole; Saliva; Sex Factors; Stomach; Tinidazole; Treatment Outcome | 2004 |
Treatment with omeprazole, metronidazole, and amoxicillin in captive South African cheetahs (Acinonyx jubatus) with spiral bacteria infection and gastritis.
Topics: Acinonyx; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter; Helicobacter Infections; Male; Metronidazole; Omeprazole; Prospective Studies; Recurrence; Treatment Outcome | 2004 |
[Successful treatment of long-standing iron-deficiency anemia in adults by eradication of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anemia, Iron-Deficiency; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole | 2004 |
Complete remission of cyclic thrombocytopenia after Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Platelet Count; Remission Induction; Thrombocytopenia | 2004 |
DNA typing for Helicobacter pylori isolates from eradication-failed patients: comparison of the isolates before and after therapy.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; DNA Fingerprinting; DNA, Bacterial; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Polymerase Chain Reaction; Treatment Outcome | 2004 |
Second-line treatment of Helicobacter pylori infection after dilution agar methods and PCR-RFLP analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Clarithromycin; Colony Count, Microbial; DNA, Bacterial; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Stomach Ulcer; Treatment Outcome | 2004 |
Resolution of Helicobacter pylori associated granulomatous gastritis in a child after eradication therapy.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Granuloma; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Treatment Outcome | 2004 |
Triple therapy with pantoprazole, clarithromycin and amoxicillin for eradication in patients with Helicobacter pylori positive duodenal ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Benzimidazoles; Clarithromycin; Developing Countries; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Jordan; Male; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Risk Assessment; Severity of Illness Index; Sulfoxides; Treatment Outcome | 2004 |
Effects of Helicobacter pylori eradication among adults with intellectual disability.
Topics: Adult; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Intellectual Disability; Male; Mental Disorders; Metronidazole; Omeprazole; Outcome Assessment, Health Care; Treatment Outcome | 2004 |
Acute colchicine intoxication during clarithromycin administration.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Colchicine; Drug Interactions; Familial Mediterranean Fever; Gastritis; Gout Suppressants; Helicobacter pylori; Humans; Male; Omeprazole | 2004 |
Eradication of Helicobacter pylori induces apoptosis and inhibits proliferation of heterotopic proliferative glands in infected Mongolian gerbils.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Bacterial Agents; Apoptosis; Cell Proliferation; Choristoma; Clarithromycin; Gastric Mucosa; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Intestines; Lansoprazole; Omeprazole; Stomach | 2004 |
Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Proton Pump Inhibitors | 2004 |
Effect of sucralfate on antibiotic therapy for Helicobacter pylori infection in mice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Area Under Curve; Chemistry, Pharmaceutical; Clarithromycin; Drug Combinations; Female; Gastritis; Half-Life; Helicobacter Infections; Helicobacter pylori; Hydrogen-Ion Concentration; Immunoglobulin G; Lansoprazole; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Omeprazole; Penicillins; Sucralfate; Viscosity | 2004 |
Results of triple eradication therapy in Japanese children: a retrospective multicenter study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Humans; Infant; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Sulfoxides | 2004 |
[The effect of Helicobacter pylori eradication on prokinetic treatment on the quality of life in functional dyspepsia].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Cisapride; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Quality of Life; Ranitidine; Reproducibility of Results; Sulfoxides; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2004 |
Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Retreatment; Time Factors | 2004 |
Standard treatment for Helicobacter pylori infection is suboptimal in non-ulcer dyspepsia compared with duodenal ulcer in Chinese.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Asian People; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Patient Compliance; Treatment Outcome | 2005 |
Amoxicillin resistance in Helicobacter pylori: studies from Tokyo, Japan from 1985 to 2003.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Rabeprazole; Tokyo | 2005 |
Eradication of Helicobacter pylori decreases mucosal alterations linked to gastric carcinogenesis in Mongolian gerbils.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Carcinogenicity Tests; Cell Proliferation; Disease Models, Animal; Drug Therapy, Combination; Epithelial Cells; Gastric Mucosa; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Hypromellose Derivatives; Male; Methylcellulose; Omeprazole; Ophthalmic Solutions; Stomach Neoplasms | 2005 |
Influence of antimicrobial treatment for Helicobacter pylori infection on the intestinal microflora in Japanese macaques.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Infective Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Clarithromycin; Enterobacteriaceae; Enterococcus; Feces; Helicobacter Infections; Helicobacter pylori; Intestines; Lansoprazole; Macaca; Omeprazole; Proton Pump Inhibitors | 2005 |
Helicobacter pylori status and symptom assessment two years after eradication in pediatric patients from a high prevalence area.
Topics: Adolescent; Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Disease Transmission, Infectious; Drug Therapy, Combination; Dyspepsia; Family; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Predictive Value of Tests; Prevalence; Risk Factors; Secondary Prevention; Social Class; Surveys and Questionnaires | 2005 |
Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Gene Rearrangement; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin Heavy Chains; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Omeprazole; Polymerase Chain Reaction; Prognosis; Remission Induction; Stomach Neoplasms | 2005 |
Anti-Helicobacter pylori therapy significantly reduces Helicobacter pylori -induced gastric mucosal damage in Mongolian gerbils.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Lansoprazole; Male; Omeprazole; Specific Pathogen-Free Organisms | 2005 |
[Is anti-helicobacter therapy a rational approach in treatment of erosive and ulcerous lesions of the gastroduodenal mucosa in patients with inflamatory bowel diseases?].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Therapy, Combination; Female; Furazolidone; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Middle Aged; Omeprazole; Organometallic Compounds; Rabeprazole; Time Factors | 2005 |
Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura.
Topics: Amoxicillin; Breath Tests; Clarithromycin; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Middle Aged; Omeprazole; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Treatment Outcome; Urea | 2005 |
Cure rate of high dose omeprazole and amoxicillin therapy for treatment-resistant Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Treatment Outcome | 2005 |
Comparison of proton pump inhibitor-based triple therapy with losec and the generic drug, Omepradex, for efficacy of Helicobacter pylori eradication.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Drugs, Generic; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome | 2005 |
Has Helicobacter pylori eradication therapy any effect on severity of rosacea symptoms?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Rosacea | 2005 |
Effectiveness of omeprazole- versus lansoprazole-based triple therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome | 2005 |
Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anemia, Iron-Deficiency; Antibodies, Bacterial; Autoantibodies; Autoimmune Diseases; Bacterial Proteins; Breath Tests; Celiac Disease; Child; Clarithromycin; Comorbidity; Drug Therapy, Combination; Female; Ferrous Compounds; Gastrins; Gastritis; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Middle Aged; Omeprazole; Parietal Cells, Gastric; Prospective Studies; Urease; Vitamin B 12 Deficiency | 2005 |
[The effect of Helicobacter pylori eradication therapy on bismuth absorption of colloidal bismuth subcitrate].
Topics: Absorption; Amoxicillin; Animals; Antacids; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Kidney; Male; Metronidazole; Omeprazole; Organometallic Compounds; Random Allocation; Rats; Rats, Sprague-Dawley | 2005 |
Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Aryl Hydrocarbon Hydroxylases; Biopsy; Clarithromycin; Colony Count, Microbial; Cytochrome P-450 CYP2C19; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Mutation; Omeprazole; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Bacterial; RNA, Ribosomal, 23S; Treatment Outcome | 2005 |
Helicobacter heilmannii infection: clinical, endoscopic and histopathological features in Japanese patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter heilmannii; Helicobacter Infections; Humans; Japan; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Microscopy, Electron, Transmission; Middle Aged; Omeprazole; Stomach; Treatment Outcome | 2005 |
Ménétrier's disease in a patient with Helicobacter pylori infection is linked to elevated glucagon-like peptide-2 activity.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Gastritis, Hypertrophic; Glucagon-Like Peptide 2; Glucagon-Like Peptides; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Minocycline; Omeprazole; Peptides; Remission Induction | 2005 |
Eradication of Helicobacter spp. from a rat breeding colony.
Topics: Amoxicillin; Animal Feed; Animals; Animals, Laboratory; Clarithromycin; DNA Primers; Electrophoresis, Agar Gel; Feces; Helicobacter; Helicobacter Infections; Metronidazole; Omeprazole; Polymerase Chain Reaction; Rats; RNA, Ribosomal, 16S; Rodent Diseases | 2005 |
Helicobacter pylori eradication decreases the expression of glycosylphosphatidylinositol-anchored complement regulators, decay-accelerating factor and homologous restriction factor 20, in human gastric epithelium.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; CD55 Antigens; CD59 Antigens; Clarithromycin; Complement C3c; Complement Inactivator Proteins; Complement System Proteins; Female; Gastric Mucosa; Gastritis; Glycosylphosphatidylinositols; Helicobacter Infections; Helicobacter pylori; Humans; Male; Membrane Cofactor Protein; Middle Aged; Omeprazole; Peptic Ulcer; Receptors, Complement | 2005 |
Determinants of non-response in Helicobacter pylori eradication trials.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Treatment Failure | 2005 |
Primary mucosa-associated lymphoid tissue lymphoma occurring in the rectum.
Topics: Amoxicillin; Biopsy, Needle; Clarithromycin; Colonoscopy; Drug Therapy, Combination; Endosonography; Female; Follow-Up Studies; Helicobacter Infections; Humans; Immunohistochemistry; Intestinal Mucosa; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Omeprazole; Rectal Neoplasms; Risk Assessment; Treatment Outcome | 2005 |
Altered expression of Skp2, c-Myc and p27 proteins but not mRNA after H. pylori eradication in chronic gastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chronic Disease; Clarithromycin; Cyclin-Dependent Kinase Inhibitor p27; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Interleukin-8; Lansoprazole; Male; Middle Aged; Omeprazole; Proteins; Proto-Oncogene Proteins c-myc; Proton Pump Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; S-Phase Kinase-Associated Proteins | 2006 |
Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Multicenter Studies as Topic; Omeprazole; Organometallic Compounds; Prospective Studies; Severity of Illness Index; Stomach Neoplasms; Survival Analysis; Taiwan; Time Factors; Treatment Outcome | 2005 |
CagA status and Helicobacter pylori eradication among dyspeptic patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Biomarkers; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Enzyme-Linked Immunosorbent Assay; Eosinophilia; Eosinophils; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphocytes; Male; Middle Aged; Omeprazole; Peptic Ulcer | 2005 |
[The cause of failure of eradication treatment of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Patient Compliance; Treatment Outcome | 2005 |
Improvement of gastrointestinal quality of life scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dyspepsia; Female; Gastrointestinal Diseases; Gastrointestinal Motility; Gastrointestinal Tract; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pain Measurement; Quality of Life; Stomach Ulcer; Surveys and Questionnaires | 2005 |
Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Lansoprazole; Male; Omeprazole; Proton Pump Inhibitors; Retrospective Studies; Stomach Ulcer; Treatment Outcome | 2005 |
Nonsecretory variant of immunoproliferative small intestinal disease: a case report with pathologic, immunophenotypic, and molecular findings.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Drug Therapy, Combination; Female; Gene Rearrangement, B-Lymphocyte, Light Chain; Humans; Immunophenotyping; Immunoproliferative Small Intestinal Disease; Intestine, Small; Lymph Nodes; Lymphoma, B-Cell, Marginal Zone; Mesentery; Metronidazole; Omeprazole; Pantoprazole; Retroperitoneal Space; Sulfoxides | 2005 |
Helicobacter pylori: factors affecting eradication and recurrence.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Biological Availability; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Recurrence; Sulfoxides | 2005 |
Rabeprazole containing triple therapy to eradicate Helicobacter pylori infection on the Texas-Mexican border.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Pilot Projects; Rabeprazole; Treatment Failure; Treatment Outcome | 2006 |
Effect of probiotics and triple eradication therapy on the cyclooxygenase (COX)-2 expression, apoptosis, and functional gastric mucosal impairment in Helicobacter pylori-infected Mongolian gerbils.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Apoptosis; bcl-2-Associated X Protein; Cyclooxygenase 2; Gastric Acid; Gastric Mucosa; Gastrins; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Male; Omeprazole; Probiotics; Proto-Oncogene Proteins c-bcl-2; Regional Blood Flow; Somatostatin; Stomach; Stomach Neoplasms; Tinidazole | 2006 |
Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Rifabutin; Sulfoxides; Treatment Outcome | 2006 |
Efficacy of Helicobacter pylori eradication on the chronic mucosal inflammation of the remnant stomach after distal gastrectomy for early gastric cancer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Gastrectomy; Gastric Mucosa; Gastric Stump; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Rabeprazole; Stomach Neoplasms | 2005 |
"Best practice' for Helicobacter pylori eradication in the primary care setting.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Cost-Benefit Analysis; Decision Trees; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Ireland; Omeprazole; Primary Health Care; Rabeprazole | 2006 |
[Pseudomembranous colitis after Helicobacter pylori eradication therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole | 2006 |
Comparison of pantoprazole- vs. omeprazole- based triple therapy regimens in the treatment of Helicobacter pylori infection and duodenal ulcer healing in a Turkish population.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Treatment Outcome | 2005 |
Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients.
Topics: Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Recurrence; Risk Factors; Tetracycline | 2006 |
Helicobacter pylori eradication in peptic dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine | 2005 |
Helicobacter pylori eradication prior to initiation of long-term non-steroidal anti-inflammatory drug therapy in Chinese patients-a cost-effectiveness analysis.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; China; Clarithromycin; Cohort Studies; Cost-Benefit Analysis; Diclofenac; Drug Administration Schedule; Female; Health Care Costs; Health Services; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Randomized Controlled Trials as Topic; Risk Factors | 2006 |
Primary cutaneous MALT-type lymphoma and Helicobacter pylori: a possible relationship.
Topics: Adult; Amoxicillin; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Omeprazole; Skin Neoplasms | 2006 |
[Long term results of treatment by simple surgical closure of perforated gastroduodenal ulcer followed by eradication of Helicobacter pylori].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer Perforation; Randomized Controlled Trials as Topic; Recurrence; Tetracycline; Time Factors | 2006 |
Management of the dyspeptic patient: anything goes?
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Denmark; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prevalence; Surveys and Questionnaires; Treatment Outcome | 2006 |
The Efficacy of Helicobacter pylori eradication in the treatment of idiopathic thrombocytopenic purpura--the first study in Turkey.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Purpura, Thrombocytopenic, Idiopathic; Turkey | 2006 |
Complete regression of low-grade mucosa-associated lymphoid tissue (MALT) lymphoma in the gastric stump after eradication of Helicobacter pylori.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Omeprazole; Remission Induction; Stomach Neoplasms | 2006 |
Triple levofloxacin-based rescue therapy is an accepted empirical third-line treatment.
Topics: Amoxicillin; Ampicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Omeprazole; Protein Synthesis Inhibitors; Tetracycline; Treatment Failure | 2006 |
[Prospective study of 420 biopsies realised in patients with duodenal ulcer with positive Helicobacter pylori].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Biopsy; Duodenal Ulcer; Duodenum; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metaplasia; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Stomach | 2006 |
Efficacy of two triple eradication regimens in children with Helicobacter pylori infection.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Bismuth; Child; Child, Preschool; Clarithromycin; Drug Combinations; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Retrospective Studies; Salicylates; Treatment Outcome | 2006 |
Eradication therapy in Helicobacter pylori-positive patients with halitosis: long-term outcome.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Gastroscopy; Halitosis; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Middle Aged; Omeprazole; Statistics, Nonparametric; Surveys and Questionnaires; Treatment Outcome | 2007 |
Adverse events reporting.
Topics: Abdominal Pain; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Fatigue; Femoral Fractures; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Paresthesia; Perceptual Disorders; Terminology as Topic; Vision, Low | 2007 |
Comparison of two invasive diagnostic tests for Helicobacter pylori after antimicrobial therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Pyloric Antrum; Sensitivity and Specificity; Treatment Outcome; Urease | 2007 |
[Helicobacter pylori infection and eradication are not related to glycosylated hemoglobin levels (HbA1c) in young patients with type 1 diabetes].
Topics: Adolescent; Adult; Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Follow-Up Studies; Glycated Hemoglobin; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Prevalence; Sex Factors; Socioeconomic Factors; Time Factors | 2007 |
[Characteristics of a combined course of duodenal ulcer and gastroesophageal reflux disease].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antidepressive Agents, Second-Generation; Clarithromycin; Duodenal Ulcer; Gastric Acidity Determination; Gastroesophageal Reflux; Heartburn; Humans; Hydrogen-Ion Concentration; Omeprazole; Psychophysiologic Disorders; Sulpiride | 2007 |
Helicobacter pylori recurrence and infection rate in Israeli adults.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Breath Tests; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Male; Middle Aged; Omeprazole; Prognosis; Prospective Studies; Recurrence; Surveys and Questionnaires | 2008 |
A quintuple therapy for H. pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactoferrin; Male; Middle Aged; Omeprazole; Probiotics; Treatment Outcome | 2007 |
An alternative salvage regimen for Helicobacter pylori-resistant patients with heart failure.
Topics: Amoxicillin; Anti-Bacterial Agents; Comorbidity; Drug Therapy, Combination; Heart Failure; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Proton Pump Inhibitors | 2008 |
Failure of sequential therapy to eradicate Helicobacter pylori in previously treated subjects.
Topics: Adolescent; Adult; Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Tinidazole; Treatment Failure | 2007 |
[Duodenal ulcer and helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Ulcer; Duodenoscopy; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole | 2007 |
[Sequential therapy regimen for Helicobacter pylori infection in children].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Multicenter Studies as Topic; Omeprazole; Prospective Studies; Time Factors | 2008 |
[Effect of Helicobacter pylori eradication on iron deficiency anemia of unknown origin].
Topics: Adult; Aged; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Combined Modality Therapy; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Absorption; Iron; Male; Middle Aged; Omeprazole; Prospective Studies; Remission Induction | 2008 |
Chronic urticaria and Helicobacter pylori.
Topics: Adolescent; Adult; Amoxicillin; Case-Control Studies; Chronic Disease; Comorbidity; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; India; Male; Metronidazole; Middle Aged; Omeprazole; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Urticaria; Young Adult | 2008 |
[Palpable purpura with severe pruritus].
Topics: Aged; Amoxicillin; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Prognosis; Pruritus; Purpura; Vasculitis, Leukocytoclastic, Cutaneous | 2008 |
Short-term triple therapy with azithromycin for Helicobacter pylori eradication: low cost, high compliance, but low efficacy.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Azithromycin; Brazil; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Peptic Ulcer; Treatment Outcome | 2008 |
A rapid lateral flow stool antigen immunoassay and (14)C-urea breath test for the diagnosis and eradication of Helicobacter pylori infection in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Breath Tests; Carbon Dioxide; Carbon Radioisotopes; Child; Child, Preschool; Clarithromycin; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunoassay; Male; Omeprazole; Sensitivity and Specificity | 2008 |
Triple therapy-based targeted nanoparticles for the treatment of Helicobacter pylori.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Gliadin; Helicobacter Infections; Helicobacter pylori; Lectins; Male; Mice; Nanoparticles; Omeprazole; Time Factors | 2008 |
Levofloxacin, Amoxicillin, and Omeprazole as first-line triple therapy for Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter pylori; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Omeprazole; Patient Compliance; Treatment Outcome | 2009 |
[Comparison of Helicobacter pylori eradication rate in patients with non-ulcer dyspepsia and peptic ulcer diseases according to proton pump inhibitors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Data Interpretation, Statistical; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole | 2008 |
Effects of helicobacter pylori eradication on chronic nonspecific pharyngeal symptoms.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Chronic Disease; Cohort Studies; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Patient Satisfaction; Pharyngeal Diseases; Probability; Prognosis; Prospective Studies; Reference Values; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 2008 |
Amoxicillin, clarithromycin, and omeprazole based targeted nanoparticles for the treatment of H. pylori.
Topics: Amoxicillin; Animals; Cells, Cultured; Chitosan; Clarithromycin; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Stability; Female; Glutamic Acid; Helicobacter Infections; Helicobacter pylori; Male; Mice; Nanoparticles; Omeprazole; Random Allocation | 2009 |
Helicobacter pylori infection in patients with chronic urticaria: correlation with pathologic findings in gastric biopsies.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Biopsy; Case-Control Studies; Chronic Disease; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Severity of Illness Index; Stomach; Urticaria | 2009 |
Parotid mucosa-associated lymphoid tissue lymphoma regression after Helicobacter pylori eradication.
Topics: Amoxicillin; Biopsy, Needle; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Lymphoma, B-Cell, Marginal Zone; Magnetic Resonance Imaging; Middle Aged; Mucous Membrane; Neoplasm Recurrence, Local; Neoplasm Staging; Omeprazole; Parotid Neoplasms; Radionuclide Imaging; Rare Diseases; Risk Assessment; Treatment Outcome | 2009 |
[Antihelicobacteric therapy for the patients with recurrent complicated postoperative gastroduodenal ulcer: indications, principles of conduction, efficacy].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Combinations; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Recurrence; Treatment Outcome | 2009 |
[Effect of eradication therapy on nitrogen oxide activity in the gastric juice of patients with chronic gastritis and ulcer disease].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Juice; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Nitric Oxide; Omeprazole; Proton Pump Inhibitors | 2009 |
Importance of CYP2C19 genetic polymorphism in the eradication of Helicobacter pylori in north Indians.
Topics: Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; India; Omeprazole; Phenotype; Polymorphism, Genetic; Tinidazole; Treatment Outcome | 2009 |
Efficacy of standard triple therapy in the treatment of Helicobacter pylori infection: experience from Kuwait.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Kuwait; Male; Middle Aged; Omeprazole; Treatment Outcome | 2010 |
Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Immunoproliferative Small Intestinal Disease; Lansoprazole; Male; Omeprazole; Organometallic Compounds; Tinidazole; Young Adult | 2010 |
Rescue therapy using a rifabutin-based regimen is effective for cure of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Rifabutin; Treatment Outcome | 2010 |
Second-line and rescue therapies for Helicobacter pylori eradication in clinical practice.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Male; Medication Adherence; Middle Aged; Ofloxacin; Omeprazole; Practice Guidelines as Topic; Proton Pump Inhibitors; Rifabutin; Time Factors; Treatment Failure | 2010 |
Helicobacter pylori eradication with a 7-day low-dose triple therapy in hemodialysis patients.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Renal Dialysis; Treatment Outcome | 2010 |
Quadruple therapy with ecabet sodium, omeprazole, amoxicillin and metronidazole is effective for eradication of Helicobacter pylori after failure of first-line therapy (KDOG0201 Study).
Topics: Abietanes; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Pilot Projects; Treatment Outcome | 2010 |
Infection: Bismuth improves PPI-based triple therapy for H. pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; China; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Treatment Outcome | 2010 |
De novo erosive esophagitis in duodenal ulcer patients related to pre-existing reflux symptoms, smoking, and patient age, but not to Helicobacter pylori eradication: a one-year follow-up study.
Topics: Adult; Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Data Interpretation, Statistical; Drug Therapy, Combination; Duodenal Ulcer; Esophagitis; Female; Follow-Up Studies; Gastroesophageal Reflux; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Multivariate Analysis; Omeprazole; Prognosis; Ranitidine; Smoking; Stomach; Time Factors | 2010 |
[Dynamics of regeneration of epitheliocytes from gastric mucosa at different modes of antirelapse treatment of ulcer disease].
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Epithelial Cells; Gastric Mucosa; Helicobacter pylori; Humans; Ki-67 Antigen; Melatonin; Middle Aged; Omeprazole; Proto-Oncogene Proteins c-bcl-2; Secondary Prevention; Young Adult | 2010 |
The efficacy and safety of long-term Helicobacter species quadruple therapy in asymptomatic cats with naturally acquired infection.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Clarithromycin; DNA, Bacterial; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Male; Metronidazole; Omeprazole; Stomach; Treatment Outcome | 2011 |
Antibiotic susceptibility patterns of Helicobacter pylori and triple therapy in a high-prevalence area.
Topics: Adolescent; Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Gastrointestinal Diseases; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pakistan; Prevalence; Statistics as Topic; Stomach Ulcer; Treatment Outcome; Young Adult | 2010 |
The efficacy of a 1-week triple therapy for eradication of Helicobacter pylori infection in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Helicobacter Infections; Humans; Male; Omeprazole; Treatment Outcome | 2011 |
Helicobacter pylori associated with chronic urticaria.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Omeprazole; Treatment Outcome; Urticaria | 2011 |
[Primary antibiotic resistance of Helicobacter pylori strains and eradication rate according to gastroduodenal disease in Korea].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Republic of Korea; Stomach Neoplasms | 2011 |
Cure of alopecia areata after eradication of Helicobacter pylori: a new association?
Topics: Adult; Alopecia Areata; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Dyspepsia; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole | 2011 |
[Characteristics of duodenogastric reflux in duodenal ulcer patients and its dynamics after Helicobacter pylori eradication].
Topics: Adult; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Duodenogastric Reflux; Female; Follow-Up Studies; Gastric Acid; Gastric Acidity Determination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Recurrence; Time Factors; Treatment Outcome | 2011 |
[The effects of pronase on drugs concentrations for treatment of Helicobacter pylori infection in gastric tissue].
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Metronidazole; Mice; Mice, Inbred C57BL; Omeprazole; Pronase | 2011 |
Seeking an optimal eradication therapy for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Asian People; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Proton Pump Inhibitors; Proton Pumps | 2012 |
[Gastric MALT lymphoma: anatomo-clinical data and outcome of early stage H. pylori-associated gastric MALT-lymphoma resistant to treatment].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antineoplastic Combined Chemotherapy Protocols; Data Collection; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Neoplasm Staging; Omeprazole; Prognosis; Retrospective Studies; Stomach Neoplasms; Treatment Outcome | 2011 |
Is quadruple therapy the new triple therapy for H pylori?
Topics: Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Tetracycline | 2012 |
Mucosal barrier defects in gastric intestinal metaplasia: in vivo evaluation by confocal endomicroscopy.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metaplasia; Microscopy, Confocal; Microscopy, Electron; Middle Aged; Omeprazole; Permeability; Statistics, Nonparametric | 2012 |
To compare the efficacy of triple therapy with furazolidone, amoxicillin and omeprazole for two weeks and three weeks in the eradication of Helicobacter pylori in Bangladeshi duodenal ulcer patients.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bangladesh; Drug Therapy, Combination; Duodenal Ulcer; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Young Adult | 2011 |
Usefulness of antimicrobial susceptibility in the eradication of Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cohort Studies; Cost-Benefit Analysis; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Retrospective Studies; Treatment Outcome | 2013 |
Second-line therapy with levofloxacin after failure of treatment to eradicate helicobacter pylori infection: time trends in a Spanish Multicenter Study of 1000 patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Logistic Models; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Ofloxacin; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Remission Induction; Spain; Surveys and Questionnaires; Time Factors; Treatment Failure | 2013 |
Recurrence of Helicobacter pylori After Eradication in Patients with Peptic Ulcer.
Topics: Amoxicillin; Anti-Bacterial Agents; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Ofloxacin; Omeprazole | 2012 |
Factors modulating the outcome of treatment for the eradication of Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Proteins; Biopsy; Drug Resistance, Bacterial; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Peptic Ulcer; Treatment Outcome | 2012 |
Severe hypoglycemia from Helicobacter pylori triple-drug therapy and insulin detemir drug interaction.
Topics: Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Interactions; Drug Therapy, Combination; Helicobacter Infections; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin Detemir; Insulin, Long-Acting; Male; Omeprazole | 2013 |
Prevalence of Helicobacter pylori and its recurrence after successful eradication in a developing nation (Morocco).
Topics: Adult; Amoxicillin; Anti-Infective Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Developing Countries; Drug Therapy, Combination; Educational Status; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Hospitals, University; Humans; Lost to Follow-Up; Male; Medication Adherence; Metronidazole; Middle Aged; Morocco; Omeprazole; Prevalence; Prospective Studies; Proton Pump Inhibitors; Recurrence; Urea; Urease; Young Adult | 2013 |
Overexpression of YKL-40 predicts plaque instability in carotid atherosclerosis with CagA-positive Helicobacter pylori infection.
Topics: Adipokines; Aged; Amoxicillin; Animals; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Biomarkers; C-Reactive Protein; Carotid Arteries; Carotid Artery Diseases; Case-Control Studies; Chitinase-3-Like Protein 1; Clarithromycin; Drug Therapy, Combination; Female; Gene Expression; Helicobacter Infections; Humans; Lectins; Male; Middle Aged; Omeprazole; Plaque, Atherosclerotic; Rabbits; Up-Regulation | 2013 |
Bismuth + metronidazole + tetracycline. Why risk adding bismuth?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Combinations; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Tetracycline | 2013 |
Trends of second-line eradication therapy for Helicobacter pylori in Japan: a multicenter study in the Tokyo metropolitan area.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Retrospective Studies; Tokyo; Young Adult | 2013 |
[Effect of schemes second line quadruple therapy on interactions of some protective factors in gastric mucosal tissue in experimental ulcer].
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Disease Models, Animal; Drug Therapy, Combination; Gastric Mucosa; Male; Nitric Oxide; Omeprazole; Organometallic Compounds; Rats; Stomach Ulcer; Tetracycline | 2013 |
[Trends in the eradication rates of Helicobacter pylori infection in Daegu and Gyeongsangbuk-do, Korea: multicenter study over 13 years].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disease Eradication; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Republic of Korea; Retrospective Studies; Treatment Outcome | 2014 |
Efficacy and pharmacological mechanism of pronase-enhanced low-dose antibiotics for Helicobacter pylori eradication.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Pronase; Stomach | 2014 |
Effects of Helicobacter pylori treatment on gastric cancer incidence and mortality in subgroups.
Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Logistic Models; Male; Middle Aged; Odds Ratio; Omeprazole; Precancerous Conditions; Proportional Hazards Models; Randomized Controlled Trials as Topic; Stomach Neoplasms; Treatment Outcome | 2014 |
[State of mucosal barrier of the stomach after Helicobacter pylori eradication and ulcer healing in patients with duodenal ulcer disease].
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biomarkers; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Digestive System; Female; Gastric Juice; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Treatment Outcome; Young Adult | 2013 |
Gastritis due to Helicobacter pylori, an unusual cause of chronic diarrhoea in HIV infected patients.
Topics: Aged; Amoxicillin; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Breath Tests; Chronic Disease; Clarithromycin; Diarrhea; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; HIV Infections; HIV-1; Humans; Male; Middle Aged; Omeprazole | 2014 |
Helicobacter pylori is not eradicated after triple therapy: a nested PCR based study.
Topics: Adenosine Triphosphate; Adult; Aged; Aged, 80 and over; Amoxicillin; Bacterial Proteins; Biopsy; Breath Tests; Chaperonin 60; Clarithromycin; DNA, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Phosphoglucomutase; Polymerase Chain Reaction; Sequence Analysis, DNA; Sigma Factor; Urease; Young Adult | 2014 |
Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group).
Topics: Amoxicillin; Chronic Disease; Clarithromycin; Disease Eradication; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Time Factors; Tokyo | 2014 |
Akkermansia muciniphila and Helicobacter typhlonius modulate intestinal tumor development in mice.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Carcinogenesis; Clarithromycin; Drug Therapy, Combination; Female; Gastrointestinal Microbiome; Goblet Cells; Helicobacter; Helicobacter Infections; Intestinal Neoplasms; Intestines; Male; Metronidazole; Mice, Inbred C57BL; Omeprazole; Verrucomicrobia | 2015 |
Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Longitudinal Studies; Metronidazole; Omeprazole; Prospective Studies; Rifabutin; Tetracycline; Treatment Failure | 2015 |
Looking for the interactions between omeprazole and amoxicillin in a disordered phase. An experimental and theoretical study.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Interactions; Magnetic Resonance Spectroscopy; Models, Molecular; Omeprazole; Powder Diffraction; Proton Pump Inhibitors; Quantum Theory; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2016 |
Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Polymorphism, Restriction Fragment Length; Proton Pump Inhibitors; Rabeprazole; Young Adult | 2016 |
Influence of CYP2C19 on Helicobacter pylori eradication in Brazilian patients with functional dyspepsia.
Topics: Adult; Aged; Amoxicillin; Brazil; Clarithromycin; Cytochrome P-450 CYP2C19; Dyspepsia; Endoscopy, Gastrointestinal; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Inactivation, Metabolic; Male; Middle Aged; Omeprazole; Polymorphism, Single Nucleotide | 2016 |
Helicobacter pylori in esplenectomized patients with immune primary trombocytopenia
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Platelet Count; Proton Pump Inhibitors; Purpura, Thrombocytopenic, Idiopathic; Splenectomy; Treatment Outcome | 2017 |
Eradication of Helicobacter pylori infection was associated with complete cure of resistant bleeding per gums.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Stomatognathic Diseases | 2018 |
Effect of Helicobacter pylori Treatment on Unexplained Iron Deficiency Anemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; California; Causality; Clarithromycin; Cohort Studies; Comorbidity; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Retrospective Studies; Young Adult | 2019 |
Digoxin toxicity precipitated by Helicobacter pylori eradication therapy.
Topics: Acute Kidney Injury; Aged, 80 and over; Amoxicillin; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Atrial Fibrillation; Bradycardia; Bundle-Branch Block; Clarithromycin; Digoxin; Drug Interactions; Electrocardiography; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hyperkalemia; Immunoglobulin Fab Fragments; Omeprazole; Tachycardia, Ventricular | 2019 |
Population Scale Retrospective Analysis Reveals Potential Risk of Cholestasis in Pregnant Women Taking Omeprazole, Lansoprazole, and Amoxicillin.
Topics: Adolescent; Adult; Amoxicillin; Child; Cholestasis; Drug Therapy, Combination; Female; Humans; Lansoprazole; Male; Middle Aged; Odds Ratio; Omeprazole; Pregnancy; Retrospective Studies; Risk Factors; Young Adult | 2019 |
Tailored Helicobacter pylori eradication based on prior intake of macrolide antibiotics allows the use of triple therapy with optimal results in an area with high clarithromycin resistance.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Electronic Health Records; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Macrolides; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Quinolones; Tetracycline; Young Adult | 2019 |
Effect of Drug Combination on Omeprazole Metabolism by Cytochrome P450 2C19 in Helicobacter pylori Eradication Therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Combinations; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Structure; Omeprazole; Tinidazole | 2019 |
[Helicobacter pylori infection in the HIV + population: a comorbidity to think about].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Ulcer Agents; Clarithromycin; Comorbidity; Drug Therapy, Combination; Dyspepsia; Female; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; HIV Infections; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Retrospective Studies; Spain | 2020 |
Comparison of four different regimens against Helicobacter pylori as a first-line treatment: A prospective, cross-sectional, comparative, open trial in Chinese children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Bismuth; Breath Tests; Child; China; Clarithromycin; Cross-Sectional Studies; Cytochrome P-450 CYP3A Inhibitors; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Prospective Studies; Proton Pump Inhibitors | 2020 |
Gastroprotective effect of phytoncide extract from Pinus koraiensis pinecone in Helicobacter pylori infection.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Proteins; Chromatography, High Pressure Liquid; Clarithromycin; Cytokines; DNA, Bacterial; Drug Evaluation, Preclinical; Flowers; Gastric Mucosa; Gastritis; Glycyrrhiza; Helicobacter Infections; Helicobacter pylori; Immunoglobulin G; Male; Mice; Mice, Inbred C57BL; Monoterpenes; Omeprazole; Pinus; Plant Extracts; Specific Pathogen-Free Organisms | 2020 |
Talicia - a 3-drug combination for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Combinations; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Proton Pump Inhibitors; Rifabutin | 2020 |
Helicobacter pylori and antibiotic resistance in the pediatric population: an update from Vietnam.
Topics: Amoxicillin; Bismuth; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Probiotics; Proton Pump Inhibitors; Vietnam | 2020 |
Rifabutin triple therapy increased
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Patients; Rifabutin | 2020 |
Recent Developments Pertaining to H. pylori Infection.
Topics: Adenocarcinoma; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Practice Guidelines as Topic; Proton Pump Inhibitors; Pyrroles; Rifabutin; Stomach Neoplasms; Sulfonamides; Tetracycline; Treatment Outcome | 2021 |
The influence of P-glycoprotein expression in the standard treatment of Helicobacter pylori infection in Sprague Dawley rats.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clarithromycin; Cyclosporine; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Male; Omeprazole; Proton Pump Inhibitors; Rats, Sprague-Dawley; Rifampin; Stomach Ulcer | 2021 |
Gastric mucosal changes, and sex differences therein, after Helicobacter pylori eradication: A long-term prospective follow-up study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Atrophy; Clarithromycin; Female; Follow-Up Studies; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metaplasia; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Sex Factors; Young Adult | 2021 |
RP-HPLC-DAD Method Development and Validation for Simultaneous Determination of Lansoprazole, Tinidazole, Amoxicillin, and Naproxen in Their Raw Materials and Combined Dosage Form: DOE Approach for Optimization of the Proposed Method.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Naproxen; Omeprazole; Research Design; Tinidazole | 2022 |
Helicobacter pylori resistance to antibiotics before and after treatment: Incidence of eradication failure.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Protein Synthesis Inhibitors; Tetracycline | 2022 |
Clinical effect of Anwei Qingyou recipe on peptic ulcer and its effect on the levels of EGF and PGE2: A retrospective study.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dinoprostone; Drug Therapy, Combination; Epidermal Growth Factor; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Retrospective Studies | 2022 |
Diagnosis and treatment patterns among patients with newly diagnosed Helicobacter pylori infection in the United States 2016-2019.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Proton Pump Inhibitors | 2023 |
Gastro-Protective and Therapeutic Effect of Punica granatum against Stomach Ulcer Caused by Helicobacter Pylori.
Topics: Amoxicillin; Animals; Helicobacter Infections; Helicobacter pylori; Omeprazole; Pomegranate; Rats; Stomach Ulcer; Ulcer | 2023 |